MOLECULE_NAME,MECHANISM_OF_ACTION,TARGET_NAME
Levocabastine,Histamine H1 receptor antagonist,Histamine H1 receptor
Fluphenazine Enanthate,Dopamine D2 receptor antagonist,Dopamine D2 receptor
Triflupromazine,Dopamine D2 receptor antagonist,Dopamine D2 receptor
Propranolol,Beta-1 adrenergic receptor antagonist,Beta-1 adrenergic receptor
Metoprolol,Beta-1 adrenergic receptor antagonist,Beta-1 adrenergic receptor
Aripiprazole,Serotonin 1a (5-HT1a) receptor partial agonist,Serotonin 1a (5-HT1a) receptor
Monobenzone,Tyrosinase inhibitor,Tyrosinase
Insulin Susp Isophane Beef/Pork,Insulin receptor agonist,Insulin receptor
Insulin Lispro,Insulin receptor agonist,Insulin receptor
Almotriptan,Serotonin 1d (5-HT1d) receptor agonist,Serotonin 1d (5-HT1d) receptor
Olanzapine,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Methixene,Serotonin 2c (5-HT2c) receptor antagonist,Serotonin 2c (5-HT2c) receptor
Remifentanil,Mu opioid receptor agonist,Mu opioid receptor
Diazoxide,"Potassium channel, inwardly rectifying, subfamily J, member 8 opener","Potassium channel, inwardly rectifying, subfamily J, member 8"
Doxycycline,Matrix metalloproteinase-1 inhibitor,Matrix metalloproteinase-1
Regorafenib,Tyrosine-protein kinase TIE-2 inhibitor,Tyrosine-protein kinase TIE-2
Roflumilast,Phosphodiesterase 4 inhibitor,Phosphodiesterase 4
Mirtazapine,Adrenergic receptor alpha-2 antagonist,Adrenergic receptor alpha-2
Levonordefrin,Adrenergic receptor alpha-2 agonist,Adrenergic receptor alpha-2
Aminosalicylic Acid,Cyclooxygenase inhibitor,Cyclooxygenase
Olsalazine,Cyclooxygenase inhibitor,Cyclooxygenase
Clevidipine,Voltage-gated L-type calcium channel blocker,Voltage-gated L-type calcium channel
Verapamil,Voltage-gated L-type calcium channel blocker,Voltage-gated L-type calcium channel
Pindolol,Beta-2 adrenergic receptor partial agonist,Beta-2 adrenergic receptor
Albendazole,Tubulin inhibitor,Tubulin
Tioconazole,Cytochrome P450 51 inhibitor,Cytochrome P450 51
Posaconazole,Cytochrome P450 51 inhibitor,Cytochrome P450 51
Darifenacin,Muscarinic acetylcholine receptor M2 antagonist,Muscarinic acetylcholine receptor M2
Fomepizole,Alcohol dehydrogenase class I inhibitor,Alcohol dehydrogenase class I
Deferasirox,Iron chelating agent,Iron
Bexarotene,Retinoid X receptor agonist,Retinoid X receptor
Sulfisoxazole Acetyl,Bacterial dihydropteroate synthase inhibitor,Bacterial dihydropteroate synthase
Imipenem,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Pyrethrins,Voltage-sensitive sodium channel alpha-subunit blocker,Voltage-sensitive sodium channel alpha-subunit
Telavancin,Cell outer membrane inhibitor,Cell outer membrane
Decitabine,DNA inhibitor,DNA
Carphenazine,Dopamine D2 receptor antagonist,Dopamine D2 receptor
Sevoflurane,Potassium channel subfamily K member 9 opener,Potassium channel subfamily K member 9
Methsuximide,Voltage-gated T-type calcium channel blocker,Voltage-gated T-type calcium channel
Cryptenamine Tannates,Unknown,
Bay-1125976,Serine/threonine-protein kinase AKT inhibitor,Serine/threonine-protein kinase AKT
Ce-245677,Tyrosine-protein kinase TIE-2 inhibitor,Tyrosine-protein kinase TIE-2
Msc-2363318a,Serine/threonine-protein kinase AKT3 inhibitor,Serine/threonine-protein kinase AKT3
Sad448,Cannabinoid CB1 receptor agonist,Cannabinoid CB1 receptor
Vantictumab,Frizzled-1 antagonist,Frizzled-1
Prs-211375,Cannabinoid CB2 receptor agonist,Cannabinoid CB2 receptor
Pratosartan,Solute carrier family 22 member 8 inhibitor,Solute carrier family 22 member 8
Donitriptan,Serotonin 1b (5-HT1b) receptor agonist,Serotonin 1b (5-HT1b) receptor
Incb-9471,C-C chemokine receptor type 5 antagonist,C-C chemokine receptor type 5
Cobimetinib,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,Dual specificity mitogen-activated protein kinase kinase 1
Otenabant,Cannabinoid CB1 receptor antagonist,Cannabinoid CB1 receptor
Siponimod,Sphingosine 1-phosphate receptor Edg-1 agonist,Sphingosine 1-phosphate receptor Edg-1
Dupilumab,Interleukin-4 receptor subunit alpha antagonist,Interleukin-4 receptor subunit alpha
Ridaforolimus,Serine/threonine-protein kinase mTOR inhibitor,Serine/threonine-protein kinase mTOR
Evacetrapib,Cholesteryl ester transfer protein inhibitor,Cholesteryl ester transfer protein
Lonafarnib,Protein farnesyltransferase inhibitor,Protein farnesyltransferase
Ertugliflozin,Sodium/glucose cotransporter 2 inhibitor,Sodium/glucose cotransporter 2
Prexasertib,Serine/threonine-protein kinase Chk1 inhibitor,Serine/threonine-protein kinase Chk1
Begelomab,Dipeptidyl peptidase IV inhibitor,Dipeptidyl peptidase IV
Bavituximab,Phosphatidylserine inhibitor,Phosphatidylserine
Mln-1202,C-C chemokine receptor type 2 antagonist,C-C chemokine receptor type 2
Ame-133v,Integrin beta-2 inhibitor,Integrin beta-2
81c6,Tenascin binding agent,Tenascin
L19tnfa,Fibronectin binding agent,Fibronectin
Perindopril,Angiotensin-converting enzyme inhibitor,Angiotensin-converting enzyme
Thiothixene,Dopamine D2 receptor antagonist,Dopamine D2 receptor
Olmesartan Medoxomil,Type-1 angiotensin II receptor antagonist,Type-1 angiotensin II receptor
Insulin Purified Beef,Insulin receptor agonist,Insulin receptor
Loxapine,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Anisindione,Vitamin K-dependent gamma-carboxylase inhibitor,Vitamin K-dependent gamma-carboxylase
Levorphanol,Mu opioid receptor agonist,Mu opioid receptor
Dihydrocodeine,Mu opioid receptor agonist,Mu opioid receptor
Prednisone,Glucocorticoid receptor agonist,Glucocorticoid receptor
Betamethasone Acetate,Glucocorticoid receptor agonist,Glucocorticoid receptor
Pazopanib,Fibroblast growth factor receptor 3 inhibitor,Fibroblast growth factor receptor 3
Mifepristone,Progesterone receptor antagonist,Progesterone receptor
Atorvastatin,HMG-CoA reductase inhibitor,HMG-CoA reductase
Memantine,Glutamate [NMDA] receptor negative allosteric modulator,Glutamate [NMDA] receptor
Guanabenz,Adrenergic receptor alpha-2 agonist,Adrenergic receptor alpha-2
Bicalutamide,Androgen Receptor antagonist,Androgen Receptor
Nadolol,Beta-2 adrenergic receptor antagonist,Beta-2 adrenergic receptor
Imiquimod,Toll-like receptor 7 agonist,Toll-like receptor 7
Sulconazole,Cytochrome P450 51 inhibitor,Cytochrome P450 51
Ganciclovir,Human herpesvirus 1 DNA polymerase inhibitor,Human herpesvirus 1 DNA polymerase
Yttrium Y 90 Ibritumomab Tiuxetan,B-lymphocyte antigen CD20 binding agent,B-lymphocyte antigen CD20
Pancuronium,Muscle-type nicotinic acetylcholine receptor antagonist,Muscle-type nicotinic acetylcholine receptor
Enflurane,GABA-A receptor; anion channel positive modulator,GABA-A receptor; anion channel
Benzylpenicillin,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Malathion,Acetylcholinesterase inhibitor,Acetylcholinesterase
Dirithromycin,Bacterial 70S ribosome inhibitor,Bacterial 70S ribosome
Interferon Alfa-2a,Interferon alpha/beta receptor agonist,Interferon alpha/beta receptor
Bleomycin,DNA inhibitor,DNA
Niclosamide,DNA inhibitor,DNA
Lidocaine,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Pyrvinium,Unknown,
Parathyroid Hormone,Parathyroid hormone receptor agonist,Parathyroid hormone receptor
Dapagliflozin,Sodium/glucose cotransporter 2 inhibitor,Sodium/glucose cotransporter 2
Alirocumab,Subtilisin/kexin type 9 inhibitor,Subtilisin/kexin type 9
Evolocumab,Subtilisin/kexin type 9 inhibitor,Subtilisin/kexin type 9
Mln-0128,Serine/threonine-protein kinase mTOR inhibitor,Serine/threonine-protein kinase mTOR
Cudc-101,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Hm-71224,Tyrosine-protein kinase BTK inhibitor,Tyrosine-protein kinase BTK
Prt-2607,Tyrosine-protein kinase SYK inhibitor,Tyrosine-protein kinase SYK
Rg-7376,Serine/threonine-protein kinase RAF inhibitor,Serine/threonine-protein kinase RAF
Zd-4190,Vascular endothelial growth factor receptor 2 inhibitor,Vascular endothelial growth factor receptor 2
Qaf805,Adenosine A2b receptor antagonist,Adenosine A2b receptor
Irampanel,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Cp-778875,Peroxisome proliferator-activated receptor alpha agonist,Peroxisome proliferator-activated receptor alpha
Naveglitazar,Peroxisome proliferator-activated receptor alpha agonist,Peroxisome proliferator-activated receptor alpha
Crenolanib,Platelet-derived growth factor receptor inhibitor,Platelet-derived growth factor receptor
Insm-18,Receptor protein-tyrosine kinase erbB-2 inhibitor,Receptor protein-tyrosine kinase erbB-2
Ipatasertib,Serine/threonine-protein kinase AKT inhibitor,Serine/threonine-protein kinase AKT
Sar-407899,Rho-associated protein kinase inhibitor,Rho-associated protein kinase
Sb-649868,Orexin receptor 1 antagonist,Orexin receptor 1
Barusiban,Oxytocin receptor antagonist,Oxytocin receptor
Gw468816,Glutamate [NMDA] receptor antagonist,Glutamate [NMDA] receptor
Av-101,Glutamate [NMDA] receptor antagonist,Glutamate [NMDA] receptor
Ama0076,Rho-associated protein kinase inhibitor,Rho-associated protein kinase
Dasolampanel,Glutamate receptor ionotropic kainate 1 antagonist,Glutamate receptor ionotropic kainate 1
Barasertib,Serine/threonine-protein kinase Aurora-B inhibitor,Serine/threonine-protein kinase Aurora-B
Tanezumab,Beta-nerve growth factor inhibitor,Beta-nerve growth factor
Crolibulin,Tubulin inhibitor,Tubulin
Veliparib,"PARP 1, 2 and 3 inhibitor","PARP 1, 2 and 3"
Mifamurtide,Nucleotide-binding oligomerization domain-containing protein 2 other,Nucleotide-binding oligomerization domain-containing protein 2
Tarenflurbil,Gamma-secretase modulator,Gamma-secretase
Begacestat,Gamma-secretase inhibitor,Gamma-secretase
Vildagliptin,Dipeptidyl peptidase IV inhibitor,Dipeptidyl peptidase IV
Liafensine,Monoamine transporter inhibitor,Monoamine transporter
Selurampanel,Glutamate receptor ionotropic kainate antagonist,Glutamate receptor ionotropic kainate
Zanolimumab,T-cell surface antigen CD4 other,T-cell surface antigen CD4
Methocarbamol,Carbonic anhydrase I inhibitor,Carbonic anhydrase I
Acetazolamide,Carbonic anhydrase II inhibitor,Carbonic anhydrase II
Epinastine,Histamine H1 receptor antagonist,Histamine H1 receptor
Avanafil,Phosphodiesterase 5A inhibitor,Phosphodiesterase 5A
Aripiprazole,Dopamine D2 receptor partial agonist,Dopamine D2 receptor
Carbidopa,DOPA decarboxylase inhibitor,DOPA decarboxylase
Latanoprost,Prostanoid FP receptor agonist,Prostanoid FP receptor
Desoxycorticosterone Acetate,Mineralocorticoid receptor agonist,Mineralocorticoid receptor
Dexmethylphenidate,Dopamine transporter inhibitor,Dopamine transporter
Hydrocortisone Valerate,Glucocorticoid receptor agonist,Glucocorticoid receptor
Sucralfate,Pepsin A inhibitor,Pepsin A
Halofantrine,Ferriprotoporphyrin IX inhibitor,Ferriprotoporphyrin IX
Ulipristal Acetate,Progesterone receptor modulator,Progesterone receptor
Nicotine,Neuronal acetylcholine receptor; alpha4/beta2 agonist,Neuronal acetylcholine receptor; alpha4/beta2
Dyphylline,Phosphodiesterase 4 inhibitor,Phosphodiesterase 4
Rifaximin,Bacterial DNA-directed RNA polymerase inhibitor,Bacterial DNA-directed RNA polymerase
Docosanol,Envelope glycoprotein inhibitor,Envelope glycoprotein
Mafenide,Bacterial dihydropteroate synthase inhibitor,Bacterial dihydropteroate synthase
Methacycline,Bacterial 70S ribosome inhibitor,Bacterial 70S ribosome
Cysteamine,Cystine reducing agent,Cystine
Phenacemide,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Asparaginase,Asparagine hydrolytic enzyme,Asparagine
Pd-0166285,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Msx-122,C-X-C chemokine receptor type 4 antagonist,C-X-C chemokine receptor type 4
Aee-788,Vascular endothelial growth factor receptor 1 inhibitor,Vascular endothelial growth factor receptor 1
Brigatinib,ALK tyrosine kinase receptor inhibitor,ALK tyrosine kinase receptor
Ci-1040,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,Dual specificity mitogen-activated protein kinase kinase 2
Tandutinib,Tyrosine-protein kinase receptor FLT3 inhibitor,Tyrosine-protein kinase receptor FLT3
Pg-760564,MAP kinase p38 alpha inhibitor,MAP kinase p38 alpha
(7s)-Hydroxyl-Staurosporine,Cyclin-dependent kinase 4 inhibitor,Cyclin-dependent kinase 4
X-82,Platelet-derived growth factor receptor inhibitor,Platelet-derived growth factor receptor
Xl-999,Fibroblast growth factor receptor inhibitor,Fibroblast growth factor receptor
Sb-649868,Orexin receptor 2 antagonist,Orexin receptor 2
Nelotanserin,Serotonin 2a (5-HT2a) receptor inverse agonist,Serotonin 2a (5-HT2a) receptor
Brivanib,Fibroblast growth factor receptor inhibitor,Fibroblast growth factor receptor
Ritobegron,Beta-3 adrenergic receptor agonist,Beta-3 adrenergic receptor
Onartuzumab,Hepatocyte growth factor receptor antagonist,Hepatocyte growth factor receptor
Apricoxib,Cyclooxygenase-2 inhibitor,Cyclooxygenase-2
Polmacoxib,Cyclooxygenase-2 inhibitor,Cyclooxygenase-2
Guselkumab,Interleukin-23 subunit alpha inhibitor,Interleukin-23 subunit alpha
Ertumaxomab,Receptor protein-tyrosine kinase erbB-2 other,Receptor protein-tyrosine kinase erbB-2
Quilizumab,Ig epsilon chain C region inhibitor,Ig epsilon chain C region
Edobacomab,Lipopolysaccharide (LPS) other,Lipopolysaccharide (LPS)
Dipraglurant,Metabotropic glutamate receptor 5 modulator,Metabotropic glutamate receptor 5
Tm30339,Neuropeptide Y receptor type 4 agonist,Neuropeptide Y receptor type 4
Fesoterodine,Muscarinic acetylcholine receptor M3 antagonist,Muscarinic acetylcholine receptor M3
Darbepoetin Alfa,Erythropoietin receptor agonist,Erythropoietin receptor
Golimumab,TNF-alpha inhibitor,TNF-alpha
Temsirolimus,FK506-binding protein 1A inhibitor,FK506-binding protein 1A
Clofibrate,Peroxisome proliferator-activated receptor alpha agonist,Peroxisome proliferator-activated receptor alpha
Testolactone,Cytochrome P450 19A1 inhibitor,Cytochrome P450 19A1
Eletriptan,Serotonin 1d (5-HT1d) receptor agonist,Serotonin 1d (5-HT1d) receptor
Carphenazine,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Ziprasidone,Serotonin 2c (5-HT2c) receptor antagonist,Serotonin 2c (5-HT2c) receptor
Decitabine,DNA (cytosine-5)-methyltransferase 3A inhibitor,DNA (cytosine-5)-methyltransferase 3A
Anileridine,Mu opioid receptor agonist,Mu opioid receptor
Dezocine,Mu opioid receptor partial agonist,Mu opioid receptor
Topiramate,Glutamate receptor ionotropic AMPA antagonist,Glutamate receptor ionotropic AMPA
"Estrogens, Esterified",Estrogen receptor agonist,Estrogen receptor
Omeprazole,Potassium-transporting ATPase inhibitor,Potassium-transporting ATPase
Tamsulosin,Adrenergic receptor alpha-1 antagonist,Adrenergic receptor alpha-1
Caspofungin,"1,3-beta-glucan synthase inhibitor","1,3-beta-glucan synthase"
Saquinavir,Human immunodeficiency virus type 1 protease inhibitor,Human immunodeficiency virus type 1 protease
Triazolam,GABA-A receptor; anion channel positive allosteric modulator,GABA-A receptor; anion channel
Carbenicillin Indanyl,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Amoxicillin,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Dacarbazine,DNA inhibitor,DNA
Norfloxacin,Bacterial DNA gyrase inhibitor,Bacterial DNA gyrase
Cytarabine,DNA polymerase (alpha/delta/epsilon) inhibitor,DNA polymerase (alpha/delta/epsilon)
Fludarabine Phosphate,DNA polymerase (alpha/delta/epsilon) inhibitor,DNA polymerase (alpha/delta/epsilon)
Chloroprocaine,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Thioridazine,D2-like dopamine receptor antagonist,D2-like dopamine receptor
Phenyl Aminosalicylate,Unknown,
Polidocanol,Unknown,
Riboflavin 5'-Phosphate,Unknown,
Sodium Phosphate,Unknown,
Riociguat,Soluble guanylate cyclase positive allosteric modulator,Soluble guanylate cyclase
Mk-1496,Serine/threonine-protein kinase PLK1 inhibitor,Serine/threonine-protein kinase PLK1
Panulisib,Serine/threonine-protein kinase receptor R3 inhibitor,Serine/threonine-protein kinase receptor R3
Rgb-286638,Cyclin-dependent kinase 9 inhibitor,Cyclin-dependent kinase 9
Ro-4987655,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,Dual specificity mitogen-activated protein kinase kinase 1
Scio-323,MAP kinase p38 alpha inhibitor,MAP kinase p38 alpha
Tak-733,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,Dual specificity mitogen-activated protein kinase kinase 2
Zyh7,Peroxisome proliferator-activated receptor alpha agonist,Peroxisome proliferator-activated receptor alpha
Ave8134,Peroxisome proliferator-activated receptor alpha agonist,Peroxisome proliferator-activated receptor alpha
Sotrastaurin,Protein kinase C (PKC) inhibitor,Protein kinase C (PKC)
Aee-788,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Azm-475271,Tyrosine-protein kinase ABL inhibitor,Tyrosine-protein kinase ABL
Elzasonan,Serotonin 1d (5-HT1d) receptor antagonist,Serotonin 1d (5-HT1d) receptor
Bay1067197,Adenosine A1 receptor agonist,Adenosine A1 receptor
Tc-6987,Neuronal acetylcholine receptor protein alpha-7 subunit agonist,Neuronal acetylcholine receptor protein alpha-7 subunit
Altinicline,Neuronal acetylcholine receptor; alpha4/beta2 agonist,Neuronal acetylcholine receptor; alpha4/beta2
Neratinib,Receptor protein-tyrosine kinase erbB-2 inhibitor,Receptor protein-tyrosine kinase erbB-2
Baricitinib,Tyrosine-protein kinase JAK1 inhibitor,Tyrosine-protein kinase JAK1
Vatalanib,Macrophage colony stimulating factor receptor inhibitor,Macrophage colony stimulating factor receptor
Orantinib,Fibroblast growth factor receptor inhibitor,Fibroblast growth factor receptor
Naluzotan,Serotonin 1a (5-HT1a) receptor agonist,Serotonin 1a (5-HT1a) receptor
Dalcetrapib,Cholesteryl ester transfer protein inhibitor,Cholesteryl ester transfer protein
Dabigatran,Thrombin inhibitor,Thrombin
Vosaroxin,DNA topoisomerase II inhibitor,DNA topoisomerase II
Di17e6,Integrin alpha-V/beta-5 inhibitor,Integrin alpha-V/beta-5
Carlumab,C-C motif chemokine 2 inhibitor,C-C motif chemokine 2
Teneliximab,Tumor necrosis factor receptor superfamily member 5 partial agonist,Tumor necrosis factor receptor superfamily member 5
Placulumab,TNF-alpha inhibitor,TNF-alpha
Trandolapril,Angiotensin-converting enzyme inhibitor,Angiotensin-converting enzyme
Azatadine,Histamine H1 receptor antagonist,Histamine H1 receptor
Hydroxyzine,Histamine H1 receptor antagonist,Histamine H1 receptor
Adalimumab,TNF-alpha inhibitor,TNF-alpha
Benzquinamide,Dopamine D2 receptor modulator,Dopamine D2 receptor
Panitumumab,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Trihexyphenidyl,Muscarinic acetylcholine receptor M1 antagonist,Muscarinic acetylcholine receptor M1
Furosemide,Sodium-(potassium)-chloride cotransporter 2 inhibitor,Sodium-(potassium)-chloride cotransporter 2
Sumatriptan,Serotonin 1b (5-HT1b) receptor agonist,Serotonin 1b (5-HT1b) receptor
Frovatriptan,Serotonin 1d (5-HT1d) receptor agonist,Serotonin 1d (5-HT1d) receptor
Asenapine,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Trazodone,Serotonin 2c (5-HT2c) receptor antagonist,Serotonin 2c (5-HT2c) receptor
Raloxifene,Estrogen receptor beta modulator,Estrogen receptor beta
Modafinil,Dopamine transporter inhibitor,Dopamine transporter
Amoxapine,Norepinephrine transporter inhibitor,Norepinephrine transporter
Dydrogesterone,Progesterone receptor agonist,Progesterone receptor
Trastuzumab Emtansine,Tubulin inhibitor,Tubulin
Pazopanib,Platelet-derived growth factor receptor inhibitor,Platelet-derived growth factor receptor
Abciximab,Integrin alpha-V/beta-3 inhibitor,Integrin alpha-V/beta-3
Terbinafine,Squalene monooxygenase inhibitor,Squalene monooxygenase
Mazindol,Monoamine transporter inhibitor,Monoamine transporter
Alprazolam,GABA-A receptor; anion channel positive allosteric modulator,GABA-A receptor; anion channel
Topiramate,GABA-A receptor; anion channel positive modulator,GABA-A receptor; anion channel
Cefmenoxime,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Ertapenem,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Clindamycin Phosphate,Bacterial 70S ribosome inhibitor,Bacterial 70S ribosome
Tigecycline,Bacterial 70S ribosome inhibitor,Bacterial 70S ribosome
Tetracycline,Bacterial 70S ribosome inhibitor,Bacterial 70S ribosome
Ethanolamine Oleate,Calcium chelating agent,Calcium
Cyclophosphamide,DNA inhibitor,DNA
Daunorubicin,DNA inhibitor,DNA
Gabapentin,Voltage-gated calcium channel modulator,Voltage-gated calcium channel
Sevoflurane,Potassium channel subfamily K member 18 opener,Potassium channel subfamily K member 18
Gadoxetic Acid,Unknown,
Estramustine Phosphate,DNA inhibitor,DNA
Azd-7451,Neurotrophic tyrosine kinase receptor type 2 inhibitor,Neurotrophic tyrosine kinase receptor type 2
Bms-387032,Cyclin-dependent kinase 2 inhibitor,Cyclin-dependent kinase 2
Ono-4059,Tyrosine-protein kinase BTK inhibitor,Tyrosine-protein kinase BTK
Pki-179,Serine/threonine-protein kinase mTOR inhibitor,Serine/threonine-protein kinase mTOR
Tg-02,Cyclin-dependent kinase 1 inhibitor,Cyclin-dependent kinase 1
Wx-554,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,Dual specificity mitogen-activated protein kinase kinase 2
Cipralisant,Histamine H3 receptor agonist,Histamine H3 receptor
Pimasertib,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,Dual specificity mitogen-activated protein kinase kinase 2
Sapitinib,Receptor tyrosine-protein kinase erbB-3 inhibitor,Receptor tyrosine-protein kinase erbB-3
Solcitinib,Tyrosine-protein kinase JAK1 inhibitor,Tyrosine-protein kinase JAK1
Kw-2450,Insulin receptor inhibitor,Insulin receptor
Ly-2090314,Glycogen synthase kinase-3 beta inhibitor,Glycogen synthase kinase-3 beta
Riviciclib,Cyclin-dependent kinase 4 inhibitor,Cyclin-dependent kinase 4
Pf-03446962,Serine/threonine-protein kinase receptor R3 inhibitor,Serine/threonine-protein kinase receptor R3
Tg100-115,PI3-kinase p110-gamma subunit inhibitor,PI3-kinase p110-gamma subunit
Etilevodopa,Dopamine D3 receptor agonist,Dopamine D3 receptor
Naronapride,Serotonin 4 (5-HT4) receptor agonist,Serotonin 4 (5-HT4) receptor
Navarixin,Interleukin-8 receptor A antagonist,Interleukin-8 receptor A
Ubrogepant,Calcitonin gene-related peptide type 1 receptor antagonist,Calcitonin gene-related peptide type 1 receptor
Gsk239512,Histamine H3 receptor antagonist,Histamine H3 receptor
Palosuran,Urotensin II receptor antagonist,Urotensin II receptor
Etalocib,Leukotriene B4 receptor 1 antagonist,Leukotriene B4 receptor 1
Fe 202767,Oxytocin receptor agonist,Oxytocin receptor
Ispronicline,Neuronal acetylcholine receptor; alpha4/beta2 partial agonist,Neuronal acetylcholine receptor; alpha4/beta2
R428,Tyrosine-protein kinase receptor UFO inhibitor,Tyrosine-protein kinase receptor UFO
Canertinib,Receptor protein-tyrosine kinase erbB-4 inhibitor,Receptor protein-tyrosine kinase erbB-4
Linsitinib,Insulin receptor inhibitor,Insulin receptor
Pacritinib,Tyrosine-protein kinase JAK2 inhibitor,Tyrosine-protein kinase JAK2
Senicapoc,Intermediate conductance calcium-activated potassium channel protein 4 blocker,Intermediate conductance calcium-activated potassium channel protein 4
Gaboxadol,GABA-A receptor; agonist GABA site agonist,GABA-A receptor; agonist GABA site
Echothiophate,Acetylcholinesterase inhibitor,Acetylcholinesterase
Talimogene Laherparepvec,Melanoma cells disrupting agent,Melanoma cells
Tezacitabine,Ribonucleoside-diphosphate reductase RR1 inhibitor,Ribonucleoside-diphosphate reductase RR1
Sagopilone,Tubulin stabiliser,Tubulin
Pradigastat,Diacylglycerol O-acyltransferase 1 inhibitor,Diacylglycerol O-acyltransferase 1
Crisaborole,Phosphodiesterase 4 inhibitor,Phosphodiesterase 4
Atacicept,Tumor necrosis factor ligand superfamily member 13B inhibitor,Tumor necrosis factor ligand superfamily member 13B
Tadocizumab,Integrin alpha-IIb/beta-3 antagonist,Integrin alpha-IIb/beta-3
Ban2401,Beta amyloid A4 protein inhibitor,Beta amyloid A4 protein
Gsk159802,Beta-2 adrenergic receptor agonist,Beta-2 adrenergic receptor
Lithium Carbonate,Inositol-1(or 4)-monophosphatase 1 inhibitor,Inositol-1(or 4)-monophosphatase 1
Enalaprilat,Angiotensin-converting enzyme inhibitor,Angiotensin-converting enzyme
Spirapril,Angiotensin-converting enzyme inhibitor,Angiotensin-converting enzyme
Eprosartan,Type-1 angiotensin II receptor antagonist,Type-1 angiotensin II receptor
Torsemide,Sodium-(potassium)-chloride cotransporter 2 inhibitor,Sodium-(potassium)-chloride cotransporter 2
Dolasetron,Serotonin 3a (5-HT3a) receptor antagonist,Serotonin 3a (5-HT3a) receptor
Citalopram,Serotonin transporter inhibitor,Serotonin transporter
Pasireotide,Somatostatin receptor 1 agonist,Somatostatin receptor 1
Pioglitazone,Peroxisome proliferator-activated receptor gamma agonist,Peroxisome proliferator-activated receptor gamma
Betazole,Histamine H2 receptor agonist,Histamine H2 receptor
Buspirone,Serotonin 1a (5-HT1a) receptor partial agonist,Serotonin 1a (5-HT1a) receptor
Insulin Zinc Susp Purified Beef/Pork,Insulin receptor agonist,Insulin receptor
Loperamide,Mu opioid receptor agonist,Mu opioid receptor
Triamcinolone Acetonide,Glucocorticoid receptor agonist,Glucocorticoid receptor
Fluorometholone,Glucocorticoid receptor agonist,Glucocorticoid receptor
Rasagiline,Monoamine oxidase B inhibitor,Monoamine oxidase B
Polyestradiol Phosphate,Estrogen receptor alpha agonist,Estrogen receptor alpha
Natalizumab,Integrin alpha-4/beta-7 inhibitor,Integrin alpha-4/beta-7
Glyburide,"Sulfonylurea receptor 1, Kir6.2 blocker","Sulfonylurea receptor 1, Kir6.2"
Dronedarone,Voltage-gated L-type calcium channel blocker,Voltage-gated L-type calcium channel
Dantrolene,Ryanodine receptor 3 antagonist,Ryanodine receptor 3
Piperazine Citrate,Nematode GABA-A receptor positive modulator,Nematode GABA-A receptor
Amprenavir,Human immunodeficiency virus type 1 protease inhibitor,Human immunodeficiency virus type 1 protease
Lypressin,Vasopressin receptor agonist,Vasopressin receptor
Sulfacetamide,Bacterial dihydropteroate synthase inhibitor,Bacterial dihydropteroate synthase
Cephapirin,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Chloramphenicol,Bacterial 70S ribosome inhibitor,Bacterial 70S ribosome
Mechlorethamine,DNA inhibitor,DNA
Idarubicin,DNA inhibitor,DNA
Ciprofloxacin,Bacterial DNA gyrase inhibitor,Bacterial DNA gyrase
Lurasidone,Dopamine D2 receptor antagonist,Dopamine D2 receptor
Troleandomycin,70S ribosome inhibitor,70S ribosome
Guanidine,Voltage-gated potassium channel blocker,Voltage-gated potassium channel
Tromethamine,Unknown,
Azelaic Acid,Unknown,
Brexpiprazole,Serotonin 1a (5-HT1a) receptor partial agonist,Serotonin 1a (5-HT1a) receptor
Sugammadex,Rocuronium sequestering agent,Rocuronium
Doramapimod,MAP kinase p38 alpha inhibitor,MAP kinase p38 alpha
Ct-1578,Tyrosine-protein kinase receptor FLT3 inhibitor,Tyrosine-protein kinase receptor FLT3
Gdc-0994,MAP kinase ERK2 inhibitor,MAP kinase ERK2
Jnj-26483327,Tyrosine-protein kinase FYN inhibitor,Tyrosine-protein kinase FYN
Rp-6530,PI3-kinase p110-delta subunit inhibitor,PI3-kinase p110-delta subunit
Rp-6530,PI3-kinase p110-gamma subunit inhibitor,PI3-kinase p110-gamma subunit
Tak-901,Serine/threonine-protein kinase Aurora-B inhibitor,Serine/threonine-protein kinase Aurora-B
Bpi-9016,Tyrosine-protein kinase receptor UFO inhibitor,Tyrosine-protein kinase receptor UFO
Apd334,Sphingosine 1-phosphate receptor Edg-1 agonist,Sphingosine 1-phosphate receptor Edg-1
Ordopidine,Dopamine D2 receptor modulator,Dopamine D2 receptor
Apn1125,Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist,Neuronal acetylcholine receptor protein alpha-7 subunit
Amg-337,Hepatocyte growth factor receptor inhibitor,Hepatocyte growth factor receptor
Varlitinib,Receptor protein-tyrosine kinase erbB-2 inhibitor,Receptor protein-tyrosine kinase erbB-2
Dactolisib,Serine/threonine-protein kinase mTOR inhibitor,Serine/threonine-protein kinase mTOR
Bms-690514,Receptor protein-tyrosine kinase erbB-4 inhibitor,Receptor protein-tyrosine kinase erbB-4
Seliciclib,Cyclin-dependent kinase 2 inhibitor,Cyclin-dependent kinase 2
Foretinib,Platelet-derived growth factor receptor inhibitor,Platelet-derived growth factor receptor
Tesevatinib,Receptor protein-tyrosine kinase erbB-2 inhibitor,Receptor protein-tyrosine kinase erbB-2
Azd2207,Cannabinoid CB1 receptor antagonist,Cannabinoid CB1 receptor
Tarafenacin,Muscarinic acetylcholine receptor M3 antagonist,Muscarinic acetylcholine receptor M3
Imetelstat Sodium,Telomerase reverse transcriptase inhibitor,Telomerase reverse transcriptase
Delamanid,Mycobacterium tuberculosis H37Rv inhibitor,Mycobacterium tuberculosis H37Rv
Fasiglifam,Free fatty acid receptor 1 positive allosteric modulator,Free fatty acid receptor 1
Pardoprunox,Serotonin 1a (5-HT1a) receptor agonist,Serotonin 1a (5-HT1a) receptor
Conbercept,Vascular endothelial growth factor A inhibitor,Vascular endothelial growth factor A
Clazakizumab,Interleukin-6 inhibitor,Interleukin-6
Tucotuzumab Celmoleukin,Epithelial cell adhesion molecule other,Epithelial cell adhesion molecule
Mlnm-2201,Integrin beta-2 inhibitor,Integrin beta-2
Sch-708980,Interleukin-10 inhibitor,Interleukin-10
Iph-2101,Killer cell immunoglobulin-like receptor 2DL2 inhibitor,Killer cell immunoglobulin-like receptor 2DL2
Dasatinib,Platelet-derived growth factor receptor beta inhibitor,Platelet-derived growth factor receptor beta
Insulin Zinc Susp Prompt Purified Pork,Insulin receptor agonist,Insulin receptor
Insulin Zinc Susp Purified Beef,Insulin receptor agonist,Insulin receptor
Iloperidone,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Cyclobenzaprine,Serotonin 2c (5-HT2c) receptor antagonist,Serotonin 2c (5-HT2c) receptor
Glucagon,Glucagon receptor agonist,Glucagon receptor
Nimodipine,Mineralocorticoid receptor antagonist,Mineralocorticoid receptor
Diflorasone Diacetate,Glucocorticoid receptor agonist,Glucocorticoid receptor
Budesonide,Glucocorticoid receptor agonist,Glucocorticoid receptor
Zoledronic Acid,Farnesyl diphosphate synthase inhibitor,Farnesyl diphosphate synthase
Ibandronic Acid,Farnesyl diphosphate synthase inhibitor,Farnesyl diphosphate synthase
Diflunisal,Cyclooxygenase inhibitor,Cyclooxygenase
Tolbutamide,"Sulfonylurea receptor 1, Kir6.2 blocker","Sulfonylurea receptor 1, Kir6.2"
Levobunolol,Beta-2 adrenergic receptor antagonist,Beta-2 adrenergic receptor
Fosaprepitant,Neurokinin 1 receptor antagonist,Neurokinin 1 receptor
Foscarnet,Human herpesvirus 1 DNA polymerase inhibitor,Human herpesvirus 1 DNA polymerase
Rapacuronium,Muscle-type nicotinic acetylcholine receptor antagonist,Muscle-type nicotinic acetylcholine receptor
Methoxyflurane,Glycine receptor (alpha-1/beta) agonist,Glycine receptor (alpha-1/beta)
Moxifloxacin,Topoisomerase IV inhibitor,Topoisomerase IV
Cefotaxime,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Succimer,Lead chelating agent,Lead
Thiotepa,DNA inhibitor,DNA
Adefovir Dipivoxil,DNA polymerase/reverse transcriptase inhibitor,DNA polymerase/reverse transcriptase
Mexiletine,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Chlorpromazine,D2-like dopamine receptor antagonist,D2-like dopamine receptor
Risperidone,Dopamine D2 receptor antagonist,Dopamine D2 receptor
Levofloxacin,Topoisomerase IV inhibitor,Topoisomerase IV
Cryptenamine Acetates,Unknown,
Tyloxapol,Surfactant agent,
Dienogest,Unknown,
Procaine Benzylpenicillin,Unknown,
Finafloxacin,DNA gyrase inhibitor,DNA gyrase
Deoxycholic Acid,Cell membrane disrupting agent,Cell membrane
Daratumumab,Lymphocyte differentiation antigen CD38 inhibitor,Lymphocyte differentiation antigen CD38
Ast-487,Tyrosine-protein kinase receptor RET inhibitor,Tyrosine-protein kinase receptor RET
Azd-1208,Serine/threonine-protein kinase PIM inhibitor,Serine/threonine-protein kinase PIM
Azd-8330,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,Dual specificity mitogen-activated protein kinase kinase 1
Ds-7423,PI3-kinase class I inhibitor,PI3-kinase class I
Pf-00477736,Serine/threonine-protein kinase Chk1 inhibitor,Serine/threonine-protein kinase Chk1
Tas-119,Serine/threonine-protein kinase Aurora-A inhibitor,Serine/threonine-protein kinase Aurora-A
Ly2881835,Free fatty acid receptor 1 agonist,Free fatty acid receptor 1
Rg7185,G protein-coupled receptor 44 antagonist,G protein-coupled receptor 44
Palovarotene,Retinoic acid receptor gamma agonist,Retinoic acid receptor gamma
Telatinib,Vascular endothelial growth factor receptor 2 inhibitor,Vascular endothelial growth factor receptor 2
Enmd-2076,Stem cell growth factor receptor inhibitor,Stem cell growth factor receptor
Mgcd-265,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Riviciclib,Cyclin-dependent kinase 1 inhibitor,Cyclin-dependent kinase 1
Gw842166x,Cannabinoid CB2 receptor agonist,Cannabinoid CB2 receptor
Burixafor,C-X-C chemokine receptor type 4 antagonist,C-X-C chemokine receptor type 4
Lesogaberan,GABA-B receptor 1 agonist,GABA-B receptor 1
Ssr180711,Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist,Neuronal acetylcholine receptor protein alpha-7 subunit
Aleglitazar,Peroxisome proliferator-activated receptor alpha agonist,Peroxisome proliferator-activated receptor alpha
Tesaglitazar,Peroxisome proliferator-activated receptor alpha agonist,Peroxisome proliferator-activated receptor alpha
Quizartinib,Tyrosine-protein kinase receptor FLT3 inhibitor,Tyrosine-protein kinase receptor FLT3
Lestaurtinib,NT-3 growth factor receptor inhibitor,NT-3 growth factor receptor
Anamorelin,Ghrelin receptor agonist,Ghrelin receptor
Terutroban,Thromboxane A2 receptor antagonist,Thromboxane A2 receptor
Flindokalner,Voltage-gated potassium channel subunit Kv7.5 activator,Voltage-gated potassium channel subunit Kv7.5
Brodalumab,Interleukin-17 receptor A antagonist,Interleukin-17 receptor A
Rucaparib,"PARP 1, 2 and 3 inhibitor","PARP 1, 2 and 3"
Bimagrumab,Activin receptor type-2B antagonist,Activin receptor type-2B
Anrukinzumab,Interleukin-13 inhibitor,Interleukin-13
Aselizumab,Leukocyte adhesion molecule-1 inhibitor,Leukocyte adhesion molecule-1
Erlizumab,Integrin beta-2 negative modulator,Integrin beta-2
L19sip,Fibronectin other,Fibronectin
Artemisinin,Unknown,
Axomadol,Kappa opioid receptor agonist,Kappa opioid receptor
Protirelin,Thyrotropin-releasing hormone receptor agonist,Thyrotropin-releasing hormone receptor
Triprolidine,Histamine H1 receptor antagonist,Histamine H1 receptor
Leuprolide,Gonadotropin-releasing hormone receptor agonist,Gonadotropin-releasing hormone receptor
Leflunomide,Dihydroorotate dehydrogenase inhibitor,Dihydroorotate dehydrogenase
Hydrocortisone Cypionate,Glucocorticoid receptor agonist,Glucocorticoid receptor
Hydrocortisone Acetate,Glucocorticoid receptor agonist,Glucocorticoid receptor
Ursodiol,Bile acid receptor FXR agonist,Bile acid receptor FXR
Ethinyl Estradiol,Estrogen receptor alpha agonist,Estrogen receptor alpha
Trilostane,3-beta-hydroxysteroid dehydrogenase/delta 5-->4-isomerase type II inhibitor,3-beta-hydroxysteroid dehydrogenase/delta 5-->4-isomerase type II
Ponatinib,Breakpoint cluster region protein inhibitor,Breakpoint cluster region protein
Ribavirin,Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor,Hepatitis C virus NS5B RNA-dependent RNA polymerase
Aflibercept,Placenta growth factor inhibitor,Placenta growth factor
Theophylline,Phosphodiesterase 3 inhibitor,Phosphodiesterase 3
Etoposide,DNA topoisomerase II inhibitor,DNA topoisomerase II
Vidarabine,Human herpesvirus 1 DNA polymerase inhibitor,Human herpesvirus 1 DNA polymerase
Dinoprostone,Prostaglandin E2 receptor agonist,Prostaglandin E2 receptor
Cephalothin,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Cefdinir,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
"Fibrinolysin, Human",Fibrinogen inhibitor,Fibrinogen
Isoflurane,Potassium channel subfamily K member 9 opener,Potassium channel subfamily K member 9
Fidaxomicin,DNA-directed RNA polymerase inhibitor,DNA-directed RNA polymerase
Vortioxetine,Serotonin 3a (5-HT3a) receptor antagonist,Serotonin 3a (5-HT3a) receptor
Ibrutinib,Tyrosine-protein kinase BTK inhibitor,Tyrosine-protein kinase BTK
Oritavancin,Peptidoglycan inhibitor,Peptidoglycan
Empagliflozin,Sodium/glucose cotransporter 2 inhibitor,Sodium/glucose cotransporter 2
Lanthanum Carbonate,Phosphate sequestering agent,Phosphate
Pasireotide,Somatostatin receptor 1 agonist,Somatostatin receptor 1
Tenofovir Alafenamide,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,Human immunodeficiency virus type 1 reverse transcriptase
Cudc-907,PI3-kinase p110-beta subunit inhibitor,PI3-kinase p110-beta subunit
Nms-1286937,Serine/threonine-protein kinase PLK1 inhibitor,Serine/threonine-protein kinase PLK1
Sc-80036,MAP kinase p38 alpha inhibitor,MAP kinase p38 alpha
Sf-1126,PI3-kinase class I inhibitor,PI3-kinase class I
Tak-960,Serine/threonine-protein kinase PLK1 inhibitor,Serine/threonine-protein kinase PLK1
Tas-115,Hepatocyte growth factor receptor inhibitor,Hepatocyte growth factor receptor
Abt-102,Vanilloid receptor antagonist,Vanilloid receptor
Gsk1482160,P2X purinoceptor 7 negative allosteric modulator,P2X purinoceptor 7
Avl-3288,Neuronal acetylcholine receptor protein alpha-7 subunit positive allosteric modulator,Neuronal acetylcholine receptor protein alpha-7 subunit
Mk-7246,G protein-coupled receptor 44 antagonist,G protein-coupled receptor 44
Cx1739,Glutamate receptor ionotropic AMPA positive allosteric modulator,Glutamate receptor ionotropic AMPA
Afimoxifene,Estrogen-related receptor gamma antagonist,Estrogen-related receptor gamma
At-9283,Serine/threonine-protein kinase Aurora-A inhibitor,Serine/threonine-protein kinase Aurora-A
Bms-690514,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Lucitanib,Fibroblast growth factor receptor 1 inhibitor,Fibroblast growth factor receptor 1
Acalisib,PI3-kinase p110-delta subunit inhibitor,PI3-kinase p110-delta subunit
Galunisertib,TGF-beta receptor type I inhibitor,TGF-beta receptor type I
Tandutinib,Platelet-derived growth factor receptor beta inhibitor,Platelet-derived growth factor receptor beta
Osi-632,Vascular endothelial growth factor receptor 2 inhibitor,Vascular endothelial growth factor receptor 2
(7s)-Hydroxyl-Staurosporine,3-phosphoinositide dependent protein kinase-1 inhibitor,3-phosphoinositide dependent protein kinase-1
Krp203,Sphingosine 1-phosphate receptor Edg-1 agonist,Sphingosine 1-phosphate receptor Edg-1
Azd5672,C-C chemokine receptor type 5 antagonist,C-C chemokine receptor type 5
Amp579,Adenosine A1 receptor agonist,Adenosine A1 receptor
Rivenprost,Prostanoid EP4 receptor agonist,Prostanoid EP4 receptor
Tabimorelin,Ghrelin receptor agonist,Ghrelin receptor
Modimelanotide,Melanocortin receptor 1 agonist,Melanocortin receptor 1
Acumapimod,MAP kinase p38 alpha inhibitor,MAP kinase p38 alpha
Azd1305,Voltage-gated L-type calcium channel blocker,Voltage-gated L-type calcium channel
Aqw051,Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist,Neuronal acetylcholine receptor protein alpha-7 subunit
Mapracorat,Glucocorticoid receptor agonist,Glucocorticoid receptor
Muraglitazar,Peroxisome proliferator-activated receptor gamma agonist,Peroxisome proliferator-activated receptor gamma
Lestaurtinib,Neurotrophic tyrosine kinase receptor type 2 inhibitor,Neurotrophic tyrosine kinase receptor type 2
Dinaciclib,Cyclin-dependent kinase 9 inhibitor,Cyclin-dependent kinase 9
Pacritinib,Tyrosine-protein kinase receptor FLT3 inhibitor,Tyrosine-protein kinase receptor FLT3
Pridopidine,Dopamine D2 receptor modulator,Dopamine D2 receptor
Grazoprevir,"Hepatitis C virus serine protease, NS3/NS4A inhibitor","Hepatitis C virus serine protease, NS3/NS4A"
Omarigliptin,Dipeptidyl peptidase IV inhibitor,Dipeptidyl peptidase IV
Niraparib,Poly [ADP-ribose] polymerase-1 inhibitor,Poly [ADP-ribose] polymerase-1
Pegsunercept,TNF-alpha inhibitor,TNF-alpha
Ar-20.5,Mucin-1 other,Mucin-1
Amg-108,Interleukin-1 receptor antagonist,Interleukin-1 receptor
Landogrozumab,Growth/differentiation factor 8 inhibitor,Growth/differentiation factor 8
Rg-7304,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,Dual specificity mitogen-activated protein kinase kinase 2
Darifenacin,Muscarinic acetylcholine receptor M3 antagonist,Muscarinic acetylcholine receptor M3
Aprotinin,Plasminogen inhibitor,Plasminogen
Fosinopril,Angiotensin-converting enzyme inhibitor,Angiotensin-converting enzyme
Clomipramine,Serotonin transporter inhibitor,Serotonin transporter
Nortriptyline,Serotonin transporter inhibitor,Serotonin transporter
Balsalazid,Peroxisome proliferator-activated receptor gamma agonist,Peroxisome proliferator-activated receptor gamma
Somatrem,Growth hormone receptor agonist,Growth hormone receptor
Cyclobenzaprine,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Levetiracetam,Synaptic vesicle glycoprotein 2A modulator,Synaptic vesicle glycoprotein 2A
Pyrazinamide,Fatty acid synthase inhibitor,Fatty acid synthase
Hydrocortisone Probutate,Glucocorticoid receptor agonist,Glucocorticoid receptor
Acarbose,Pancreatic alpha-amylase inhibitor,Pancreatic alpha-amylase
Venlafaxine,Norepinephrine transporter inhibitor,Norepinephrine transporter
Flucytosine,Thymidylate synthase inhibitor,Thymidylate synthase
Norethindrone,Progesterone receptor agonist,Progesterone receptor
Brimonidine,Adrenergic receptor alpha-2 agonist,Adrenergic receptor alpha-2
Tranylcypromine,Monoamine oxidase inhibitor,Monoamine oxidase
Anileridine,Kappa opioid receptor agonist,Kappa opioid receptor
Dyphylline,Phosphodiesterase 3A inhibitor,Phosphodiesterase 3A
Rifapentine,Bacterial DNA-directed RNA polymerase inhibitor,Bacterial DNA-directed RNA polymerase
Flucytosine,Thymidylate synthase inhibitor,Thymidylate synthase
Methamphetamine,Monoamine transporter inhibitor,Monoamine transporter
Midazolam,GABA-A receptor; anion channel positive allosteric modulator,GABA-A receptor; anion channel
Moxalactam,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Desflurane,Potassium channel subfamily K member 18 opener,Potassium channel subfamily K member 18
Procaine,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Cromolyn,Unknown,
Isotretinoin,Retinoic acid receptor agonist,Retinoic acid receptor
Metformin,Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor,Mitochondrial glycerol-3-phosphate dehydrogenase
Pasireotide,Somatostatin receptor 5 agonist,Somatostatin receptor 5
Su-14813,Tyrosine-protein kinase receptor FLT3 inhibitor,Tyrosine-protein kinase receptor FLT3
Hyodeoxycholic_Acid,LXR-beta agonist,LXR-beta
Ave0847,Peroxisome proliferator-activated receptor gamma agonist,Peroxisome proliferator-activated receptor gamma
As-602868,Tyrosine-protein kinase receptor FLT3 inhibitor,Tyrosine-protein kinase receptor FLT3
Sulfatinib,Fibroblast growth factor receptor 1 inhibitor,Fibroblast growth factor receptor 1
Panulisib,PI3-kinase class I inhibitor,PI3-kinase class I
Sar-260301,PI3-kinase p110-beta subunit inhibitor,PI3-kinase p110-beta subunit
Vx-970,Serine-protein kinase ATR inhibitor,Serine-protein kinase ATR
Xl-019,Tyrosine-protein kinase JAK2 inhibitor,Tyrosine-protein kinase JAK2
St1535,Adenosine A2a receptor antagonist,Adenosine A2a receptor
Cep-2563,Protein kinase C (PKC) inhibitor,Protein kinase C (PKC)
Azd8108,Glutamate [NMDA] receptor antagonist,Glutamate [NMDA] receptor
Sdx-101,Retinoid X receptor alpha modulator,Retinoid X receptor alpha
Enmd-2076,Macrophage colony stimulating factor receptor inhibitor,Macrophage colony stimulating factor receptor
Capmatinib,Hepatocyte growth factor receptor inhibitor,Hepatocyte growth factor receptor
Mavoglurant,Metabotropic glutamate receptor 5 antagonist,Metabotropic glutamate receptor 5
Ly545694,Metabotropic glutamate receptor 5 antagonist,Metabotropic glutamate receptor 5
Klh-2109,Gonadotropin-releasing hormone receptor antagonist,Gonadotropin-releasing hormone receptor
Davalintide,Calcitonin gene-related peptide type 1 receptor agonist,Calcitonin gene-related peptide type 1 receptor
Azd2624,Neurokinin 3 receptor antagonist,Neurokinin 3 receptor
Dovitinib,Stem cell growth factor receptor inhibitor,Stem cell growth factor receptor
Cebranopadol,Nociceptin receptor agonist,Nociceptin receptor
Teplizumab,T-cell surface glycoprotein CD3 epsilon chain other,T-cell surface glycoprotein CD3 epsilon chain
Cilansetron,Serotonin 3 (5-HT3) receptor antagonist,Serotonin 3 (5-HT3) receptor
Emicizumab,Coagulation factor IX and X other,Coagulation factor IX and X
Intetumumab,Integrin alpha-V/beta-5 antagonist,Integrin alpha-V/beta-5
Olokizumab,Interleukin-6 inhibitor,Interleukin-6
Biib059,C-type lectin domain family 4 member C inhibitor,C-type lectin domain family 4 member C
Pwt-33579,PI3-kinase p110-alpha subunit inhibitor,PI3-kinase p110-alpha subunit
Tiotropium,Muscarinic acetylcholine receptor M3 antagonist,Muscarinic acetylcholine receptor M3
Liraglutide,Glucagon-like peptide 1 receptor agonist,Glucagon-like peptide 1 receptor
Brinzolamide,Carbonic anhydrase II inhibitor,Carbonic anhydrase II
Daunorubicin,DNA topoisomerase II alpha inhibitor,DNA topoisomerase II alpha
Idarubicin,DNA topoisomerase II alpha inhibitor,DNA topoisomerase II alpha
Diphenylpyraline,Histamine H1 receptor antagonist,Histamine H1 receptor
Abarelix,Gonadotropin-releasing hormone receptor antagonist,Gonadotropin-releasing hormone receptor
Vorinostat,Histone deacetylase 6 inhibitor,Histone deacetylase 6
Ethacrynic Acid,Sodium-(potassium)-chloride cotransporter 2 inhibitor,Sodium-(potassium)-chloride cotransporter 2
Famotidine,Histamine H2 receptor antagonist,Histamine H2 receptor
Methantheline,Histamine H2 receptor antagonist,Histamine H2 receptor
Letrozole,Cytochrome P450 19A1 inhibitor,Cytochrome P450 19A1
Insulin Zinc Susp Extended Beef,Insulin receptor agonist,Insulin receptor
Aripiprazole,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Difenoxin,Mu opioid receptor agonist,Mu opioid receptor
Paramethasone Acetate,Glucocorticoid receptor agonist,Glucocorticoid receptor
Fluocinonide,Glucocorticoid receptor agonist,Glucocorticoid receptor
Icatibant,Bradykinin B2 receptor antagonist,Bradykinin B2 receptor
Ivacaftor,Cystic fibrosis transmembrane conductance regulator positive modulator,Cystic fibrosis transmembrane conductance regulator
Regorafenib,Tyrosine-protein kinase FRK inhibitor,Tyrosine-protein kinase FRK
Bismuth Subsalicylate,Cyclooxygenase inhibitor,Cyclooxygenase
Teniposide,DNA topoisomerase II inhibitor,DNA topoisomerase II
Tretinoin,Retinoic acid receptor agonist,Retinoic acid receptor
Methohexital,GABA-A receptor; anion channel positive allosteric modulator,GABA-A receptor; anion channel
Cefamandole Nafate,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Azithromycin,Bacterial 70S ribosome inhibitor,Bacterial 70S ribosome
Nelarabine,DNA inhibitor,DNA
Chlorambucil,DNA inhibitor,DNA
Azacitidine,RNA inhibitor,RNA
Nalidixic Acid,Bacterial DNA gyrase inhibitor,Bacterial DNA gyrase
Mephenytoin,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Proparacaine,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Mephentermine,Adrenergic receptor agonist,Adrenergic receptor
Elosulfase Alfa,Keratan sulfate hydrolytic enzyme,Keratan sulfate
Mibefradil,Voltage-gated T-type calcium channel blocker,Voltage-gated T-type calcium channel
Sebelipase Alfa,Cholesterol ester hydrolytic enzyme,Cholesterol ester
Ag-24322,Cyclin-dependent kinase 2 inhibitor,Cyclin-dependent kinase 2
Arq-736,Serine/threonine-protein kinase RAF inhibitor,Serine/threonine-protein kinase RAF
Cep-11981,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Leo-15520,MAP kinase p38 alpha inhibitor,MAP kinase p38 alpha
Rg-7666,PI3-kinase class I inhibitor,PI3-kinase class I
Gdc-0810,Estrogen receptor alpha antagonist,Estrogen receptor alpha
Afuresertib,Serine/threonine-protein kinase AKT inhibitor,Serine/threonine-protein kinase AKT
Gsk189254,Histamine H3 receptor antagonist,Histamine H3 receptor
Pratosartan,Solute carrier family 22 member 6 inhibitor,Solute carrier family 22 member 6
Jnj-39393406,Neuronal acetylcholine receptor protein alpha-7 subunit positive allosteric modulator,Neuronal acetylcholine receptor protein alpha-7 subunit
Alvocidib,Cyclin-dependent kinase 4 inhibitor,Cyclin-dependent kinase 4
Enzastaurin,Protein kinase C beta inhibitor,Protein kinase C beta
Apatinib,Vascular endothelial growth factor receptor 2 inhibitor,Vascular endothelial growth factor receptor 2
Reparixin,Interleukin-8 receptor A modulator,Interleukin-8 receptor A
Flindokalner,Voltage-gated potassium channel subunit Kv7.4 activator,Voltage-gated potassium channel subunit Kv7.4
Otelixizumab,T-cell surface glycoprotein CD3 epsilon chain other,T-cell surface glycoprotein CD3 epsilon chain
Elacytarabine,DNA Inhibitor,DNA
Selinexor,Exportin-1 inhibitor,Exportin-1
Elacytarabine,RNA Inhibitor,RNA
Mocetinostat,Histone deacetylase 11,Histone deacetylase 11
Vatelizumab,Integrin alpha-2 antagonist,Integrin alpha-2
Siplizumab,T-cell surface antigen CD2 inhibitor,T-cell surface antigen CD2
Medi-551,B-lymphocyte antigen CD19 inhibitor,B-lymphocyte antigen CD19
Mm-121,Receptor tyrosine-protein kinase erbB-3 antagonist,Receptor tyrosine-protein kinase erbB-3
Cdp-860,Platelet-derived growth factor receptor beta inhibitor,Platelet-derived growth factor receptor beta
Trastuzumab,Receptor protein-tyrosine kinase erbB-2 inhibitor,Receptor protein-tyrosine kinase erbB-2
Desloratadine,Histamine H1 receptor antagonist,Histamine H1 receptor
Doxylamine,Histamine H1 receptor antagonist,Histamine H1 receptor
Phenylpropanolamine,Alpha-1a adrenergic receptor agonist,Alpha-1a adrenergic receptor
Everolimus,FK506-binding protein 1A inhibitor,FK506-binding protein 1A
Vilazodone,Serotonin transporter inhibitor,Serotonin transporter
Secretin Synthetic Porcine,Secretin receptor agonist,Secretin receptor
Doxercalciferol,Vitamin D receptor agonist,Vitamin D receptor
Neostigmine,Acetylcholinesterase inhibitor,Acetylcholinesterase
Tenofovir Disoproxil,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,Human immunodeficiency virus type 1 reverse transcriptase
Miglitol,Lysosomal alpha-glucosidase inhibitor,Lysosomal alpha-glucosidase
Ruxolitinib,Tyrosine-protein kinase JAK2 inhibitor,Tyrosine-protein kinase JAK2
Crofelemer,Cystic fibrosis transmembrane conductance regulator inhibitor,Cystic fibrosis transmembrane conductance regulator
Norelgestromin,Progesterone receptor agonist,Progesterone receptor
Ambrisentan,"Endothelin receptor, ET-A/ET-B antagonist","Endothelin receptor, ET-A/ET-B"
Suprofen,Cyclooxygenase inhibitor,Cyclooxygenase
Pentoxifylline,Adenosine A2 receptor antagonist,Adenosine A2 receptor
Tolazamide,"Sulfonylurea receptor 1, Kir6.2 blocker","Sulfonylurea receptor 1, Kir6.2"
Terbutaline,Beta-2 adrenergic receptor agonist,Beta-2 adrenergic receptor
Ezetimibe,Niemann-Pick C1-like protein 1 inhibitor,Niemann-Pick C1-like protein 1
Rifampicin,Bacterial DNA-directed RNA polymerase inhibitor,Bacterial DNA-directed RNA polymerase
Clonazepam,GABA-A receptor; anion channel positive allosteric modulator,GABA-A receptor; anion channel
Lorazepam,GABA-A receptor; anion channel positive allosteric modulator,GABA-A receptor; anion channel
Cefoperazone,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Peginterferon Alfa-2b,Interferon alpha/beta receptor agonist,Interferon alpha/beta receptor
Haloprogin,Cell membrane inhibitor,Cell membrane
Riluzole,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Primidone,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Clozapine,Dopamine D2 receptor antagonist,Dopamine D2 receptor
Magnesium Sulfate Anhydrous,Unknown,
Mersalyl,Unknown,
Chlophedianol,Unknown,
Umeclidinium,Muscarinic acetylcholine receptor M3 antagonist,Muscarinic acetylcholine receptor M3
Asfotase Alfa,Pyrophosphate hydrolytic enzyme,Pyrophosphate
Azd-8055,Serine/threonine-protein kinase mTOR inhibitor,Serine/threonine-protein kinase mTOR
Jnj-26483327,Vascular endothelial growth factor receptor 3 inhibitor,Vascular endothelial growth factor receptor 3
L-21649,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Mln-2480,RAF serine/threonine protein kinase inhibitor,RAF serine/threonine protein kinase
Pbf-509,Adenosine A2a receptor antagonist,Adenosine A2a receptor
Las190792,Beta-2 adrenergic receptor agonist,Beta-2 adrenergic receptor
Puquitinib,Vascular endothelial growth factor receptor 2 inhibitor,Vascular endothelial growth factor receptor 2
Cep-2563,Platelet-derived growth factor receptor beta inhibitor,Platelet-derived growth factor receptor beta
Equol,Estrogen receptor beta agonist,Estrogen receptor beta
Foretinib,Stem cell growth factor receptor inhibitor,Stem cell growth factor receptor
Chir-265,Vascular endothelial growth factor receptor 2 inhibitor,Vascular endothelial growth factor receptor 2
Gsk163090,Serotonin transporter antagonist,Serotonin transporter
Mk3207,Calcitonin gene-related peptide type 1 receptor antagonist,Calcitonin gene-related peptide type 1 receptor
Tecalcet,Calcium sensing receptor modulator,Calcium sensing receptor
Relcovaptan,Vasopressin V1a receptor antagonist,Vasopressin V1a receptor
Imd-1041,Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor,Inhibitor of nuclear factor kappa B kinase beta subunit
Sarizotan,Dopamine D4 receptor agonist,Dopamine D4 receptor
Motesanib,Stem cell growth factor receptor inhibitor,Stem cell growth factor receptor
Berubicin,DNA topoisomerase II inhibitor,DNA topoisomerase II
Emixustat,Retinoid isomerohydrolase inhibitor,Retinoid isomerohydrolase
Baminercept,Heterotrimeric lymphotoxin LTa1b2 inhibitor,Heterotrimeric lymphotoxin LTa1b2
Conatumumab,Tumor necrosis factor receptor superfamily member 10B agonist,Tumor necrosis factor receptor superfamily member 10B
Rovelizumab,Integrin alpha-L/beta-2 (LFA-1) antagonist,Integrin alpha-L/beta-2 (LFA-1)
Mdx-210,High affinity immunoglobulin gamma Fc receptor I other,High affinity immunoglobulin gamma Fc receptor I
Opicinumab,Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 inhibitor,Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1
Imagabalin,Voltage-gated calcium channel modulator,Voltage-gated calcium channel
Alprostadil,Prostanoid EP1 receptor agonist,Prostanoid EP1 receptor
Mesalamine,Arachidonate 5-lipoxygenase inhibitor,Arachidonate 5-lipoxygenase
Frovatriptan,Serotonin 1b (5-HT1b) receptor agonist,Serotonin 1b (5-HT1b) receptor
Nefazodone,Serotonin transporter inhibitor,Serotonin transporter
Teriflunomide,Dihydroorotate dehydrogenase inhibitor,Dihydroorotate dehydrogenase
Insulin Susp Protamine Zinc Purified Pork,Insulin receptor agonist,Insulin receptor
Insulin Glargine,Insulin receptor agonist,Insulin receptor
Droperidol,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Dipyridamole,Equilibrative nucleoside transporter 1 inhibitor,Equilibrative nucleoside transporter 1
Fentanyl,Mu opioid receptor agonist,Mu opioid receptor
Dextroamphetamine,Norepinephrine transporter releasing agent,Norepinephrine transporter
Regorafenib,Fibroblast growth factor receptor 1 inhibitor,Fibroblast growth factor receptor 1
Danazol,Progesterone receptor agonist,Progesterone receptor
Acetohexamide,"Sulfonylurea receptor 1, Kir6.2 blocker","Sulfonylurea receptor 1, Kir6.2"
Tiagabine,GABA transporter 1 inhibitor,GABA transporter 1
Alemtuzumab,CAMPATH-1 antigen inhibitor,CAMPATH-1 antigen
Eculizumab,Complement C5 inhibitor,Complement C5
Griseofulvin,Tubulin inhibitor,Tubulin
Voriconazole,Cytochrome P450 51 inhibitor,Cytochrome P450 51
Dextroamphetamine,Synaptic vesicular amine transporter inhibitor,Synaptic vesicular amine transporter
Sorafenib,Tyrosine-protein kinase receptor RET inhibitor,Tyrosine-protein kinase receptor RET
Sunitinib,Tyrosine-protein kinase receptor RET inhibitor,Tyrosine-protein kinase receptor RET
Tositumomab,B-lymphocyte antigen CD20 inhibitor,B-lymphocyte antigen CD20
Diazepam,GABA-A receptor; anion channel positive allosteric modulator,GABA-A receptor; anion channel
Oxazepam,GABA-A receptor; anion channel positive allosteric modulator,GABA-A receptor; anion channel
Etomidate,GABA-A receptor; anion channel positive modulator,GABA-A receptor; anion channel
Flurazepam,GABA-A receptor; anion channel positive allosteric modulator,GABA-A receptor; anion channel
Triclofos,GABA-A receptor; anion channel positive modulator,GABA-A receptor; anion channel
Glycerol Phenylbutyrate,Glutamine sequestering agent,Glutamine
Cephaloglycin,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Basiliximab,Interleukin-2 receptor inhibitor,Interleukin-2 receptor
Oxamniquine,DNA inhibitor,DNA
Hexylcaine,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Zonisamide,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Dipivefrin,Adrenergic receptor agonist,Adrenergic receptor
Veratrum Viride,Unknown,
Phenylbutanoic Acid,Glutamine sequestering agent,Glutamine
Deferiprone,Unknown,
Afatinib,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Dolutegravir,Human immunodeficiency virus type 1 integrase inhibitor,Human immunodeficiency virus type 1 integrase
Vortioxetine,Serotonin transporter inhibitor,Serotonin transporter
Mepolizumab,Interleukin-5 inhibitor,Interleukin-5
Bay-1161909,Dual specificity protein kinase TTK inhibitor,Dual specificity protein kinase TTK
Falnidamol,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Cudc-101,Receptor protein-tyrosine kinase erbB-2 inhibitor,Receptor protein-tyrosine kinase erbB-2
Jnj-26483327,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Am-461,G protein-coupled receptor 44 antagonist,G protein-coupled receptor 44
Bi-2536,Serine/threonine-protein kinase PLK1 inhibitor,Serine/threonine-protein kinase PLK1
Bi-811283,Serine/threonine-protein kinase Aurora-B inhibitor,Serine/threonine-protein kinase Aurora-B
Fx-005,MAP kinase p38 alpha inhibitor,MAP kinase p38 alpha
Filgotinib,Tyrosine-protein kinase JAK1 inhibitor,Tyrosine-protein kinase JAK1
Ns-018,Tyrosine-protein kinase JAK2 inhibitor,Tyrosine-protein kinase JAK2
Tak-715,MAP kinase p38 alpha inhibitor,MAP kinase p38 alpha
Ssr125543,Corticotropin releasing factor receptor 1 antagonist,Corticotropin releasing factor receptor 1
Pbf-680,Adenosine A1 receptor antagonist,Adenosine A1 receptor
Fevipiprant,G protein-coupled receptor 44 antagonist,G protein-coupled receptor 44
Sparsentan,Endothelin receptor ET-A antagonist,Endothelin receptor ET-A
Azd2516,Metabotropic glutamate receptor 5 negative allosteric modulator,Metabotropic glutamate receptor 5
Drinabant,Cannabinoid CB1 receptor antagonist,Cannabinoid CB1 receptor
Nonabine,Cannabinoid CB2 receptor agonist,Cannabinoid CB2 receptor
Selepressin,Vasopressin V1a receptor agonist,Vasopressin V1a receptor
Azd7009,HERG blocker,HERG
Pf-04531083,Sodium channel protein type X alpha subunit blocker,Sodium channel protein type X alpha subunit
Linifanib,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Quizartinib,Platelet-derived growth factor receptor inhibitor,Platelet-derived growth factor receptor
Briakinumab,Interleukin-12 subunit beta inhibitor,Interleukin-12 subunit beta
Gevokizumab,Interleukin-1 beta negative allosteric modulator,Interleukin-1 beta
Elbasvir,Nonstructural protein 5A inhibitor,Nonstructural protein 5A
Olmesartan,Type-1 angiotensin II receptor antagonist,Type-1 angiotensin II receptor
Esketamine,Glutamate [NMDA] receptor negative allosteric modulator,Glutamate [NMDA] receptor
Vinflunine,Tubulin inhibitor,Tubulin
Duvoglustat,Lysosomal alpha-glucosidase stabiliser,Lysosomal alpha-glucosidase
Niraparib,Poly [ADP-ribose] polymerase 2 inhibitor,Poly [ADP-ribose] polymerase 2
Lipegfilgrastim,Granulocyte colony stimulating factor receptor agonist,Granulocyte colony stimulating factor receptor
Talazoparib,Poly [ADP-ribose] polymerase 2 inhibitor,Poly [ADP-ribose] polymerase 2
Lumiliximab,Immunoglobulin epsilon Fc receptor antagonist,Immunoglobulin epsilon Fc receptor
Qax-576,Interleukin-13 inhibitor,Interleukin-13
Mdx-070,Glutamate carboxypeptidase II other,Glutamate carboxypeptidase II
L19il2,Fibronectin binding agent,Fibronectin
Diphenhydramine,Histamine H1 receptor antagonist,Histamine H1 receptor
Dasatinib,Tyrosine-protein kinase ABL inhibitor,Tyrosine-protein kinase ABL
Metipranolol,Beta-1 adrenergic receptor antagonist,Beta-1 adrenergic receptor
Dobutamine,Beta-1 adrenergic receptor agonist,Beta-1 adrenergic receptor
Disulfiram,Aldehyde dehydrogenase inhibitor,Aldehyde dehydrogenase
Sunitinib,Tyrosine-protein kinase receptor FLT3 inhibitor,Tyrosine-protein kinase receptor FLT3
Insulin Human,Insulin receptor agonist,Insulin receptor
Felodipine,Mineralocorticoid receptor antagonist,Mineralocorticoid receptor
Echothiophate,Acetylcholinesterase inhibitor,Acetylcholinesterase
Prednicarbate,Glucocorticoid receptor agonist,Glucocorticoid receptor
Trimipramine,Norepinephrine transporter inhibitor,Norepinephrine transporter
Zanamivir,Neuraminidase inhibitor,Neuraminidase
Elvitegravir,Human immunodeficiency virus type 1 integrase inhibitor,Human immunodeficiency virus type 1 integrase
Perampanel,Glutamate receptor ionotropic AMPA antagonist,Glutamate receptor ionotropic AMPA
Docetaxel,Tubulin inhibitor,Tubulin
Theophylline Glycinate,Phosphodiesterase 3 inhibitor,Phosphodiesterase 3
Pergolide,Dopamine receptor agonist,Dopamine receptor
Octreotide,Somatostatin receptor agonist,Somatostatin receptor
Oxymetazoline,Adrenergic receptor alpha agonist,Adrenergic receptor alpha
Isocarboxazid,Monoamine oxidase inhibitor,Monoamine oxidase
Rivastigmine,Cholinesterases; ACHE & BCHE inhibitor,Cholinesterases; ACHE & BCHE
Palivizumab,Fusion glycoprotein F0 inhibitor,Fusion glycoprotein F0
Darunavir,Human immunodeficiency virus type 1 protease inhibitor,Human immunodeficiency virus type 1 protease
Ticarcillin,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Cefazolin,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Chloramphenicol Succinic Acid,Bacterial 70S ribosome inhibitor,Bacterial 70S ribosome
Muromonab-Cd3,T cell surface glycoprotein CD3 inhibitor,T cell surface glycoprotein CD3
Ustekinumab,Interleukin-23 inhibitor,Interleukin-23
Fluorouracil,DNA inhibitor,DNA
Labetalol,Adrenergic receptor antagonist,Adrenergic receptor
Taliglucerase Alfa,Glucocerebroside hydrolytic enzyme,Glucocerebroside
Vorapaxar,Proteinase-activated receptor 1 antagonist,Proteinase-activated receptor 1
Aripiprazole Lauroxil,Dopamine D2 receptor partial agonist,Dopamine D2 receptor
Alectinib,Tyrosine-protein kinase receptor RET inhibitor,Tyrosine-protein kinase receptor RET
Glpg0492,Androgen Receptor modulator,Androgen Receptor
Azd-7451,Nerve growth factor receptor Trk-A inhibitor,Nerve growth factor receptor Trk-A
Ct-1578,Macrophage colony stimulating factor receptor inhibitor,Macrophage colony stimulating factor receptor
Pd-0166285,Fibroblast growth factor receptor 1 inhibitor,Fibroblast growth factor receptor 1
Plx-7486,NT-3 growth factor receptor inhibitor,NT-3 growth factor receptor
Brigatinib,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
At-9283,Tyrosine-protein kinase ABL inhibitor,Tyrosine-protein kinase ABL
Pelitinib,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Abemaciclib,Cyclin-dependent kinase 4 inhibitor,Cyclin-dependent kinase 4
Ly2624803,Histamine H1 receptor antagonist,Histamine H1 receptor
Itacitinib,Tyrosine-protein kinase JAK1 inhibitor,Tyrosine-protein kinase JAK1
Mf101,Estrogen receptor beta agonist,Estrogen receptor beta
Obeticholic Acid,Bile acid receptor FXR agonist,Bile acid receptor FXR
Bardoxolone Methyl,Peroxisome proliferator-activated receptor gamma antagonist,Peroxisome proliferator-activated receptor gamma
Tigatuzumab,Tumor necrosis factor receptor superfamily member 10B agonist,Tumor necrosis factor receptor superfamily member 10B
Remogliflozin Etabonate,Sodium/glucose cotransporter 2 inhibitor,Sodium/glucose cotransporter 2
Tirasemtiv,Fast skeletal troponin complex activator,Fast skeletal troponin complex
Caplacizumab,von Willebrand factor inhibitor,von Willebrand factor
Teprotumumab,Insulin-like growth factor I receptor antagonist,Insulin-like growth factor I receptor
Ficlatuzumab,Hepatocyte growth factor inhibitor,Hepatocyte growth factor
Mk-2201,Serine/threonine-protein kinase AKT inhibitor,Serine/threonine-protein kinase AKT
Tranexamic Acid,Plasminogen inhibitor,Plasminogen
Valrubicin,DNA topoisomerase II alpha inhibitor,DNA topoisomerase II alpha
Levocetirizine,Histamine H1 receptor antagonist,Histamine H1 receptor
Lapatinib,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Isopropamide,Muscarinic acetylcholine receptor M1 antagonist,Muscarinic acetylcholine receptor M1
Scopolamine,Muscarinic acetylcholine receptor M1 antagonist,Muscarinic acetylcholine receptor M1
Dasatinib,Stem cell growth factor receptor inhibitor,Stem cell growth factor receptor
Tinzaparin Sodium,Antithrombin-III activator,Antithrombin-III
Metyrosine,Tyrosine 3-hydroxylase inhibitor,Tyrosine 3-hydroxylase
Insulin Zinc Susp Purified Pork,Insulin receptor agonist,Insulin receptor
Meperidine,Mu opioid receptor agonist,Mu opioid receptor
Betamethasone Phosphoric Acid,Glucocorticoid receptor agonist,Glucocorticoid receptor
Drotrecogin Alfa (Activated),Coagulation factor VIII inhibitor,Coagulation factor VIII
Crizotinib,ALK tyrosine kinase receptor inhibitor,ALK tyrosine kinase receptor
Tirofiban,Integrin alpha-IIb/beta-3 inhibitor,Integrin alpha-IIb/beta-3
Pentolinium,Neuronal acetylcholine receptor; alpha3/beta4 antagonist,Neuronal acetylcholine receptor; alpha3/beta4
Nilutamide,Androgen Receptor antagonist,Androgen Receptor
Anidulafungin,"1,3-beta-glucan synthase inhibitor","1,3-beta-glucan synthase"
Cobicistat,Cytochrome P450 3A inhibitor,Cytochrome P450 3A
Belimumab,Tumor necrosis factor ligand superfamily member 13B inhibitor,Tumor necrosis factor ligand superfamily member 13B
Methicillin,Penicillin-binding protein inhibitor,Penicillin-binding protein
Ritonavir,Human immunodeficiency virus type 1 protease inhibitor,Human immunodeficiency virus type 1 protease
Cefadroxil,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Doxorubicin,DNA inhibitor,DNA
Protamine Sulfate,Heparin inhibitor,Heparin
Sevoflurane,Potassium channel subfamily K member 2 opener,Potassium channel subfamily K member 2
Viomycin,70S ribosome inhibitor,70S ribosome
Tobramycin,70S ribosome inhibitor,70S ribosome
Laronidase,Dermatan sulfate hydrolytic enzyme,Dermatan sulfate
Sulfabenzamide,Unknown,
Dipyridamole,"3',5'-cyclic phosphodiesterase inhibitor","3',5'-cyclic phosphodiesterase"
Dronedarone,Inward rectifier potassium channel 2 blocker,Inward rectifier potassium channel 2
Pf-05019702,Progesterone receptor antagonist,Progesterone receptor
Cerdulatinib,Tyrosine-protein kinase JAK3 inhibitor,Tyrosine-protein kinase JAK3
Bay-1082439,PI3-kinase p110-beta subunit inhibitor,PI3-kinase p110-beta subunit
Hmpl-523,Tyrosine-protein kinase SYK inhibitor,Tyrosine-protein kinase SYK
Pf-03758309,Serine/threonine-protein kinase PAK 4 inhibitor,Serine/threonine-protein kinase PAK 4
Pha-543613,Neuronal acetylcholine receptor protein alpha-7 subunit agonist,Neuronal acetylcholine receptor protein alpha-7 subunit
Org-34517,Glucocorticoid receptor antagonist,Glucocorticoid receptor
Cc-401,c-Jun N-terminal kinase 3 inhibitor,c-Jun N-terminal kinase 3
Tanzisertib,c-Jun N-terminal kinase 2 inhibitor,c-Jun N-terminal kinase 2
E-6201,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,Dual specificity mitogen-activated protein kinase kinase 1
Batefenterol,Muscarinic acetylcholine receptor M2 antagonist,Muscarinic acetylcholine receptor M2
Abt-288,Histamine H3 receptor antagonist,Histamine H3 receptor
Asp7991,Calcium sensing receptor positive allosteric modulator,Calcium sensing receptor
Amp579,Adenosine A2a receptor agonist,Adenosine A2a receptor
Dwp05195,Vanilloid receptor antagonist,Vanilloid receptor
Quizartinib,Macrophage colony stimulating factor receptor inhibitor,Macrophage colony stimulating factor receptor
Clazosentan,Endothelin receptor ET-A antagonist,Endothelin receptor ET-A
Iti-007,Serotonin transporter inhibitor,Serotonin transporter
Abagovomab,Mucin-16 other,Mucin-16
Tedisamil,Voltage-gated potassium channel blocker,Voltage-gated potassium channel
Retaspimycin,Heat shock protein HSP90 inhibitor,Heat shock protein HSP90
Elobixibat,Ileal bile acid transporter inhibitor,Ileal bile acid transporter
Bexagliflozin,Sodium/glucose cotransporter 2 inhibitor,Sodium/glucose cotransporter 2
Nivocasan,Caspase-1 inhibitor,Caspase-1
Blisibimod,Tumor necrosis factor ligand superfamily member 13B inhibitor,Tumor necrosis factor ligand superfamily member 13B
Olaratumab,Platelet-derived growth factor receptor alpha antagonist,Platelet-derived growth factor receptor alpha
Benralizumab,Interleukin-5 receptor subunit alpha inhibitor,Interleukin-5 receptor subunit alpha
Acrivastine,Histamine H1 receptor antagonist,Histamine H1 receptor
Biperiden,Muscarinic acetylcholine receptor M1 antagonist,Muscarinic acetylcholine receptor M1
Hydrochlorothiazide,Thiazide-sensitive sodium-chloride cotransporter inhibitor,Thiazide-sensitive sodium-chloride cotransporter
Vasopressin Tannate,Vasopressin V1a receptor agonist,Vasopressin V1a receptor
Chlorprothixene,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Pegfilgrastim,Granulocyte colony stimulating factor receptor agonist,Granulocyte colony stimulating factor receptor
Demecarium,Acetylcholinesterase inhibitor,Acetylcholinesterase
Hydrocortisone Phosphoric Acid,Glucocorticoid receptor agonist,Glucocorticoid receptor
Dabrafenib,Serine/threonine-protein kinase B-raf inhibitor,Serine/threonine-protein kinase B-raf
"Synthetic Conjugated Estrogens, B",Estrogen receptor agonist,Estrogen receptor
Hydrocodone,Opioid receptors; mu/kappa/delta agonist,Opioid receptors; mu/kappa/delta
Ixabepilone,Tubulin inhibitor,Tubulin
Isoproterenol,Adrenergic receptor beta agonist,Adrenergic receptor beta
Clonidine,Adrenergic receptor alpha-2 agonist,Adrenergic receptor alpha-2
Pramlintide,Amylin receptor AMY3; CALCR/RAMP3 agonist,Amylin receptor AMY3; CALCR/RAMP3
Pazopanib,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Micafungin,"1,3-beta-glucan synthase inhibitor","1,3-beta-glucan synthase"
Ticlopidine,Purinergic receptor P2Y12 antagonist,Purinergic receptor P2Y12
Butabarbital,GABA-A receptor; anion channel positive allosteric modulator,GABA-A receptor; anion channel
Streptomycin,Bacterial 70S ribosome inhibitor,Bacterial 70S ribosome
Sargramostim,Granulocyte-macrophage colony-stimulating factor receptor agonist,Granulocyte-macrophage colony-stimulating factor receptor
Epirubicin,DNA inhibitor,DNA
Oxaliplatin,DNA inhibitor,DNA
Enoxacin,DNA gyrase inhibitor,DNA gyrase
Pentamidine,DNA inhibitor,DNA
Omega-3-Acid Ethyl Esters,Unknown,
Ivabradine,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 blocker,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4
Eluxadoline,Mu opioid receptor agonist,Mu opioid receptor
Elotuzumab,SLAM family member 7 inhibitor,SLAM family member 7
Azd-6482,PI3-kinase class I inhibitor,PI3-kinase class I
Bgb-283,Serine/threonine-protein kinase B-raf inhibitor,Serine/threonine-protein kinase B-raf
Cudc-101,Histone deacetylase inhibitor,Histone deacetylase
Jnj-26483327,Tyrosine-protein kinase SRC inhibitor,Tyrosine-protein kinase SRC
R-348,Tyrosine-protein kinase JAK3 inhibitor,Tyrosine-protein kinase JAK3
Sar-125844,Hepatocyte growth factor receptor inhibitor,Hepatocyte growth factor receptor
Ta-5493,MAP kinase p38 alpha inhibitor,MAP kinase p38 alpha
Vs-5584,Serine/threonine-protein kinase mTOR inhibitor,Serine/threonine-protein kinase mTOR
Vantictumab,Frizzled-8 antagonist,Frizzled-8
Xen403,Sodium channel protein type IX alpha subunit blocker,Sodium channel protein type IX alpha subunit
Anlotinib,Vascular endothelial growth factor receptor 3 inhibitor,Vascular endothelial growth factor receptor 3
At-9283,Tyrosine-protein kinase receptor FLT3 inhibitor,Tyrosine-protein kinase receptor FLT3
Azd-1480,Tyrosine-protein kinase JAK2 inhibitor,Tyrosine-protein kinase JAK2
C-1311,DNA topoisomerase II inhibitor,DNA topoisomerase II
Seliciclib,Cyclin-dependent kinase 9 inhibitor,Cyclin-dependent kinase 9
Glpg-0259,MAP kinase-activated protein kinase 5 inhibitor,MAP kinase-activated protein kinase 5
Ly-2090314,Glycogen synthase kinase-3 alpha inhibitor,Glycogen synthase kinase-3 alpha
Danusertib,Serine/threonine-protein kinase Aurora inhibitor,Serine/threonine-protein kinase Aurora
Pictilisib,PI3-kinase class I inhibitor,PI3-kinase class I
Evodenoson,Adenosine A2a receptor agonist,Adenosine A2a receptor
Ly377604,Beta-1 adrenergic receptor antagonist,Beta-1 adrenergic receptor
Velusetrag,Serotonin 4 (5-HT4) receptor agonist,Serotonin 4 (5-HT4) receptor
Serlopitant,Neurokinin 1 receptor antagonist,Neurokinin 1 receptor
Ccx168,C5a anaphylatoxin chemotactic receptor antagonist,C5a anaphylatoxin chemotactic receptor
Selurampanel,Glutamate receptor ionotropic AMPA antagonist,Glutamate receptor ionotropic AMPA
Fgf401,Fibroblast growth factor receptor 4 inhibitor,Fibroblast growth factor receptor 4
Resequinil,GABA-A receptor; benzodiazepine site inverse agonist,GABA-A receptor; benzodiazepine site
Cep-1347,Mitogen-activated protein kinase kinase kinase 11 inhibitor,Mitogen-activated protein kinase kinase kinase 11
Cep-1347,Mitogen-activated protein kinase kinase kinase 13 inhibitor,Mitogen-activated protein kinase kinase kinase 13
Cep-1347,Mitogen-activated protein kinase kinase kinase 12 inhibitor,Mitogen-activated protein kinase kinase kinase 12
Flindokalner,"Voltage-gated potassium channel, KQT; KCNQ2(Kv7.2)/KCNQ3(Kv7.3) activator","Voltage-gated potassium channel, KQT; KCNQ2(Kv7.2)/KCNQ3(Kv7.3)"
Flindokalner,Voltage-gated potassium channel KCNQ3/KCNQ4 activator,Voltage-gated potassium channel KCNQ3/KCNQ4
Afegostat,Beta-glucocerebrosidase stabiliser,Beta-glucocerebrosidase
Adecatumumab,Epithelial cell adhesion molecule inhibitor,Epithelial cell adhesion molecule
Biib067,SOD1 mRNA inhibitor,SOD1 mRNA
Solifenacin,Muscarinic acetylcholine receptor M3 antagonist,Muscarinic acetylcholine receptor M3
Enalapril,Angiotensin-converting enzyme inhibitor,Angiotensin-converting enzyme
Orphenadrine,Histamine H1 receptor antagonist,Histamine H1 receptor
Trimipramine,Histamine H1 receptor antagonist,Histamine H1 receptor
Fluphenazine,Dopamine D2 receptor antagonist,Dopamine D2 receptor
Cabergoline,Dopamine D2 receptor agonist,Dopamine D2 receptor
Chlorprothixene,Dopamine D2 receptor antagonist,Dopamine D2 receptor
Calcitonin Human,Calcitonin receptor agonist,Calcitonin receptor
Methysergide,Serotonin 2b (5-HT2b) receptor antagonist,Serotonin 2b (5-HT2b) receptor
Human Lh,Luteinizing hormone/Choriogonadotropin receptor agonist,Luteinizing hormone/Choriogonadotropin receptor
Degarelix,Gonadotropin-releasing hormone receptor antagonist,Gonadotropin-releasing hormone receptor
Levobetaxolol,Beta-1 adrenergic receptor antagonist,Beta-1 adrenergic receptor
Insulin Zinc Susp Extended Recombinant Human,Insulin receptor agonist,Insulin receptor
Ziprasidone,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Mirtazapine,Serotonin 2c (5-HT2c) receptor antagonist,Serotonin 2c (5-HT2c) receptor
Azacitidine,DNA (cytosine-5)-methyltransferase 3A inhibitor,DNA (cytosine-5)-methyltransferase 3A
Aprotinin,Plasma kallikrein inhibitor,Plasma kallikrein
Pasireotide,Somatostatin receptor 3 agonist,Somatostatin receptor 3
Flurandrenolide,Glucocorticoid receptor agonist,Glucocorticoid receptor
Estradiol Cypionate,Estrogen receptor alpha agonist,Estrogen receptor alpha
Phendimetrazine,Norepinephrine transporter inhibitor,Norepinephrine transporter
Oseltamivir,Neuraminidase inhibitor,Neuraminidase
Vandetanib,Tyrosine-protein kinase BRK inhibitor,Tyrosine-protein kinase BRK
Levonorgestrel,Progesterone receptor agonist,Progesterone receptor
Vandetanib,Tyrosine-protein kinase TIE-2 inhibitor,Tyrosine-protein kinase TIE-2
Tizanidine,Adrenergic receptor alpha-2 agonist,Adrenergic receptor alpha-2
Amoxapine,Dopamine receptor antagonist,Dopamine receptor
Sulfasalazine,Cyclooxygenase inhibitor,Cyclooxygenase
Sorafenib,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Brentuximab Vedotin,Tumor necrosis factor receptor superfamily member 8 inhibitor,Tumor necrosis factor receptor superfamily member 8
Piperonyl Butoxide,Cytochrome P450 inhibitor,Cytochrome P450
Nabilone,Cannabinoid CB1 receptor agonist,Cannabinoid CB1 receptor
Reserpine,Synaptic vesicular amine transporter inhibitor,Synaptic vesicular amine transporter
Fosamprenavir,Human immunodeficiency virus type 1 protease inhibitor,Human immunodeficiency virus type 1 protease
Desmopressin,Vasopressin receptor agonist,Vasopressin receptor
Mupirocin,Isoleucyl-tRNA synthetase inhibitor,Isoleucyl-tRNA synthetase
Pentetic Acid,Radioactive metals chelating agent,Radioactive metals
Enfuvirtide,Transmembrane glycoprotein gp41 inhibitor,Transmembrane glycoprotein gp41
Imiglucerase,Glucocerebroside hydrolytic enzyme,Glucocerebroside
Ingenol Mebutate,Unknown,
Isavuconazonium,Lanosterol 14-alpha demethylase inhibitor,Lanosterol 14-alpha demethylase
Paritaprevir,"Hepatitis C virus serine protease, NS3/NS4A inhibitor","Hepatitis C virus serine protease, NS3/NS4A"
Lesinurad,Solute carrier family 22 member 12 inhibitor,Solute carrier family 22 member 12
Azd3514,Androgen Receptor modulator,Androgen Receptor
Arry-382,Macrophage colony stimulating factor receptor inhibitor,Macrophage colony stimulating factor receptor
Gsk-2256098,Focal adhesion kinase 1 inhibitor,Focal adhesion kinase 1
Me-344,Mitochondrial complex I (NADH dehydrogenase) inhibitor,Mitochondrial complex I (NADH dehydrogenase)
Msc-2363318a,Ribosomal protein S6 kinase (P70S6K) inhibitor,Ribosomal protein S6 kinase (P70S6K)
Rebastinib,Tyrosine-protein kinase ABL inhibitor,Tyrosine-protein kinase ABL
Enmd-2076,Serine/threonine-protein kinase Aurora-A inhibitor,Serine/threonine-protein kinase Aurora-A
Tideglusib,Glycogen synthase kinase-3 beta inhibitor,Glycogen synthase kinase-3 beta
Taselisib,PI3-kinase class I inhibitor,PI3-kinase class I
X-82,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Xl-281,Serine/threonine-protein kinase B-raf inhibitor,Serine/threonine-protein kinase B-raf
Xl-820,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Gsk163090,Serotonin 1b (5-HT1b) receptor antagonist,Serotonin 1b (5-HT1b) receptor
Emicerfont,Corticotropin releasing factor receptor 1 antagonist,Corticotropin releasing factor receptor 1
Pf-05212377,Serotonin 6 (5-HT6) receptor antagonist,Serotonin 6 (5-HT6) receptor
Burapitant,Neurokinin 1 receptor antagonist,Neurokinin 1 receptor
Trelanserin,Serotonin 1b (5-HT1b) receptor antagonist,Serotonin 1b (5-HT1b) receptor
Anatibant,Bradykinin B2 receptor antagonist,Bradykinin B2 receptor
Abt-126,Neuronal acetylcholine receptor protein alpha-7 subunit agonist,Neuronal acetylcholine receptor protein alpha-7 subunit
Tc-6499,Neuronal acetylcholine receptor; alpha3/beta4 agonist,Neuronal acetylcholine receptor; alpha3/beta4
Z160,Voltage-gated N-type calcium channel alpha-1B subunit blocker,Voltage-gated N-type calcium channel alpha-1B subunit
Tivantinib,Hepatocyte growth factor receptor inhibitor,Hepatocyte growth factor receptor
Momelotinib,Tyrosine-protein kinase JAK2 inhibitor,Tyrosine-protein kinase JAK2
Velcalcetide,Calcium sensing receptor agonist,Calcium sensing receptor
Gavilimomab,Basigin other,Basigin
Sb-742457,Serotonin 6 (5-HT6) receptor antagonist,Serotonin 6 (5-HT6) receptor
Darapladib,LDL-associated phospholipase A2 inhibitor,LDL-associated phospholipase A2
Di17e6,Integrin alpha-V/beta-6 inhibitor,Integrin alpha-V/beta-6
Vepalimomab,"Amine oxidase, copper containing inhibitor","Amine oxidase, copper containing"
Anatumomab Mafenatox,Trophoblast glycoprotein other,Trophoblast glycoprotein
Az-9773,TNF-alpha inhibitor,TNF-alpha
Exenatide,Glucagon-like peptide 1 receptor agonist,Glucagon-like peptide 1 receptor
Ethopropazine,Muscarinic acetylcholine receptor M1 antagonist,Muscarinic acetylcholine receptor M1
Dalteparin Sodium,Antithrombin-III activator,Antithrombin-III
Sorafenib,Tyrosine-protein kinase receptor FLT3 inhibitor,Tyrosine-protein kinase receptor FLT3
Carphenazine,Serotonin 2c (5-HT2c) receptor antagonist,Serotonin 2c (5-HT2c) receptor
Diphenoxylate,Mu opioid receptor agonist,Mu opioid receptor
Hydrocortisone,Glucocorticoid receptor agonist,Glucocorticoid receptor
Cortisone Acetate,Glucocorticoid receptor agonist,Glucocorticoid receptor
Rilpivirine,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,Human immunodeficiency virus type 1 reverse transcriptase
Desvenlafaxine,Norepinephrine transporter inhibitor,Norepinephrine transporter
Menthol,Transient receptor potential cation channel subfamily M member 8 opener,Transient receptor potential cation channel subfamily M member 8
Vismodegib,Smoothened homolog inhibitor,Smoothened homolog
Fulvestrant,Estrogen receptor antagonist,Estrogen receptor
Tolazoline,Adrenergic receptor alpha antagonist,Adrenergic receptor alpha
Dobutamine,Beta-2 adrenergic receptor agonist,Beta-2 adrenergic receptor
Sibutramine,Monoamine transporter inhibitor,Monoamine transporter
Amdinocillin,Bacterial penicillin-binding protein 2 inhibitor,Bacterial penicillin-binding protein 2
Mercaptopurine,DNA inhibitor,DNA
Gemifloxacin,DNA gyrase inhibitor,DNA gyrase
Enflurane,Potassium channel subfamily K member 10 opener,Potassium channel subfamily K member 10
Pyrazinamide,70S ribosome inhibitor,70S ribosome
Carisoprodol,Unknown,
Unoprostone Isopropyl,Unknown,
Uridine Triacetate,Unknown,
Abt-700,Hepatocyte growth factor receptor inhibitor,Hepatocyte growth factor receptor
Aew-541,Insulin-like growth factor I receptor inhibitor,Insulin-like growth factor I receptor
Gsk-461364,Serine/threonine-protein kinase PLK1 inhibitor,Serine/threonine-protein kinase PLK1
Hmn-214,Serine/threonine-protein kinase PLK1 inhibitor,Serine/threonine-protein kinase PLK1
Jnj-26483327,Tyrosine-protein kinase Lyn inhibitor,Tyrosine-protein kinase Lyn
Rgb-286638,Cyclin-dependent kinase 5 inhibitor,Cyclin-dependent kinase 5
Tak-593,Platelet-derived growth factor receptor inhibitor,Platelet-derived growth factor receptor
Rg-1530,Tyrosine-protein kinase receptor FLT3 inhibitor,Tyrosine-protein kinase receptor FLT3
Elpetrigine,Voltage-gated P/Q-type calcium channel alpha-1A subunit blocker,Voltage-gated P/Q-type calcium channel alpha-1A subunit
Cc-401,c-Jun N-terminal kinase 2 inhibitor,c-Jun N-terminal kinase 2
Gandotinib,Tyrosine-protein kinase JAK2 inhibitor,Tyrosine-protein kinase JAK2
Tozasertib,Serine/threonine-protein kinase Aurora inhibitor,Serine/threonine-protein kinase Aurora
Triciribine Phosphate,Serine/threonine-protein kinase AKT inhibitor,Serine/threonine-protein kinase AKT
Batefenterol,Muscarinic acetylcholine receptor M3 antagonist,Muscarinic acetylcholine receptor M3
Saf312,Vanilloid receptor inhibitor,Vanilloid receptor
Pf-06372865,GABA-A receptor; anion channel agonist,GABA-A receptor; anion channel
Tesaglitazar,Peroxisome proliferator-activated receptor gamma agonist,Peroxisome proliferator-activated receptor gamma
Linsitinib,Insulin-like growth factor I receptor inhibitor,Insulin-like growth factor I receptor
Fostamatinib,Tyrosine-protein kinase SYK inhibitor,Tyrosine-protein kinase SYK
Bevenopran,Mu opioid receptor antagonist,Mu opioid receptor
Motesanib,Platelet-derived growth factor receptor inhibitor,Platelet-derived growth factor receptor
Sirukumab,Interleukin-6 inhibitor,Interleukin-6
Bectumomab,CD22 other,CD22
Lintuzumab,Myeloid cell surface antigen CD33 other,Myeloid cell surface antigen CD33
Rozrolimupab,Rhesus D antigen inhibitor,Blood group Rh(D) polypeptide
Telbermin,Vascular endothelial growth factor receptor 1 and 2 (Flt-1 and KDR) agonist,Vascular endothelial growth factor receptor 1 and 2 (Flt-1 and KDR)
Bimosiamose,Selectin inhibitor,Selectin
Nalfurafine,Kappa opioid receptor agonist,Kappa opioid receptor
Lifitegrast,Integrin alpha-L/beta-2 (LFA-1) antagonist,Integrin alpha-L/beta-2 (LFA-1)
Navitoclax,Apoptosis regulator Bcl-W inhibitor,Apoptosis regulator Bcl-W
Sontuzumab,Mucin-1 other,Mucin-1
Intetumumab,Integrin alpha-V/beta-1 antagonist,Integrin alpha-V/beta-1
Icm3,Intercellular adhesion molecule 3 inhibitor,Intercellular adhesion molecule 3
Rg-7652,Subtilisin/kexin type 9 inhibitor,Subtilisin/kexin type 9
Tol-101,T-cell receptor inhibitor,T-cell receptor
Sgn-30,Tumor necrosis factor receptor superfamily member 8 agonist,Tumor necrosis factor receptor superfamily member 8
Oxyphenonium,Muscarinic acetylcholine receptor M3 antagonist,Muscarinic acetylcholine receptor M3
Alteplase,Plasminogen activator,Plasminogen
Pyrilamine,Histamine H1 receptor antagonist,Histamine H1 receptor
Buclizine,Histamine H1 receptor antagonist,Histamine H1 receptor
Timolol,Beta-1 adrenergic receptor antagonist,Beta-1 adrenergic receptor
Mesalamine,Peroxisome proliferator-activated receptor gamma agonist,Peroxisome proliferator-activated receptor gamma
Alogliptin,Dipeptidyl peptidase IV inhibitor,Dipeptidyl peptidase IV
Mecasermin Rinfabate,Insulin-like growth factor I receptor agonist,Insulin-like growth factor I receptor
25-Hydroxycholecalciferol,Vitamin D receptor agonist,Vitamin D receptor
Tolcapone,Catechol O-methyltransferase inhibitor,Catechol O-methyltransferase
Cabozantinib,Vascular endothelial growth factor receptor 2 inhibitor,Vascular endothelial growth factor receptor 2
Acarbose,Maltase-glucoamylase inhibitor,Maltase-glucoamylase
Bretylium,Norepinephrine transporter substrate,Norepinephrine transporter
Topiramate,Carbonic anhydrase IV inhibitor,Carbonic anhydrase IV
Brentuximab Vedotin,Tubulin inhibitor,Tubulin
Anagrelide,Phosphodiesterase 3 inhibitor,Phosphodiesterase 3
Theophylline,Adenosine receptor antagonist,Adenosine receptor
Enzalutamide,Androgen Receptor antagonist,Androgen Receptor
Danazol,Androgen Receptor agonist,Androgen Receptor
Salmeterol,Beta-2 adrenergic receptor agonist,Beta-2 adrenergic receptor
Propafenone,Beta-2 adrenergic receptor antagonist,Beta-2 adrenergic receptor
Caspofungin,"1,3-beta-glucan synthase inhibitor","1,3-beta-glucan synthase"
Interferon Alfacon-1,Interferon alpha/beta receptor agonist,Interferon alpha/beta receptor
Procarbazine,DNA inhibitor,DNA
Lamivudine,DNA polymerase/reverse transcriptase inhibitor,DNA polymerase/reverse transcriptase
Ethotoin,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Monoctanoin,Unknown,
Primaquine,Unknown,
Samarium(Ii) Lexidronam,Unknown,
Asparaginase Erwinia Chrysanthemi,Asparagine hydrolytic enzyme,Asparagine
Ledipasvir,Nonstructural protein 5A inhibitor,Nonstructural protein 5A
Ferric Citrate,Phosphate sequestering agent,Phosphate
Pilocarpine,Muscarinic acetylcholine receptor M1 agonist,Muscarinic acetylcholine receptor M1
Sugammadex,Vecuronium sequestering agent,Vecuronium
Mgl-3196,Thyroid hormone receptor beta-1 agonist,Thyroid hormone receptor beta-1
Cerdulatinib,Tyrosine-protein kinase TYK2 inhibitor,Tyrosine-protein kinase TYK2
Ly-3009120,Serine/threonine-protein kinase B-raf inhibitor,Serine/threonine-protein kinase B-raf
Ly-3009120,Serine/threonine-protein kinase RAF inhibitor,Serine/threonine-protein kinase RAF
Rpr749,Adenosine A1 receptor agonist,Adenosine A1 receptor
Dsp-2230,Sodium channel protein type IX alpha subunit blocker,Sodium channel protein type IX alpha subunit
Dilmapimod,MAP kinase p38 alpha inhibitor,MAP kinase p38 alpha
Sar-103168,Unknown,
Xl-999,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Glasdegib,Smoothened homolog antagonist,Smoothened homolog
Elinogrel,Purinergic receptor P2Y12 antagonist,Purinergic receptor P2Y12
Tedatioxetine,Norepinephrine transporter inhibitor,Norepinephrine transporter
Tedatioxetine,Serotonin 2c (5-HT2c) receptor antagonist,Serotonin 2c (5-HT2c) receptor
Ono-2333ms,Corticotropin releasing factor receptor 1 antagonist,Corticotropin releasing factor receptor 1
Olcegepant,Calcitonin gene-related peptide type 1 receptor antagonist,Calcitonin gene-related peptide type 1 receptor
Qav680,G protein-coupled receptor 44 antagonist,G protein-coupled receptor 44
Surinabant,Cannabinoid CB1 receptor antagonist,Cannabinoid CB1 receptor
Azd1305,HERG blocker,HERG
Indantadol,Monoamine oxidase A inhibitor,Monoamine oxidase A
Alvocidib,Cyclin-dependent kinase 1 inhibitor,Cyclin-dependent kinase 1
Sarizotan,Serotonin 1a (5-HT1a) receptor agonist,Serotonin 1a (5-HT1a) receptor
Macimorelin,Ghrelin receptor agonist,Ghrelin receptor
Tabalumab,Tumor necrosis factor ligand superfamily member 13B inhibitor,Tumor necrosis factor ligand superfamily member 13B
Teglarinad,Nicotinamide phosphoribosyltransferase inhibitor,Nicotinamide phosphoribosyltransferase
Denufosol,Purinergic receptor P2Y2 agonist,Purinergic receptor P2Y2
Etirinotecan Pegol,DNA topoisomerase I inhibitor,DNA topoisomerase I
Obatoclax,Apoptosis regulator Bcl-W inhibitor,Apoptosis regulator Bcl-W
Cixutumumab,Insulin-like growth factor I receptor antagonist,Insulin-like growth factor I receptor
3f8,Disialoganglioside GD2 other,Disialoganglioside GD2
Ink-1117,PI3-kinase p110-alpha subunit inhibitor,PI3-kinase p110-alpha subunit
Glycopyrrolate,Muscarinic acetylcholine receptor M3 antagonist,Muscarinic acetylcholine receptor M3
Aflibercept,Vascular endothelial growth factor A inhibitor,Vascular endothelial growth factor A
Ponatinib,Tyrosine-protein kinase ABL inhibitor,Tyrosine-protein kinase ABL
Bumetanide,Sodium-(potassium)-chloride cotransporter 2 inhibitor,Sodium-(potassium)-chloride cotransporter 2
Heparin Calcium,Antithrombin-III activator,Antithrombin-III
Spironolactone,Mineralocorticoid receptor antagonist,Mineralocorticoid receptor
Morphine,Mu opioid receptor agonist,Mu opioid receptor
Alvimopan,Mu opioid receptor antagonist,Mu opioid receptor
Mometasone Furoate,Glucocorticoid receptor agonist,Glucocorticoid receptor
Delavirdine,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,Human immunodeficiency virus type 1 reverse transcriptase
Isoetharine,Beta-2 adrenergic receptor agonist,Beta-2 adrenergic receptor
Thiabendazole,Tubulin inhibitor,Tubulin
Tubocurarine,Muscle-type nicotinic acetylcholine receptor antagonist,Muscle-type nicotinic acetylcholine receptor
Methyprylon,GABA-A receptor; anion channel positive allosteric modulator,GABA-A receptor; anion channel
Cefuroxime Axetil,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Ceftriaxone,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Oxacillin,Penicillin-binding protein inhibitor,Penicillin-binding protein
Spectinomycin,Bacterial 70S ribosome inhibitor,Bacterial 70S ribosome
Gramicidin,Cell membrane inhibitor,Cell membrane
Polymyxin B,Cell outer membrane inhibitor,Cell outer membrane
Desoxyribonuclease,DNA hydrolytic enzyme,DNA
Levofloxacin,DNA gyrase inhibitor,DNA gyrase
Lacosamide,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Norepinephrine,Adrenergic receptor agonist,Adrenergic receptor
Apomorphine,D2-like dopamine receptor agonist,D2-like dopamine receptor
Glucarpidase,Methotrexate hydrolytic enzyme,Methotrexate
Halothane,Potassium channel subfamily K member 9 opener,Potassium channel subfamily K member 9
Albumin Human,Bilirubin sequestering agent,Bilirubin
Raxibacumab,Protective antigen binding agent,Protective antigen
Palbociclib,CDK4/cyclin D1 inhibitor,Cyclin-dependent kinase 4/cyclin D1
Blinatumomab,B-lymphocyte antigen CD19 cross-linking agent,B-lymphocyte antigen CD19
Finafloxacin,Topoisomerase IV inhibitor,Topoisomerase IV
Erismodegib,Smoothened homolog inhibitor,Smoothened homolog
Idarucizumab,Dabigatran sequestering agent,Dabigatran
Cort 125134,Glucocorticoid receptor antagonist,Glucocorticoid receptor
Ct-1578,Tyrosine-protein kinase JAK2 inhibitor,Tyrosine-protein kinase JAK2
Cudc-907,PI3-kinase p110-alpha subunit inhibitor,PI3-kinase p110-alpha subunit
S-222611,Receptor protein-tyrosine kinase erbB-2 inhibitor,Receptor protein-tyrosine kinase erbB-2
Pbf-999,Adenosine A2a receptor antagonist,Adenosine A2a receptor
Srx251,Vasopressin V1a receptor antagonist,Vasopressin V1a receptor
Amg-517,Vanilloid receptor antagonist,Vanilloid receptor
Nw-3509,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Irampanel,Glutamate receptor ionotropic AMPA antagonist,Glutamate receptor ionotropic AMPA
Sodelglitazar,Peroxisome proliferator-activated receptor agonist,Peroxisome proliferator-activated receptor
Naveglitazar,Peroxisome proliferator-activated receptor gamma agonist,Peroxisome proliferator-activated receptor gamma
Xl-999,Platelet-derived growth factor receptor inhibitor,Platelet-derived growth factor receptor
Vibegron,Beta-3 adrenergic receptor agonist,Beta-3 adrenergic receptor
Lasmiditan,Serotonin 1f (5-HT1f) receptor agonist,Serotonin 1f (5-HT1f) receptor
Ly2590443,Serotonin 7 (5-HT7) receptor antagonist,Serotonin 7 (5-HT7) receptor
Azd1981,G protein-coupled receptor 44 antagonist,G protein-coupled receptor 44
Bvt.115959,Adenosine A2a receptor agonist,Adenosine A2a receptor
Gilteritinib,Tyrosine-protein kinase receptor UFO inhibitor,Tyrosine-protein kinase receptor UFO
Azd7325,GABA receptor alpha-3 subunit positive allosteric modulator,GABA receptor alpha-3 subunit
Neboglamine,Glutamate [NMDA] receptor positive allosteric modulator,Glutamate [NMDA] receptor
Cnv2197944,Voltage-gated N-type calcium channel alpha-1B subunit blocker,Voltage-gated N-type calcium channel alpha-1B subunit
Quizartinib,Tyrosine-protein kinase receptor RET inhibitor,Tyrosine-protein kinase receptor RET
Elagolix,Gonadotropin-releasing hormone receptor antagonist,Gonadotropin-releasing hormone receptor
Briakinumab,Interleukin-12 inhibitor,Interleukin-12
Tralokinumab,Interleukin-13 inhibitor,Interleukin-13
Alg-991,Urushiol inhibitor,Urushiol
Tafamidis,Transthyretin stabiliser,Transthyretin
Pixantrone,DNA cross-linking agent,DNA
Ulipristal,Progesterone receptor modulator,Progesterone receptor
Nivocasan,Caspase-8 inhibitor,Caspase-8
Navitoclax,Apoptosis regulator Bcl-2 inhibitor,Apoptosis regulator Bcl-2
Irinotecan Sucrosofate,DNA topoisomerase I inhibitor,DNA topoisomerase I
Faldaprevir,"Hepatitis C virus serine protease, NS3/NS4A inhibitor","Hepatitis C virus serine protease, NS3/NS4A"
Icrucumab,Vascular endothelial growth factor receptor 1 antagonist,Vascular endothelial growth factor receptor 1
Lmb-2,Interleukin-2 receptor alpha chain binding agent,Interleukin-2 receptor alpha chain
Parsatuzumab,Epidermal growth factor-like protein 7 inhibitor,Epidermal growth factor-like protein 7
Atropine,Muscarinic acetylcholine receptor M3 antagonist,Muscarinic acetylcholine receptor M3
Vorinostat,Histone deacetylase 1 inhibitor,Histone deacetylase 1
Fluphenazine Decanoate,Dopamine D2 receptor antagonist,Dopamine D2 receptor
Lutropin Alfa,Luteinizing hormone/Choriogonadotropin receptor agonist,Luteinizing hormone/Choriogonadotropin receptor
Olsalazine,Arachidonate 5-lipoxygenase inhibitor,Arachidonate 5-lipoxygenase
Benztropine,Muscarinic acetylcholine receptor M1 antagonist,Muscarinic acetylcholine receptor M1
Nadolol,Beta-1 adrenergic receptor antagonist,Beta-1 adrenergic receptor
Polythiazide,Thiazide-sensitive sodium-chloride cotransporter inhibitor,Thiazide-sensitive sodium-chloride cotransporter
Cinacalcet,Calcium sensing receptor positive allosteric modulator,Calcium sensing receptor
Phenprocoumon,Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor,Vitamin k epoxide reductase complex subunit 1 isoform 1
Thyrotropin,Thyroid stimulating hormone receptor agonist,Thyroid stimulating hormone receptor
Lorcaserin,Serotonin 2c (5-HT2c) receptor agonist,Serotonin 2c (5-HT2c) receptor
Sufentanil,Mu opioid receptor agonist,Mu opioid receptor
Cycloserine,D-alanylalanine synthetase inhibitor,D-alanylalanine synthetase
Triamcinolone Hexacetonide,Glucocorticoid receptor agonist,Glucocorticoid receptor
Fenoldopam,Dopamine D1 receptor agonist,Dopamine D1 receptor
Milnacipran,Norepinephrine transporter inhibitor,Norepinephrine transporter
Levetiracetam,Voltage-gated N-type calcium channel alpha-1B subunit blocker,Voltage-gated N-type calcium channel alpha-1B subunit
Regorafenib,Serine/threonine-protein kinase B-raf inhibitor,Serine/threonine-protein kinase B-raf
Artemether,Ferriprotoporphyrin IX inhibitor,Ferriprotoporphyrin IX
Lubiprostone,Chloride channel protein 2 opener,Chloride channel protein 2
Eptifibatide,Integrin alpha-IIb/beta-3 inhibitor,Integrin alpha-IIb/beta-3
Amantadine,Glutamate [NMDA] receptor antagonist,Glutamate [NMDA] receptor
Amantadine,Matrix protein 2 inhibitor,Matrix protein 2
Trimethaphan,Neuronal acetylcholine receptor; alpha3/beta4 antagonist,Neuronal acetylcholine receptor; alpha3/beta4
Oxandrolone,Androgen Receptor agonist,Androgen Receptor
Lisdexamfetamine,Synaptic vesicular amine transporter inhibitor,Synaptic vesicular amine transporter
Desflurane,GABA-A receptor; anion channel positive allosteric modulator,GABA-A receptor; anion channel
Halothane,GABA-A receptor; anion channel positive allosteric modulator,GABA-A receptor; anion channel
Cephradine,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Aztreonam,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Cefoxitin,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Merethoxylline Procaine,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Orphenadrine,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Acrisorcin,Unknown,
Metreleptin,Leptin receptor agonist,Leptin receptor
Pirfenidone,Unknown,
Peramivir,Neuraminidase inhibitor,Neuraminidase
Bms-852927,LXR-alpha modulator,LXR-alpha
Theliatinib,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Pf-562271,Focal adhesion kinase 1 inhibitor,Focal adhesion kinase 1
Tak-441,Smoothened homolog antagonist,Smoothened homolog
Sad448,Cannabinoid CB2 receptor agonist,Cannabinoid CB2 receptor
Vantictumab,Frizzled-7 antagonist,Frizzled-7
Rxdx-103,Cell division cycle 7-related protein kinase inhibitor,Cell division cycle 7-related protein kinase
Delucemine,Glutamate [NMDA] receptor antagonist,Glutamate [NMDA] receptor
Uprosertib,Serine/threonine-protein kinase AKT inhibitor,Serine/threonine-protein kinase AKT
Ralimetinib,MAP kinase p38 alpha inhibitor,MAP kinase p38 alpha
Famitinib,Vascular endothelial growth factor receptor 2 inhibitor,Vascular endothelial growth factor receptor 2
Tg100-801,Vascular endothelial growth factor receptor 2 inhibitor,Vascular endothelial growth factor receptor 2
Zstk-474,PI3-kinase class I inhibitor,PI3-kinase class I
Tabimorelin,Cytochrome P450 3A4 inhibitor,Cytochrome P450 3A4
Pf-05089771,Sodium channel protein type IX alpha subunit blocker,Sodium channel protein type IX alpha subunit
Lorediplon,GABA-A receptor; benzodiazepine site positive allosteric modulator,GABA-A receptor; benzodiazepine site
Odm-201,Androgen Receptor antagonist,Androgen Receptor
Simotinib,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Paclitaxel Poliglumex,Tubulin stabiliser,Tubulin
Polmacoxib,Carbonic anhydrase II inhibitor,Carbonic anhydrase II
Sa237,IL6Ralpha/GP130 antagonist,IL6Ralpha/GP130
Ibalizumab,T-cell surface antigen CD4 inhibitor,T-cell surface antigen CD4
Namilumab,Granulocyte-macrophage colony-stimulating factor inhibitor,Granulocyte-macrophage colony-stimulating factor
Roledumab,Blood group Rh(D) polypeptide inhibitor,Blood group Rh(D) polypeptide
Pascolizumab,Interleukin-4 inhibitor,Interleukin-4
Urokinase,Plasminogen activator,Plasminogen
Topiramate,Carbonic anhydrase II inhibitor,Carbonic anhydrase II
Etoposide Phosphate,DNA topoisomerase II alpha inhibitor,DNA topoisomerase II alpha
Chlorpheniramine,Histamine H1 receptor antagonist,Histamine H1 receptor
Mesoridazine,Dopamine D2 receptor antagonist,Dopamine D2 receptor
Nilotinib,Tyrosine-protein kinase ABL inhibitor,Tyrosine-protein kinase ABL
Diazoxide,"Potassium channel, inwardly rectifying, subfamily J, member 11 opener","Potassium channel, inwardly rectifying, subfamily J, member 11"
Vasopressin Tannate,Vasopressin V1b receptor agonist,Vasopressin V1b receptor
Pegvisomant,Growth hormone receptor antagonist,Growth hormone receptor
Insulin Zinc Susp Beef,Insulin receptor agonist,Insulin receptor
Thiothixene,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Galantamine,Acetylcholinesterase inhibitor,Acetylcholinesterase
Bupropion,Norepinephrine transporter inhibitor,Norepinephrine transporter
Tapentadol,Norepinephrine transporter inhibitor,Norepinephrine transporter
Ospemifene,Estrogen receptor modulator,Estrogen receptor
Isosorbide Dinitrate,Soluble guanylate cyclase activator,Soluble guanylate cyclase
Ergoloid,Adrenergic receptor alpha antagonist,Adrenergic receptor alpha
Gemcitabine,Ribonucleoside-diphosphate reductase RR1 inhibitor,Ribonucleoside-diphosphate reductase RR1
Oxymetholone,Androgen Receptor agonist,Androgen Receptor
Miconazole,Cytochrome P450 51 inhibitor,Cytochrome P450 51
Meloxicam,Cyclooxygenase-2 inhibitor,Cyclooxygenase-2
Gallium Nitrate,Hydroxyapatite sequestering agent,Hydroxyapatite
Trimethoprim,Bacterial dihydrofolate reductase inhibitor,Bacterial dihydrofolate reductase
Meclocycline Sulfosalicylate,Bacterial 70S ribosome inhibitor,Bacterial 70S ribosome
Melphalan,DNA inhibitor,DNA
Cholestyramine,Bile acids sequestering agent,Bile acids
Siltuximab,Interleukin-6 inhibitor,Interleukin-6
Finafloxacin,Topoisomerase IV inhibitor,Topoisomerase IV
Ave0847,Peroxisome proliferator-activated receptor delta agonist,Peroxisome proliferator-activated receptor delta
Bi-853520,Focal adhesion kinase 1 inhibitor,Focal adhesion kinase 1
Cep-32496,Serine/threonine-protein kinase B-raf inhibitor,Serine/threonine-protein kinase B-raf
Cep-32496,Tyrosine-protein kinase receptor RET inhibitor,Tyrosine-protein kinase receptor RET
Ly-2584702,Ribosomal protein S6 kinase 1 inhibitor,Ribosomal protein S6 kinase 1
Balamapimod,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,Dual specificity mitogen-activated protein kinase kinase 1
Wx-554,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,Dual specificity mitogen-activated protein kinase kinase 1
Atilmotin,Motilin receptor agonist,Motilin receptor
Axp-107-11,Unknown,
Dactolisib,PI3-kinase class I inhibitor,PI3-kinase class I
Xl-820,Platelet-derived growth factor receptor inhibitor,Platelet-derived growth factor receptor
Bavisant,Histamine H3 receptor antagonist,Histamine H3 receptor
Toreforant,Histamine H4 receptor antagonist,Histamine H4 receptor
Bkt140,C-X-C chemokine receptor type 4 antagonist,C-X-C chemokine receptor type 4
Asm-024,Muscarinic acetylcholine receptor M1 antagonist,Muscarinic acetylcholine receptor M1
Brivanib,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Flumatinib,Tyrosine-protein kinase ABL inhibitor,Tyrosine-protein kinase ABL
Bremelanotide,Melanocortin receptor 1 agonist,Melanocortin receptor 1
Briakinumab,Interleukin-23 inhibitor,Interleukin-23
Defibrotide Sodium,Plasminogen activator,Plasminogen
Odanacatib,Cathepsin K inhibitor,Cathepsin K
Sapacitabine,DNA inhibitor,DNA
Sotagliflozin,Sodium/glucose cotransporter 1 inhibitor,Sodium/glucose cotransporter 1
Oncolysin S,Neural cell adhesion molecule 1 binding agent,Neural cell adhesion molecule 1
Demcizumab,Delta-like protein 4 inhibitor,Delta-like protein 4
Telotristat Ethyl,Tryptophan 5-hydroxylase inhibitor,Tryptophan 5-hydroxylase
Lgx-806,Serine/threonine-protein kinase B-raf inhibitor,Serine/threonine-protein kinase B-raf
R-343,Tyrosine-protein kinase SYK inhibitor,Tyrosine-protein kinase SYK
Propantheline,Muscarinic acetylcholine receptor M3 antagonist,Muscarinic acetylcholine receptor M3
Ipratropium,Muscarinic acetylcholine receptor M3 antagonist,Muscarinic acetylcholine receptor M3
Bevacizumab,Vascular endothelial growth factor A inhibitor,Vascular endothelial growth factor A
Tadalafil,Phosphodiesterase 5A inhibitor,Phosphodiesterase 5A
Calcitonin Salmon,Calcitonin receptor agonist,Calcitonin receptor
Oxyphencyclimine,Muscarinic acetylcholine receptor M1 antagonist,Muscarinic acetylcholine receptor M1
Sirolimus,FK506-binding protein 1A inhibitor,FK506-binding protein 1A
Secretin Synthetic Human,Secretin receptor agonist,Secretin receptor
Insulin Purified Pork,Insulin receptor agonist,Insulin receptor
Nevirapine,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,Human immunodeficiency virus type 1 reverse transcriptase
Plerixafor,C-X-C chemokine receptor type 4 partial agonist,C-X-C chemokine receptor type 4
Regorafenib,Fibroblast growth factor receptor 2 inhibitor,Fibroblast growth factor receptor 2
Bosentan,"Endothelin receptor, ET-A/ET-B antagonist","Endothelin receptor, ET-A/ET-B"
Minoxidil,"Sulfonylurea receptor 2, Kir6.2 opener","Sulfonylurea receptor 2, Kir6.2"
Tetrahydrozoline,Adrenergic receptor alpha agonist,Adrenergic receptor alpha
Albuterol,Beta-2 adrenergic receptor agonist,Beta-2 adrenergic receptor
Cycloserine,Alanine racemase inhibitor,Alanine racemase
Clotrimazole,Cytochrome P450 51 inhibitor,Cytochrome P450 51
Ketoconazole,Cytochrome P450 51 inhibitor,Cytochrome P450 51
Lamivudine,DNA inhibitor,DNA
Sulfadiazine,Bacterial dihydropteroate synthase inhibitor,Bacterial dihydropteroate synthase
Ceftibuten,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Cefditoren Pivoxil,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Dapsone,Dihydropteroate synthase 1 inhibitor,Dihydropteroate synthase 1
Interferon Alfa-N3,Interferon alpha/beta receptor agonist,Interferon alpha/beta receptor
Trioxsalen,DNA inhibitor,DNA
Hydroxystilbamidine,RNA inhibitor,RNA
Desflurane,Potassium channel subfamily K member 10 opener,Potassium channel subfamily K member 10
Gemifloxacin,Topoisomerase IV inhibitor,Topoisomerase IV
Guaifenesin,Unknown,
Potassium Iodide,Unknown,
Palbociclib,CDK6/cyclin D1 inhibitor,CDK6/cyclin D1
Ink-128,Serine/threonine-protein kinase mTOR inhibitor,Serine/threonine-protein kinase mTOR
Vk5211,Androgen Receptor modulator,Androgen Receptor
Cenisertib,Serine/threonine-protein kinase Aurora inhibitor,Serine/threonine-protein kinase Aurora
Cm-082,Platelet-derived growth factor receptor beta inhibitor,Platelet-derived growth factor receptor beta
Gs-4997,Mitogen-activated protein kinase kinase kinase 5 inhibitor,Mitogen-activated protein kinase kinase kinase 5
Gsk-2636771,PI3-kinase p110-beta subunit inhibitor,PI3-kinase p110-beta subunit
Merestinib,Hepatocyte growth factor receptor inhibitor,Hepatocyte growth factor receptor
Indirubin Sulfate,Cyclin-dependent kinase 2 inhibitor,Cyclin-dependent kinase 2
Whi-P131,Tyrosine-protein kinase JAK3 inhibitor,Tyrosine-protein kinase JAK3
Sar425899,Glucagon receptor agonist,Glucagon receptor
Idoxifene,Estrogen receptor modulator,Estrogen receptor
Bentamapimod,"c-Jun N-terminal kinase, JNK inhibitor","c-Jun N-terminal kinase, JNK"
Seliciclib,Cyclin-dependent kinase 5 inhibitor,Cyclin-dependent kinase 5
Foretinib,Tyrosine-protein kinase receptor FLT3 inhibitor,Tyrosine-protein kinase receptor FLT3
Famitinib,Tyrosine-protein kinase receptor FLT3 inhibitor,Tyrosine-protein kinase receptor FLT3
Epelsiban,Oxytocin receptor antagonist,Oxytocin receptor
Pf-04634817,C-C chemokine receptor type 2 antagonist,C-C chemokine receptor type 2
Setmelanotide,Melanocortin receptor 4 agonist,Melanocortin receptor 4
Pol6326,C-X-C chemokine receptor type 4 antagonist,C-X-C chemokine receptor type 4
Sofinicline,Neuronal acetylcholine receptor; alpha4/beta2 agonist,Neuronal acetylcholine receptor; alpha4/beta2
Darusentan,Endothelin receptor ET-A antagonist,Endothelin receptor ET-A
Flindokalner,Voltage-gated potassium channel subunit Kv7.2 activator,Voltage-gated potassium channel subunit Kv7.2
Motesanib,Tyrosine-protein kinase receptor RET inhibitor,Tyrosine-protein kinase receptor RET
Celivarone,Unknown,
Tariquidar,P-glycoprotein 1 inhibitor,P-glycoprotein 1
Eritoran,Toll-like receptor 4/MD-2 antagonist,Toll-like receptor 4/MD-2
Atorolimumab,Blood group Rh(D) polypeptide other,Blood group Rh(D) polypeptide
Alacizumab Pegol,Vascular endothelial growth factor receptor 2 antagonist,Vascular endothelial growth factor receptor 2
Atacicept,Tumor necrosis factor ligand superfamily member 13 inhibitor,Tumor necrosis factor ligand superfamily member 13
Mdx-447,High affinity immunoglobulin gamma Fc receptor I other,High affinity immunoglobulin gamma Fc receptor I
Lirilumab,Killer cell immunoglobulin-like receptor 2DL1 inhibitor,Killer cell immunoglobulin-like receptor 2DL1
Bromodiphenhydramine,Histamine H1 receptor antagonist,Histamine H1 receptor
Pheniramine,Histamine H1 receptor antagonist,Histamine H1 receptor
Paliperidone,Dopamine D2 receptor antagonist,Dopamine D2 receptor
Saralasin,Type-1 angiotensin II receptor antagonist,Type-1 angiotensin II receptor
Pentazocine,Sigma opioid receptor modulator,Sigma opioid receptor
Conivaptan,Vasopressin V1a receptor antagonist,Vasopressin V1a receptor
Mesoridazine,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Nefazodone,Norepinephrine transporter inhibitor,Norepinephrine transporter
Bosutinib,Tyrosine-protein kinase HCK inhibitor,Tyrosine-protein kinase HCK
Risedronic Acid,Farnesyl diphosphate synthase inhibitor,Farnesyl diphosphate synthase
Pamidronic Acid,Farnesyl diphosphate synthase inhibitor,Farnesyl diphosphate synthase
Theophylline Glycinate,Adenosine receptor antagonist,Adenosine receptor
Atracurium,Muscle-type nicotinic acetylcholine receptor antagonist,Muscle-type nicotinic acetylcholine receptor
Sucralfate,Glycoproteins cross-linking agent,Glycoproteins
Prazepam,GABA-A receptor; anion channel positive allosteric modulator,GABA-A receptor; anion channel
Sulfamethazine,Bacterial dihydropteroate synthase inhibitor,Bacterial dihydropteroate synthase
Pentetic Acid,Radioactive metals chelating agent,Radioactive metals
Metronidazole,DNA inhibitor,DNA
Retapamulin,70S ribosome inhibitor,70S ribosome
Etidronic Acid,ATP inhibitor,ATP
Sevoflurane,Potassium channel subfamily K member 10 opener,Potassium channel subfamily K member 10
Disopyramide,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Colesevelam Hydrochloride,Bile acids sequestering agent,Bile acids
Pentosan Polysulfate Sodium,Unknown,
Hydralazine,Unknown,
Enmd-981693,SRC inhibitor,SRC
Imd-0354,Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor,Inhibitor of nuclear factor kappa B kinase beta subunit
Ds-3078a,Serine/threonine-protein kinase mTOR inhibitor,Serine/threonine-protein kinase mTOR
Jnj-38877605,Hepatocyte growth factor receptor inhibitor,Hepatocyte growth factor receptor
Krn-633,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Loxo-101,Neurotrophic tyrosine kinase receptor inhibitor,Neurotrophic tyrosine kinase receptor
Rwj-67657,MAP kinase p38 beta inhibitor,MAP kinase p38 beta
Rg-1530,Fibroblast growth factor receptor 2 inhibitor,Fibroblast growth factor receptor 2
Phe377,Vanilloid receptor antagonist,Vanilloid receptor
Nrx195183,Retinoic acid receptor alpha agonist,Retinoic acid receptor alpha
Pimasertib,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,Dual specificity mitogen-activated protein kinase kinase 1
Bms-754807,Insulin receptor inhibitor,Insulin receptor
Lucitanib,Fibroblast growth factor receptor 2 inhibitor,Fibroblast growth factor receptor 2
Fruquintinib,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Kc-706,MAP kinase p38 alpha inhibitor,MAP kinase p38 alpha
Naxifylline,Adenosine A1 receptor antagonist,Adenosine A1 receptor
Netazepide,Cholecystokinin B receptor antagonist,Cholecystokinin B receptor
Vapitadine,Histamine H1 receptor antagonist,Histamine H1 receptor
Andolast,Calcium-activated potassium channel subunit alpha-1 activator,Calcium-activated potassium channel subunit alpha-1
Seocalcitol,Vitamin D receptor agonist,Vitamin D receptor
Vatalanib,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Esmirtazapine,Serotonin 2c (5-HT2c) receptor antagonist,Serotonin 2c (5-HT2c) receptor
Mirogabalin,Voltage-gated calcium channel alpha2/delta subunit 1 modulator,Voltage-gated calcium channel alpha2/delta subunit 1
Larazotide,Neuronal acetylcholine receptor; alpha3/beta4 partial agonist,Neuronal acetylcholine receptor; alpha3/beta4
Bifeprunox,Serotonin 1a (5-HT1a) receptor partial agonist,Serotonin 1a (5-HT1a) receptor
Mocetinostat,Histone deacetylase 8 inhibitor,Histone deacetylase 8
Andecaliximab,Matrix metalloproteinase 9 inhibitor,Matrix metalloproteinase 9
Lorvotuzumab Mertansine,Neural cell adhesion molecule 1 binding agent,Neural cell adhesion molecule 1
Ing-1,Epithelial cell adhesion molecule other,Epithelial cell adhesion molecule
Ni-0801,C-X-C motif chemokine 10 inhibitor,C-X-C motif chemokine 10
Claudiximab,Claudin-18 binding agent,Claudin-18
Pf-00547659,Mucosal addressin cell adhesion molecule-1 inhibitor,Mucosal addressin cell adhesion molecule-1
Rg-547,Cyclin-dependent kinase 1 inhibitor,Cyclin-dependent kinase 1
Teriparatide Acetate,Parathyroid hormone receptor agonist,Parathyroid hormone receptor
Doxorubicin,DNA topoisomerase II alpha inhibitor,DNA topoisomerase II alpha
Sildenafil,Phosphodiesterase 5A inhibitor,Phosphodiesterase 5A
Diphemanil,Muscarinic acetylcholine receptor M1 antagonist,Muscarinic acetylcholine receptor M1
Rizatriptan,Serotonin 1b (5-HT1b) receptor agonist,Serotonin 1b (5-HT1b) receptor
Ergocalciferol,Vitamin D receptor agonist,Vitamin D receptor
Ambenonium,Acetylcholinesterase inhibitor,Acetylcholinesterase
Dexamethasone,Glucocorticoid receptor agonist,Glucocorticoid receptor
Zanamivir,Neuraminidase inhibitor,Neuraminidase
Mirabegron,Beta-3 adrenergic receptor agonist,Beta-3 adrenergic receptor
Ergoloid,Dopamine receptor agonist,Dopamine receptor
Nicardipine,Voltage-gated L-type calcium channel blocker,Voltage-gated L-type calcium channel
Stanozolol,Androgen Receptor agonist,Androgen Receptor
Benzonatate,Slowly adapting pulmonary stretch receptor inhibitor,Slowly adapting pulmonary stretch receptor
Botulinum Toxin Type B,Vesicle-associated membrane protein 2 inhibitor,Vesicle-associated membrane protein 2
Trospium,Muscarinic acetylcholine receptor M2 antagonist,Muscarinic acetylcholine receptor M2
Cefpodoxime Proxetil,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Telithromycin,Bacterial 70S ribosome inhibitor,Bacterial 70S ribosome
Clindamycin Palmitate,Bacterial 70S ribosome inhibitor,Bacterial 70S ribosome
Carbamazepine,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Lodoxamide,Unknown,
Methylhomatropine,Unknown,
Acetaminophen,Anandamide amidohydrolase inhibitor,Anandamide amidohydrolase
Cariprazine,Dopamine D2 receptor modulator,Dopamine D2 receptor
At-13148,Rho-associated protein kinase inhibitor,Rho-associated protein kinase
Cal-263,PI3-kinase p110-delta subunit inhibitor,PI3-kinase p110-delta subunit
Mk-8033,Macrophage-stimulating protein receptor inhibitor,Macrophage-stimulating protein receptor
Pf-03814735,Serine/threonine-protein kinase Aurora-A inhibitor,Serine/threonine-protein kinase Aurora-A
Plx-7486,Neurotrophic tyrosine kinase receptor type 2 inhibitor,Neurotrophic tyrosine kinase receptor type 2
S-222611,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Seridopidine,Dopamine D2 receptor modulator,Dopamine D2 receptor
Bay-1217389,Dual specificity protein kinase TTK inhibitor,Dual specificity protein kinase TTK
Fispemifene,Estrogen receptor modulator,Estrogen receptor
Mk-6913,Estrogen receptor agonist,Estrogen receptor
Lunacalcipol,Vitamin D receptor agonist,Vitamin D receptor
Ulixertinib,MAP kinase ERK1 inhibitor,MAP kinase ERK1
Golvatinib,Hepatocyte growth factor receptor inhibitor,Hepatocyte growth factor receptor
Kx2-391,Tyrosine-protein kinase SRC inhibitor,Tyrosine-protein kinase SRC
Ph-797804,MAP kinase p38 alpha inhibitor,MAP kinase p38 alpha
Tg100-115,PI3-kinase p110-delta subunit inhibitor,PI3-kinase p110-delta subunit
Gsk-2269557,PI3-kinase p110-delta subunit inhibitor,PI3-kinase p110-delta subunit
Pf-03654746,Histamine H3 receptor antagonist,Histamine H3 receptor
Afacifenacin,Sodium channel protein type XI alpha subunit blocker,Sodium channel protein type XI alpha subunit
Grc-15300,Transient receptor potential cation channel subfamily V member 3 antagonist,Transient receptor potential cation channel subfamily V member 3
Semaglutide,Glucagon-like peptide 1 receptor agonist,Glucagon-like peptide 1 receptor
Liprotamase,Triglyceride hydrolytic enzyme,Triglyceride
Colestilan Chloride,Phosphate sequestering agent,Phosphate
Safinamide,Monoamine oxidase B inhibitor,Monoamine oxidase B
Pevonedistat,NEDD8 activating enzyme inhibitor,NEDD8 activating enzyme
Obatoclax,Bcl-2-related protein A1 inhibitor,Bcl-2-related protein A1
Trebananib,Angiopoietin-2 inhibitor,Angiopoietin-2
Bertilimumab,Eotaxin inhibitor,Eotaxin
Cat-3888,CD22 binding agent,CD22
Mr-1817,Vanilloid receptor antagonist,Vanilloid receptor
Lithium Citrate,Inositol-1(or 4)-monophosphatase 1 inhibitor,Inositol-1(or 4)-monophosphatase 1
Dichlorphenamide,Carbonic anhydrase II inhibitor,Carbonic anhydrase II
Hexocyclium,Muscarinic acetylcholine receptor M1 antagonist,Muscarinic acetylcholine receptor M1
Fondaparinux,Antithrombin-III activator,Antithrombin-III
Trazodone,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Nefazodone,Serotonin 2c (5-HT2c) receptor antagonist,Serotonin 2c (5-HT2c) receptor
Propoxyphene,Mu opioid receptor agonist,Mu opioid receptor
Entacapone,Catechol O-methyltransferase inhibitor,Catechol O-methyltransferase
Hydroxyprogesterone Caproate,Progesterone receptor agonist,Progesterone receptor
Ketamine,Glutamate [NMDA] receptor negative allosteric modulator,Glutamate [NMDA] receptor
Adenosine,Adenosine receptor agonist,Adenosine receptor
Nitroprusside,Soluble guanylate cyclase activator,Soluble guanylate cyclase
Telaprevir,"Hepatitis C virus serine protease, NS3/NS4A inhibitor","Hepatitis C virus serine protease, NS3/NS4A"
Nitisinone,4-hydroxyphenylpyruvate dioxygenase inhibitor,4-hydroxyphenylpyruvate dioxygenase
Celecoxib,Cyclooxygenase-2 inhibitor,Cyclooxygenase-2
Cidofovir,Human herpesvirus 1 DNA polymerase inhibitor,Human herpesvirus 1 DNA polymerase
Prasugrel,Purinergic receptor P2Y12 antagonist,Purinergic receptor P2Y12
Decamethonium,Muscle-type nicotinic acetylcholine receptor partial agonist,Muscle-type nicotinic acetylcholine receptor
Gallamine,Muscle-type nicotinic acetylcholine receptor antagonist,Muscle-type nicotinic acetylcholine receptor
Acitretin,Retinoid receptor agonist,Retinoid receptor
Fluorouracil,RNA inhibitor,RNA
Epinephrine,Adrenergic receptor agonist,Adrenergic receptor
Hydroxyamphetamine,Adrenergic receptor agonist,Adrenergic receptor
Promazine,D2-like dopamine receptor antagonist,D2-like dopamine receptor
Ropinirole,D2-like dopamine receptor agonist,D2-like dopamine receptor
Desflurane,Potassium channel subfamily K member 9 opener,Potassium channel subfamily K member 9
Fomivirsen Sodium,Major intermediate early region 2 mRNA antisense inhibitor,Major intermediate early region 2 mRNA
Afatinib,Receptor protein-tyrosine kinase erbB-2 inhibitor,Receptor protein-tyrosine kinase erbB-2
Tasimelteon,Melatonin receptor agonist,Melatonin receptor
Suvorexant,Orexin receptor antagonist,Orexin receptor
Idelalisib,PI3-kinase p110-delta subunit inhibitor,PI3-kinase p110-delta subunit
Cobimetinib,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,Dual specificity mitogen-activated protein kinase kinase 1
Bms-852927,LXR-beta modulator,LXR-beta
Ilorasertib,Platelet-derived growth factor receptor inhibitor,Platelet-derived growth factor receptor
Amg-548,MAP kinase p38 alpha inhibitor,MAP kinase p38 alpha
Ar-12,3-phosphoinositide dependent protein kinase-1 inhibitor,3-phosphoinositide dependent protein kinase-1
Azd-8186,PI3-kinase p110-beta subunit inhibitor,PI3-kinase p110-beta subunit
Bms-817378,Hepatocyte growth factor receptor inhibitor,Hepatocyte growth factor receptor
Cal-263,PI3-kinase p110-gamma subunit inhibitor,PI3-kinase p110-gamma subunit
Sgx-523,Hepatocyte growth factor receptor inhibitor,Hepatocyte growth factor receptor
Xl-844,Serine/threonine-protein kinase Chk1 inhibitor,Serine/threonine-protein kinase Chk1
Pbf-999,Phosphodiesterase 10A inhibitor,Phosphodiesterase 10A
Henatinib,Vascular endothelial growth factor receptor 2 inhibitor,Vascular endothelial growth factor receptor 2
Rg6029,Sodium channel protein type IX alpha subunit blocker,Sodium channel protein type IX alpha subunit
Galeterone,Androgen Receptor antagonist,Androgen Receptor
Elocalcitol,Vitamin D receptor agonist,Vitamin D receptor
V81444,Adenosine A2a receptor antagonist,Adenosine A2a receptor
Derenofylline,Adenosine A1 receptor antagonist,Adenosine A1 receptor
Traxoprodil,Glutamate NMDA receptor; GRIN1/GRIN2B antagonist,Glutamate NMDA receptor; GRIN1/GRIN2B
Dasolampanel,Glutamate receptor ionotropic AMPA antagonist,Glutamate receptor ionotropic AMPA
Xen-D0501,Vanilloid receptor antagonist,Vanilloid receptor
Canertinib,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Rolofylline,Adenosine A1 receptor antagonist,Adenosine A1 receptor
Vapreotide,Somatostatin receptor 5 agonist,Somatostatin receptor 5
Asapiprant,Prostanoid DP receptor antagonist,Prostanoid DP receptor
Ganitumab,Insulin-like growth factor I receptor antagonist,Insulin-like growth factor I receptor
Delantercept,Growth/differentiation factor 2 inhibitor,Growth/differentiation factor 2
Pafuramidine,Kinetoplast DNA inhibitor,Kinetoplast DNA
Betrixaban,Coagulation factor X inhibitor,Coagulation factor X
Edivoxetine,Norepinephrine transporter inhibitor,Norepinephrine transporter
Plinabulin,Tubulin inhibitor,Tubulin
Avagacestat,Gamma-secretase inhibitor,Gamma-secretase
Muparfostat,Heparanase inhibitor,Heparanase
Ro-4905417,P-selectin inhibitor,P-selectin
Ublituximab,B-lymphocyte antigen CD20 other,B-lymphocyte antigen CD20
Mm-302,DNA inhibitor,DNA
Artenimol,Unknown,
Tolvaptan,Vasopressin V2 receptor antagonist,Vasopressin V2 receptor
Lisinopril,Angiotensin-converting enzyme inhibitor,Angiotensin-converting enzyme
Pertuzumab,Receptor protein-tyrosine kinase erbB-2 inhibitor,Receptor protein-tyrosine kinase erbB-2
Emedastine,Histamine H1 receptor antagonist,Histamine H1 receptor
Propantheline,Muscarinic acetylcholine receptor M1 antagonist,Muscarinic acetylcholine receptor M1
Metolazone,Thiazide-sensitive sodium-chloride cotransporter inhibitor,Thiazide-sensitive sodium-chloride cotransporter
Insulin Glulisine,Insulin receptor agonist,Insulin receptor
Hexafluorenium,Acetylcholinesterase inhibitor,Acetylcholinesterase
Methylergonovine,Dopamine D1 receptor antagonist,Dopamine D1 receptor
Dasatinib,Ephrin type-A receptor 2 inhibitor,Ephrin type-A receptor 2
Dexmethylphenidate,Norepinephrine transporter inhibitor,Norepinephrine transporter
Probenecid,Solute carrier family 22 member 11 inhibitor,Solute carrier family 22 member 11
Oxymorphone,Opioid receptors; mu/kappa/delta agonist,Opioid receptors; mu/kappa/delta
Vinblastine,Tubulin inhibitor,Tubulin
Meclofenamic Acid,Cyclooxygenase inhibitor,Cyclooxygenase
Nimodipine,Voltage-gated L-type calcium channel blocker,Voltage-gated L-type calcium channel
Dimethyl Fumarate,Kelch-like ECH-associated protein 1 inhibitor,Kelch-like ECH-associated protein 1
Baclofen,GABA-B receptor agonist,GABA-B receptor
Abobotulinumtoxina,Synaptosomal-associated protein 25 inhibitor,Synaptosomal-associated protein 25
Clioquinol,Iron chelating agent,Iron
Tazobactam,Bacterial beta-lactamase TEM inhibitor,Bacterial beta-lactamase TEM
Oxytetracycline,Bacterial 70S ribosome inhibitor,Bacterial 70S ribosome
Ifosfamide,DNA inhibitor,DNA
Phenytoin,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Lucinactant,Surfactant agent,
Sodium Phenylacetate,Glutamine sequestering agent,Glutamine
Ramucirumab,Vascular endothelial growth factor receptor 2 inhibitor,Vascular endothelial growth factor receptor 2
Nintedanib,Platelet-derived growth factor receptor inhibitor,Platelet-derived growth factor receptor
Naloxegol,Mu opioid receptor antagonist,Mu opioid receptor
Astemizole,Histamine H1 receptor antagonist,Histamine H1 receptor
Osimertinib,Epidermal growth factor receptor inhibitor,Epidermal growth factor receptor
Su-014813,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Navarixin,Interleukin-8 receptor B antagonist,Interleukin-8 receptor B
Azd-7624,MAP kinase p38 alpha inhibitor,MAP kinase p38 alpha
Bms-387032,Cyclin-dependent kinase 7 inhibitor,Cyclin-dependent kinase 7
Jnj-26483327,Receptor protein-tyrosine kinase erbB-4 inhibitor,Receptor protein-tyrosine kinase erbB-4
Plx-7486,Macrophage colony stimulating factor receptor inhibitor,Macrophage colony stimulating factor receptor
R-348,Tyrosine-protein kinase SYK inhibitor,Tyrosine-protein kinase SYK
Qaf805,Adenosine A3 receptor antagonist,Adenosine A3 receptor
Rg-1530,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Me-401,PI3-kinase p110-delta subunit inhibitor,PI3-kinase p110-delta subunit
Cb-189625,Transient receptor potential cation channel subfamily A member 1 antagonist,Transient receptor potential cation channel subfamily A member 1
Indeglitazar,Peroxisome proliferator-activated receptor agonist,Peroxisome proliferator-activated receptor
Cr 1447,Estrogen receptor beta agonist,Estrogen receptor beta
Int131,Peroxisome proliferator-activated receptor gamma modulator,Peroxisome proliferator-activated receptor gamma
Azd-5363,Serine/threonine-protein kinase AKT inhibitor,Serine/threonine-protein kinase AKT
Telatinib,Vascular endothelial growth factor receptor 3 inhibitor,Vascular endothelial growth factor receptor 3
Ly377604,Beta-2 adrenergic receptor antagonist,Beta-2 adrenergic receptor
Orvepitant,Neurokinin 1 receptor antagonist,Neurokinin 1 receptor
Safotibant,Bradykinin B1 receptor antagonist,Bradykinin B1 receptor
Nd0801,Neuronal acetylcholine receptor protein alpha-7 subunit agonist,Neuronal acetylcholine receptor protein alpha-7 subunit
Nerispirdine,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Enobosarm,Androgen Receptor modulator,Androgen Receptor
Masitinib,Stem cell growth factor receptor inhibitor,Stem cell growth factor receptor
Semaxanib,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Casopitant,Neurokinin 1 receptor antagonist,Neurokinin 1 receptor
Amibegron,Beta-3 adrenergic receptor agonist,Beta-3 adrenergic receptor
Balugrastim,Granulocyte colony stimulating factor receptor agonist,Granulocyte colony stimulating factor receptor
Talarozole,Cytochrome P450 26A1 inhibitor,Cytochrome P450 26A1
Talazoparib,Poly [ADP-ribose] polymerase 2 inhibitor,Poly [ADP-ribose] polymerase 2
Lenalidomide,CRL4(CRBN) E3 ubiquitin ligase inhibitor,CRL4(CRBN) E3 ubiquitin ligase
Huhmfg1,Mucin-1 other,Mucin-1
Trebananib,Angiopoietin-1 inhibitor,Angiopoietin-1
Taplitumomab Paptox,B-lymphocyte antigen CD19 binding agent,B-lymphocyte antigen CD19
Pritumumab,Vimentin other,Vimentin
Ozanezumab,Reticulon-4 inhibitor,Reticulon-4
Zolimomab Aritox,T-cell surface glycoprotein CD5 binding agent,T-cell surface glycoprotein CD5
Humax-Il8,Interleukin-8 inhibitor,Interleukin-8
Radiprodil,Glutamate NMDA receptor; GRIN1/GRIN2B antagonist,Glutamate NMDA receptor; GRIN1/GRIN2B
Carbachol,Muscarinic acetylcholine receptor M3 agonist,Muscarinic acetylcholine receptor M3
Lepirudin,Thrombin inhibitor,Thrombin
Loratadine,Histamine H1 receptor antagonist,Histamine H1 receptor
Histamine,Histamine H1 receptor agonist,Histamine H1 receptor
Choriogonadotropin Alfa,Luteinizing hormone/Choriogonadotropin receptor agonist,Luteinizing hormone/Choriogonadotropin receptor
Atropine,Muscarinic acetylcholine receptor M1 antagonist,Muscarinic acetylcholine receptor M1
Esmolol,Beta-1 adrenergic receptor antagonist,Beta-1 adrenergic receptor
Paroxetine,Serotonin transporter inhibitor,Serotonin transporter
Trifluoperazine,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Azacitidine,DNA (cytosine-5)-methyltransferase 1 inhibitor,DNA (cytosine-5)-methyltransferase 1
Loteprednol Etabonate,Glucocorticoid receptor agonist,Glucocorticoid receptor
Pemetrexed,Dihydrofolate reductase inhibitor,Dihydrofolate reductase
Phenylpropanolamine,Norepinephrine transporter releasing agent,Norepinephrine transporter
Raltegravir,Human immunodeficiency virus type 1 integrase inhibitor,Human immunodeficiency virus type 1 integrase
Felbamate,Glutamate [NMDA] receptor antagonist,Glutamate [NMDA] receptor
Phenylephrine,Adrenergic receptor alpha-1 agonist,Adrenergic receptor alpha-1
Glimepiride,"Sulfonylurea receptor 1, Kir6.2 blocker","Sulfonylurea receptor 1, Kir6.2"
Cloxacillin,Penicillin-binding protein inhibitor,Penicillin-binding protein
Ocriplasmin,Collagen hydrolytic enzyme,Collagen
Thiabendazole,Tubulin inhibitor,Tubulin
Cephalexin,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Carbenicillin,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Amikacin,Bacterial 70S ribosome inhibitor,Bacterial 70S ribosome
Candicidin,Cell membrane inhibitor,Cell membrane
Retapamulin,70S ribosome inhibitor,70S ribosome
Carboplatin,DNA inhibitor,DNA
Enflurane,Potassium channel subfamily K member 2 opener,Potassium channel subfamily K member 2
Sevelamer Hydrochloride,Phosphate sequestering agent,Phosphate
Glatiramer Acetate,Unknown,
Vasopressin,Vasopressin receptor agonist,Vasopressin receptor
Panobinostat,Histone deacetylase inhibitor,Histone deacetylase
Irx4310,Retinoic acid receptor antagonist,Retinoic acid receptor
Arq-736,Serine/threonine-protein kinase B-raf inhibitor,Serine/threonine-protein kinase B-raf
Ly-2780301,Serine/threonine-protein kinase AKT inhibitor,Serine/threonine-protein kinase AKT
Qc-12,Unknown,
Rgb-286638,Cyclin-dependent kinase 2 inhibitor,Cyclin-dependent kinase 2
Sch-900776,Serine/threonine-protein kinase Chk1 inhibitor,Serine/threonine-protein kinase Chk1
Fk453,Adenosine A1 receptor antagonist,Adenosine A1 receptor
Cafusertib,Serine/threonine-protein kinase PLK1 inhibitor,Serine/threonine-protein kinase PLK1
Elpetrigine,Voltage-gated N-type calcium channel alpha-1B subunit blocker,Voltage-gated N-type calcium channel alpha-1B subunit
Anlotinib,Stem cell growth factor receptor inhibitor,Stem cell growth factor receptor
At-9283,Serine/threonine-protein kinase Aurora-B inhibitor,Serine/threonine-protein kinase Aurora-B
Mgcd-265,Hepatocyte growth factor receptor inhibitor,Hepatocyte growth factor receptor
(7s)-Hydroxyl-Staurosporine,Cyclin-dependent kinase 6 inhibitor,Cyclin-dependent kinase 6
Vipadenant,Adenosine A2a receptor antagonist,Adenosine A2a receptor
Lanicemine,Glutamate [NMDA] receptor blocker,Glutamate [NMDA] receptor
Laropiprant,Prostanoid DP receptor antagonist,Prostanoid DP receptor
Quizartinib,Stem cell growth factor receptor inhibitor,Stem cell growth factor receptor
Pomaglumetad Methionil,Metabotropic glutamate receptor 2 agonist,Metabotropic glutamate receptor 2
Pomaglumetad Methionil,Metabotropic glutamate receptor 3 agonist,Metabotropic glutamate receptor 3
Naproxen Etemesil,Cyclooxygenase inhibitor,Cyclooxygenase
Pomalidomide,CRL4(CRBN) E3 ubiquitin ligase inhibitor,CRL4(CRBN) E3 ubiquitin ligase
Medi-551,B-lymphocyte antigen CD19 other,B-lymphocyte antigen CD19
Inolimomab,Interleukin-2 receptor alpha chain antagonist,Interleukin-2 receptor alpha chain
Lgx-806,Serine/threonine-protein kinase RAF inhibitor,Serine/threonine-protein kinase RAF
Vardenafil,Phosphodiesterase 5A inhibitor,Phosphodiesterase 5A
Saxagliptin,Dipeptidyl peptidase IV inhibitor,Dipeptidyl peptidase IV
Rizatriptan,Serotonin 1d (5-HT1d) receptor agonist,Serotonin 1d (5-HT1d) receptor
Molindone,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Quetiapine,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Haloperidol,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Loxapine,Serotonin 2c (5-HT2c) receptor antagonist,Serotonin 2c (5-HT2c) receptor
Tafluprost,Prostanoid FP receptor agonist,Prostanoid FP receptor
Miglustat,Ceramide glucosyltransferase inhibitor,Ceramide glucosyltransferase
Estradiol,Estrogen receptor alpha agonist,Estrogen receptor alpha
Toremifene,Estrogen receptor modulator,Estrogen receptor
Testosterone Enanthate,Androgen Receptor agonist,Androgen Receptor
Vilanterol,Beta-2 adrenergic receptor agonist,Beta-2 adrenergic receptor
Apixaban,Coagulation factor X inhibitor,Coagulation factor X
Triclosan,Bacterial enoyl-[acyl-carrier-protein] reductase inhibitor,Bacterial enoyl-[acyl-carrier-protein] reductase
Albendazole,Tubulin inhibitor,Tubulin
Rofecoxib,Cyclooxygenase-2 inhibitor,Cyclooxygenase-2
Benzphetamine,Synaptic vesicular amine transporter inhibitor,Synaptic vesicular amine transporter
Indinavir,Human immunodeficiency virus type 1 protease inhibitor,Human immunodeficiency virus type 1 protease
Tolterodine,Muscarinic acetylcholine receptor M2 antagonist,Muscarinic acetylcholine receptor M2
Vecuronium,Muscle-type nicotinic acetylcholine receptor antagonist,Muscle-type nicotinic acetylcholine receptor
Ribavirin,RNA inhibitor,RNA
Propofol,GABA-A receptor; anion channel positive allosteric modulator,GABA-A receptor; anion channel
Bacampicillin,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Ceftazidime,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Carglumic Acid,"Carbamoyl-phosphate synthase [ammonia], mitochondrial positive allosteric modulator","Carbamoyl-phosphate synthase [ammonia], mitochondrial"
Dyclonine,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Nitazoxanide,Pyruvate:ferredoxin oxidoreductase inhibitor,Pyruvate:ferredoxin oxidoreductase
Gatifloxacin,Topoisomerase IV inhibitor,Topoisomerase IV
Enflurane,Potassium channel subfamily K member 9 opener,Potassium channel subfamily K member 9
Sacrosidase,Sucrose hydrolytic enzyme,Sucrose
Chromic Phosphate,Unknown,
Methyl Salicylate,Unknown,
Simeprevir,"Hepatitis C virus serine protease, NS3/NS4A inhibitor","Hepatitis C virus serine protease, NS3/NS4A"
Dasabuvir,Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor,Hepatitis C virus NS5B RNA-dependent RNA polymerase
Daclatasvir,Nonstructural protein 5A inhibitor,Nonstructural protein 5A
Turofexorate Isopropyl,Bile acid receptor FXR agonist,Bile acid receptor FXR
Cer-002,Peroxisome proliferator-activated receptor delta agonist,Peroxisome proliferator-activated receptor delta
Ac-480,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Gsk-1059615,PI3-kinase class I inhibitor,PI3-kinase class I
Osi-930,Stem cell growth factor receptor inhibitor,Stem cell growth factor receptor
Cep-2563,Tyrosine-protein kinase receptor FLT3 inhibitor,Tyrosine-protein kinase receptor FLT3
Ly2623091,Mineralocorticoid receptor antagonist,Mineralocorticoid receptor
Xl550,Mineralocorticoid receptor antagonist,Mineralocorticoid receptor
Azm-475271,Tyrosine-protein kinase SRC inhibitor,Tyrosine-protein kinase SRC
Sar-113945,Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor,Inhibitor of nuclear factor kappa B kinase beta subunit
Tesevatinib,Ephrin type-B receptor 4 inhibitor,Ephrin type-B receptor 4
Ly2940094,Nociceptin receptor antagonist,Nociceptin receptor
Odelepran,Opioid receptors; mu/kappa/delta antagonist,Opioid receptors; mu/kappa/delta
Befiradol,Serotonin 1a (5-HT1a) receptor agonist,Serotonin 1a (5-HT1a) receptor
Nebentan,Endothelin receptor ET-A antagonist,Endothelin receptor ET-A
Syl-1001,Vanilloid receptor antagonist,Vanilloid receptor
Masitinib,Platelet-derived growth factor receptor inhibitor,Platelet-derived growth factor receptor
Lestaurtinib,Tyrosine-protein kinase receptor RET inhibitor,Tyrosine-protein kinase receptor RET
Vapreotide,Somatostatin receptor 3 agonist,Somatostatin receptor 3
Motavizumab,Fusion glycoprotein F0 inhibitor,Fusion glycoprotein F0
Desmoteplase,Plasminogen activator,Plasminogen
Tildrakizumab,Interleukin-23 subunit alpha inhibitor,Interleukin-23 subunit alpha
Ic14,Monocyte differentiation antigen CD14 inhibitor,Monocyte differentiation antigen CD14
F16il2,Tenascin other,Tenascin
Aluminum Acetate,Unknown,
Argatroban,Thrombin inhibitor,Thrombin
Cyclizine,Histamine H1 receptor antagonist,Histamine H1 receptor
Alcaftadine,Histamine H1 receptor antagonist,Histamine H1 receptor
Dapiprazole,Alpha-1a adrenergic receptor antagonist,Alpha-1a adrenergic receptor
Dantrolene,Ryanodine receptor 1 antagonist,Ryanodine receptor 1
Regorafenib,Tyrosine-protein kinase ABL inhibitor,Tyrosine-protein kinase ABL
Alprostadil,Prostanoid EP2 receptor agonist,Prostanoid EP2 receptor
Zolmitriptan,Serotonin 1b (5-HT1b) receptor agonist,Serotonin 1b (5-HT1b) receptor
Ceruletide,Cholecystokinin A receptor agonist,Cholecystokinin A receptor
Fluoxetine,Serotonin transporter inhibitor,Serotonin transporter
Amitriptyline,Serotonin transporter inhibitor,Serotonin transporter
Vandetanib,Tyrosine-protein kinase SRC inhibitor,Tyrosine-protein kinase SRC
Lisdexamfetamine,Dopamine transporter releasing agent,Dopamine transporter
Beclomethasone Dipropionate,Glucocorticoid receptor agonist,Glucocorticoid receptor
Fluticasone Furoate,Glucocorticoid receptor agonist,Glucocorticoid receptor
Alclometasone Dipropionate,Glucocorticoid receptor agonist,Glucocorticoid receptor
Amitriptyline,Norepinephrine transporter inhibitor,Norepinephrine transporter
Trametinib,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,Dual specificity mitogen-activated protein kinase kinase 2
Pazopanib,Fibroblast growth factor receptor 1 inhibitor,Fibroblast growth factor receptor 1
Desogestrel,Progesterone receptor agonist,Progesterone receptor
Theophylline,Phosphodiesterase 4 inhibitor,Phosphodiesterase 4
Aspirin,Cyclooxygenase inhibitor,Cyclooxygenase
Indomethacin,Cyclooxygenase inhibitor,Cyclooxygenase
Bitolterol,Beta-2 adrenergic receptor agonist,Beta-2 adrenergic receptor
Vorinostat,Histone deacetylase 2 inhibitor,Histone deacetylase 2
Desflurane,Glycine receptor (alpha-1/beta) positive modulator,Glycine receptor (alpha-1/beta)
Sulfanilamide,Bacterial dihydropteroate synthase inhibitor,Bacterial dihydropteroate synthase
Cefaclor,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Cefprozil,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Cefonicid,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Mitoxantrone,DNA inhibitor,DNA
Trifluridine,DNA inhibitor,DNA
Haloperidol,D2-like dopamine receptor inverse agonist,D2-like dopamine receptor
Lindane,GABA-A receptor negative allosteric modulator,GABA-A receptor
Pemoline,Unknown,
Miltefosine,Unknown,
Tipiracil,Thymidine phosphorylase inhibitor,Thymidine phosphorylase
Bms-698769,Hepatocyte growth factor receptor inhibitor,Hepatocyte growth factor receptor
Cc-115,DNA-dependent protein kinase inhibitor,DNA-dependent protein kinase
Cep-37440,Focal adhesion kinase 1 inhibitor,Focal adhesion kinase 1
Olocrolimus,FK506-binding protein 1A inhibitor,FK506-binding protein 1A
Xl-418,Serine/threonine-protein kinase AKT inhibitor,Serine/threonine-protein kinase AKT
Bi113823,Bradykinin B1 receptor antagonist,Bradykinin B1 receptor
Efatutazone,Peroxisome proliferator-activated receptor gamma agonist,Peroxisome proliferator-activated receptor gamma
Foretinib,Hepatocyte growth factor receptor inhibitor,Hepatocyte growth factor receptor
Bafetinib,Tyrosine-protein kinase ABL inhibitor,Tyrosine-protein kinase ABL
Tg100-801,Fibroblast growth factor receptor 1 inhibitor,Fibroblast growth factor receptor 1
Ly-3023414,Serine/threonine-protein kinase mTOR inhibitor,Serine/threonine-protein kinase mTOR
Revexepride,Serotonin 4 (5-HT4) receptor agonist,Serotonin 4 (5-HT4) receptor
Fasitibant,Bradykinin B2 receptor antagonist,Bradykinin B2 receptor
Afacifenacin,Muscarinic acetylcholine receptor antagonist,Muscarinic acetylcholine receptor
Minopafant,Platelet activating factor receptor antagonist,Platelet activating factor receptor
Donitriptan,G protein-coupled receptor 44 antagonist,G protein-coupled receptor 44
Jts-653,Vanilloid receptor antagonist,Vanilloid receptor
Lecozotan,Serotonin 1a (5-HT1a) receptor antagonist,Serotonin 1a (5-HT1a) receptor
Ib-Meca,Adenosine A3 receptor agonist,Adenosine A3 receptor
Insulin Peglispro,Insulin receptor agonist,Insulin receptor
Forigerimod,Heat shock cognate 71 kDa protein inhibitor,Heat shock cognate 71 kDa protein
Etoricoxib,Cyclooxygenase-2 inhibitor,Cyclooxygenase-2
Emixustat,Retinoid isomerohydrolase inhibitor,Retinoid isomerohydrolase
Muparfostat,Basic fibroblast growth factor inhibitor,Basic fibroblast growth factor
Durvalumab,Programmed cell death 1 ligand 1 inhibitor,Programmed cell death 1 ligand 1
Cantuzumab Mertansine,Mucin-1 binding agent,Mucin-1
Dacetuzumab,Tumor necrosis factor receptor superfamily member 5 inhibitor,Tumor necrosis factor receptor superfamily member 5
Naptumomab Estafenatox,Trophoblast glycoprotein other,Trophoblast glycoprotein
Tregalizumab,T-cell surface antigen CD4 agonist,T-cell surface antigen CD4
Mor-103,Granulocyte-macrophage colony-stimulating factor inhibitor,Granulocyte-macrophage colony-stimulating factor
Bi-505,Intercellular adhesion molecule-1 antagonist,Intercellular adhesion molecule-1
Oncolysin Cd6,T-cell differentiation antigen CD6 binding agent,T-cell differentiation antigen CD6
Mbx-2044,Peroxisome proliferator-activated receptor gamma modulator,Peroxisome proliferator-activated receptor gamma
Pasireotide,Somatostatin receptor 5 agonist,Somatostatin receptor 5
Pazopanib,Macrophage colony stimulating factor receptor inhibitor,Macrophage colony stimulating factor receptor
Goserelin,Gonadotropin-releasing hormone receptor agonist,Gonadotropin-releasing hormone receptor
Palonosetron,Serotonin 3a (5-HT3a) receptor antagonist,Serotonin 3a (5-HT3a) receptor
Venlafaxine,Serotonin transporter inhibitor,Serotonin transporter
Imatinib,Stem cell growth factor receptor inhibitor,Stem cell growth factor receptor
Chlorprothixene,Serotonin 2c (5-HT2c) receptor antagonist,Serotonin 2c (5-HT2c) receptor
Amphetamine,Dopamine transporter releasing agent,Dopamine transporter
Oxycodone,Mu opioid receptor agonist,Mu opioid receptor
Tesamorelin,Growth hormone-releasing hormone receptor agonist,Growth hormone-releasing hormone receptor
Betamethasone Dipropionate,Glucocorticoid receptor agonist,Glucocorticoid receptor
Dexamethasone Acetate,Glucocorticoid receptor agonist,Glucocorticoid receptor
Mifepristone,Glucocorticoid receptor antagonist,Glucocorticoid receptor
Estrone,Estrogen receptor alpha agonist,Estrogen receptor alpha
Bethanidine,Norepinephrine transporter substrate,Norepinephrine transporter
Quinine,Ferriprotoporphyrin IX inhibitor,Ferriprotoporphyrin IX
Prazosin,Adrenergic receptor alpha-1 antagonist,Adrenergic receptor alpha-1
Fenoprofen,Cyclooxygenase inhibitor,Cyclooxygenase
Phentolamine,Adrenergic receptor alpha antagonist,Adrenergic receptor alpha
Tetrabenazine,Synaptic vesicular amine transporter inhibitor,Synaptic vesicular amine transporter
Meprobamate,GABA-A receptor; anion channel agonist,GABA-A receptor; anion channel
Peginterferon Alfa-2a,Interferon alpha/beta receptor agonist,Interferon alpha/beta receptor
Idoxuridine,DNA inhibitor,DNA
Enflurane,Potassium channel subfamily K member 18 opener,Potassium channel subfamily K member 18
Lamotrigine,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Pramlintide,Amylin receptor AMY2; CALCR/RAMP2 agonist,Amylin receptor AMY2; CALCR/RAMP2
Colestipol Hydrochloride,Bile acids sequestering agent,Bile acids
Alglucosidase Alfa,Starch hydrolytic enzyme,Starch
Chymotrypsin,Polypeptides proteolytic enzyme,Polypeptides
Levoleucovorin,Unknown,
Belinostat,Histone deacetylase inhibitor,Histone deacetylase
Nintedanib,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Olaparib,"PARP 1, 2 & 3 inhibitor","PARP 1, 2 and 3"
Lgd-2941,Androgen Receptor modulator,Androgen Receptor
Bms-779788,LXR-beta agonist,LXR-beta
Chiauranib,Serine/threonine-protein kinase Aurora-B inhibitor,Serine/threonine-protein kinase Aurora-B
Kw-2449,Serine/threonine-protein kinase Aurora-A inhibitor,Serine/threonine-protein kinase Aurora-A
Mp-412,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Rg-1530,Fibroblast growth factor receptor 1 inhibitor,Fibroblast growth factor receptor 1
Dsp-2230,Sodium channel protein type X alpha subunit blocker,Sodium channel protein type X alpha subunit
Mk-0773,Androgen Receptor modulator,Androgen Receptor
Semapimod,MAP kinase p38 alpha inhibitor,MAP kinase p38 alpha
Seliciclib,Cyclin-dependent kinase 1 inhibitor,Cyclin-dependent kinase 1
Ji-101,Platelet-derived growth factor receptor beta inhibitor,Platelet-derived growth factor receptor beta
Atopaxar,Proteinase-activated receptor 1 antagonist,Proteinase-activated receptor 1
Relcovaptan,Oxytocin receptor antagonist,Oxytocin receptor
Elsiglutide,Glucagon-like peptide 2 receptor agonist,Glucagon-like peptide 2 receptor
Azd7009,Sodium channel protein type V alpha subunit blocker,Sodium channel protein type V alpha subunit
Rapastinel,Glutamate [NMDA] receptor partial agonist,Glutamate [NMDA] receptor
P-1037,"Amiloride-sensitive sodium channel, ENaC blocker","Amiloride-sensitive sodium channel, ENaC"
Brivanib Alaninate,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Ruboxistaurin,Protein kinase C beta inhibitor,Protein kinase C beta
Dovitinib,Tyrosine-protein kinase receptor FLT3 inhibitor,Tyrosine-protein kinase receptor FLT3
Dovitinib,Platelet-derived growth factor receptor inhibitor,Platelet-derived growth factor receptor
Zibotentan,Endothelin receptor ET-A antagonist,Endothelin receptor ET-A
Siponimod,Sphingosine 1-phosphate receptor Edg-8 agonist,Sphingosine 1-phosphate receptor Edg-8
Darusentan,Endothelin receptor ET-B antagonist,Endothelin receptor ET-B
Iti-007,Dopamine D2 receptor partial agonist,Dopamine D2 receptor
Mirogabalin,Voltage-gated calcium channel alpha2/delta subunit 2 modulator,Voltage-gated calcium channel alpha2/delta subunit 2
Efungumab,Heat shock protein 90 homolog inhibitor,Heat shock protein 90 homolog
Lym-1,"HLA class II histocompatibility antigen, DRB1-10 beta chain other","HLA class II histocompatibility antigen, DRB1-10 beta chain"
Iodine I 124 Girentuximab,Carbonic anhydrase IX binding agent,Carbonic anhydrase IX
Cg250 177lu,Carbonic anhydrase IX binding agent,Carbonic anhydrase IX
Atacicept,Tumor necrosis factor ligand superfamily member 13B inhibitor,Tumor necrosis factor ligand superfamily member 13B
Semagacestat,Gamma-secretase inhibitor,Gamma-secretase
Liprotamase,Polypeptides proteolytic enzyme,Polypeptides
Blosozumab,Sclerostin inhibitor,Sclerostin
Crenezumab,Beta amyloid A4 protein other,Beta amyloid A4 protein
Oncolysin M,Myeloid cell surface antigen CD33 binding agent,Myeloid cell surface antigen CD33
Clemastine,Histamine H1 receptor antagonist,Histamine H1 receptor
Carbinoxamine,Histamine H1 receptor antagonist,Histamine H1 receptor
Dextromethorphan,Sigma opioid receptor agonist,Sigma opioid receptor
Methyclothiazide,Thiazide-sensitive sodium-chloride cotransporter inhibitor,Thiazide-sensitive sodium-chloride cotransporter
Paricalcitol,Vitamin D receptor agonist,Vitamin D receptor
Phenmetrazine,Dopamine transporter inhibitor,Dopamine transporter
Oxytocin,Oxytocin receptor agonist,Oxytocin receptor
Pralatrexate,Dihydrofolate reductase inhibitor,Dihydrofolate reductase
Abiraterone Acetate,Cytochrome P450 17A1 inhibitor,Cytochrome P450 17A1
"Estrogens, Conjugated",Estrogen receptor agonist,Estrogen receptor
Alfuzosin,Adrenergic receptor alpha-1 agonist,Adrenergic receptor alpha-1
Tacrine,Cholinesterases; ACHE & BCHE inhibitor,Cholinesterases; ACHE & BCHE
Protokylol,Beta-2 adrenergic receptor agonist,Beta-2 adrenergic receptor
Indacaterol,Beta-2 adrenergic receptor agonist,Beta-2 adrenergic receptor
Clopidogrel,Purinergic receptor P2Y12 antagonist,Purinergic receptor P2Y12
Clavulanic Acid,Bacterial beta-lactamase TEM inhibitor,Bacterial beta-lactamase TEM
Clarithromycin,Bacterial 70S ribosome inhibitor,Bacterial 70S ribosome
Halothane,Potassium channel subfamily K member 10 opener,Potassium channel subfamily K member 10
Propafenone,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Doxapram,Potassium channel subfamily K member 3 blocker,Potassium channel subfamily K member 3
Blinatumomab,T cell surface glycoprotein CD3 cross-linking agent,T cell surface glycoprotein CD3
Lumacaftor,Cystic fibrosis transmembrane conductance regulator stabiliser,Cystic fibrosis transmembrane conductance regulator
Enmd-981693,Tyrosine-protein kinase receptor FLT3 inhibitor,Tyrosine-protein kinase receptor FLT3
Ilx23-7553,Vitamin D receptor agonist,Vitamin D receptor
Bay-1125976,Serine/threonine-protein kinase AKT2 inhibitor,Serine/threonine-protein kinase AKT2
Cm-082,Vascular endothelial growth factor receptor 2 inhibitor,Vascular endothelial growth factor receptor 2
Jnj-26483327,Receptor protein-tyrosine kinase erbB-2 inhibitor,Receptor protein-tyrosine kinase erbB-2
Recilisib,PI3-kinase class I inhibitor,PI3-kinase class I
Ps-516895,MAP kinase p38 alpha inhibitor,MAP kinase p38 alpha
Hemay-022,Receptor protein-tyrosine kinase erbB-2 inhibitor,Receptor protein-tyrosine kinase erbB-2
Pf-03893787,Histamine H4 receptor antagonist,Histamine H4 receptor
Sonolisib,PI3-kinase class I inhibitor,PI3-kinase class I
Ralinepag,Prostanoid IP receptor agonist,Prostanoid IP receptor
Adc3680,G protein-coupled receptor 44 antagonist,G protein-coupled receptor 44
Azd1386,Vanilloid receptor antagonist,Vanilloid receptor
Grc-17536,Transient receptor potential cation channel subfamily A member 1 antagonist,Transient receptor potential cation channel subfamily A member 1
Acolbifene,Estrogen receptor modulator,Estrogen receptor
Lestaurtinib,Nerve growth factor receptor Trk-A inhibitor,Nerve growth factor receptor Trk-A
Dinaciclib,Cyclin-dependent kinase 1 inhibitor,Cyclin-dependent kinase 1
Fedratinib,Tyrosine-protein kinase JAK2 inhibitor,Tyrosine-protein kinase JAK2
Lixivaptan,Vasopressin V2 receptor antagonist,Vasopressin V2 receptor
Ralfinamide,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Ezatiostat,Glutathione S-transferase Pi inhibitor,Glutathione S-transferase Pi
Oprozomib,26S proteosome inhibitor,26S proteosome
Litronesib,Kinesin-like protein 1 inhibitor,Kinesin-like protein 1
Sotagliflozin,Sodium/glucose cotransporter 2 inhibitor,Sodium/glucose cotransporter 2
Muparfostat,Acidic fibroblast growth factor inhibitor,Acidic fibroblast growth factor
Cilengitide,Integrin alpha-V/beta-5 antagonist,Integrin alpha-V/beta-5
Priliximab,T-cell surface antigen CD4 negative modulator,T-cell surface antigen CD4
Keliximab,T-cell surface antigen CD4 negative modulator,T-cell surface antigen CD4
Mapatumumab,TRAIL receptor-1 agonist,TRAIL receptor-1
Artesunate,Unknown,
Isopropamide,Muscarinic acetylcholine receptor M3 antagonist,Muscarinic acetylcholine receptor M3
Ranibizumab,Vascular endothelial growth factor A inhibitor,Vascular endothelial growth factor A
Azelastine,Histamine H1 receptor antagonist,Histamine H1 receptor
Dexchlorpheniramine,Histamine H1 receptor antagonist,Histamine H1 receptor
Bepotastine,Histamine H1 receptor antagonist,Histamine H1 receptor
Cetuximab,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Gefitinib,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Zileuton,Arachidonate 5-lipoxygenase inhibitor,Arachidonate 5-lipoxygenase
Anisotropine,Muscarinic acetylcholine receptor M1 antagonist,Muscarinic acetylcholine receptor M1
Eltrombopag,Thrombopoietin receptor agonist,Thrombopoietin receptor
Regorafenib,Serine/threonine-protein kinase RAF inhibitor,Serine/threonine-protein kinase RAF
Amoxapine,Serotonin transporter inhibitor,Serotonin transporter
Sorafenib,Stem cell growth factor receptor inhibitor,Stem cell growth factor receptor
Fluorouracil,Thymidylate synthase inhibitor,Thymidylate synthase
Dofetilide,HERG blocker,HERG
Insulin Detemir,Insulin receptor agonist,Insulin receptor
Buprenorphine,Mu opioid receptor agonist,Mu opioid receptor
Rimexolone,Glucocorticoid receptor agonist,Glucocorticoid receptor
Drotrecogin Alfa (Activated),Coagulation factor V inhibitor,Coagulation factor V
Probenecid,Solute carrier family 22 member 8 inhibitor,Solute carrier family 22 member 8
Sunitinib,Platelet-derived growth factor receptor inhibitor,Platelet-derived growth factor receptor
Testosterone,Androgen Receptor agonist,Androgen Receptor
Azlocillin,Penicillin-binding protein inhibitor,Penicillin-binding protein
Ethchlorvynol,GABA-A receptor; anion channel positive modulator,GABA-A receptor; anion channel
Chloramphenicol Palmitate,Bacterial 70S ribosome inhibitor,Bacterial 70S ribosome
Daptomycin,Cell membrane inhibitor,Cell membrane
Crystal Violet,DNA inhibitor,DNA
Cladribine,DNA inhibitor,DNA
Alatrofloxacin,Bacterial DNA gyrase inhibitor,Bacterial DNA gyrase
Dalfampridine,Voltage-gated potassium channel blocker,Voltage-gated potassium channel
Methyl Aminolevulinate,DNA inhibitor,DNA
Ast-487,Tyrosine-protein kinase receptor FLT3 inhibitor,Tyrosine-protein kinase receptor FLT3
Cm-082,Tyrosine-protein kinase receptor FLT3 inhibitor,Tyrosine-protein kinase receptor FLT3
Gsk-1070916,Serine/threonine-protein kinase Aurora-C inhibitor,Serine/threonine-protein kinase Aurora-C
Gsk-690693,Serine/threonine-protein kinase AKT inhibitor,Serine/threonine-protein kinase AKT
Gsk-690693,cAMP-dependent protein kinase (PKA) inhibitor,cAMP-dependent protein kinase (PKA)
Ly-3007113,MAP kinase p38 alpha inhibitor,MAP kinase p38 alpha
Mk-8033,Hepatocyte growth factor receptor inhibitor,Hepatocyte growth factor receptor
Plx-8394,Serine/threonine-protein kinase B-raf inhibitor,Serine/threonine-protein kinase B-raf
Tas-115,Vascular endothelial growth factor receptor 2 inhibitor,Vascular endothelial growth factor receptor 2
Xl-228,Insulin-like growth factor I receptor inhibitor,Insulin-like growth factor I receptor
Temanogrel,Serotonin 2a (5-HT2a) receptor inverse agonist,Serotonin 2a (5-HT2a) receptor
Ly2979165,Metabotropic glutamate receptor 2 agonist,Metabotropic glutamate receptor 2
Gsk2798745,Transient receptor potential cation channel subfamily V member 4 antagonist,Transient receptor potential cation channel subfamily V member 4
Finerenone,Mineralocorticoid receptor antagonist,Mineralocorticoid receptor
Peficitinib,Janus Kinase (JAK) inhibitor,Janus Kinase (JAK)
Enmd-2076,Serine/threonine-protein kinase Aurora-B inhibitor,Serine/threonine-protein kinase Aurora-B
Mk-2461,Hepatocyte growth factor receptor inhibitor,Hepatocyte growth factor receptor
Milciclib,Cyclin-dependent kinase 4 inhibitor,Cyclin-dependent kinase 4
Pamapimod,MAP kinase p38 alpha inhibitor,MAP kinase p38 alpha
Cerlapirdine,Serotonin 6 (5-HT6) receptor antagonist,Serotonin 6 (5-HT6) receptor
Selodenoson,Adenosine A1 receptor agonist,Adenosine A1 receptor
Cenicriviroc,C-C chemokine receptor type 2 antagonist,C-C chemokine receptor type 2
Lemborexant,Orexin receptor 2 antagonist,Orexin receptor 2
Azd2066,Metabotropic glutamate receptor 5 modulator,Metabotropic glutamate receptor 5
Fadolmidine,Adrenergic receptor alpha-2 agonist,Adrenergic receptor alpha-2
Etalocib,Peroxisome proliferator-activated receptor gamma agonist,Peroxisome proliferator-activated receptor gamma
Ngd-8243,Vanilloid receptor antagonist,Vanilloid receptor
Baricitinib,Tyrosine-protein kinase JAK2 inhibitor,Tyrosine-protein kinase JAK2
Binodenoson,Adenosine A2a receptor agonist,Adenosine A2a receptor
Idalopirdine,Serotonin 6 (5-HT6) receptor antagonist,Serotonin 6 (5-HT6) receptor
Volinanserin,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Iferanserin,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Zoptarelin Doxorubicin,Gonadotropin-releasing hormone receptor agonist,Gonadotropin-releasing hormone receptor
Moxetumomab Pasudotox,CD22 other,CD22
Entolimod,Toll-like receptor 5 agonist,Toll-like receptor 5
Naproxcinod,Cyclooxygenase inhibitor,Cyclooxygenase
Neramexane,Glutamate [NMDA] receptor antagonist,Glutamate [NMDA] receptor
Delantercept,Bone morphogenetic protein 10 inhibitor,Bone morphogenetic protein 10
Enokizumab,Interleukin-9 inhibitor,Interleukin-9
Ponezumab,Beta amyloid A4 protein other,Beta amyloid A4 protein
Emd-273063,Disialoganglioside GD2 other,Disialoganglioside GD2
Biw-8962,Disialoganglioside GD2 inhibitor,Disialoganglioside GD2
Al-901,Ig epsilon chain C region inhibitor,Ig epsilon chain C region
Pg-102,Tumor necrosis factor receptor superfamily member 5 inhibitor,Tumor necrosis factor receptor superfamily member 5
Cdp-7657,CD40 ligand inhibitor,CD40 ligand
Iph-2101,Killer cell immunoglobulin-like receptor 2DL1 inhibitor,Killer cell immunoglobulin-like receptor 2DL1
Propylthiouracil,Thyroid peroxidase inhibitor,Thyroid peroxidase
Ethionamide,Enoyl-[acyl-carrier-protein] reductase inhibitor,Enoyl-[acyl-carrier-protein] reductase
Balsalazid,Arachidonate 5-lipoxygenase inhibitor,Arachidonate 5-lipoxygenase
Sulfasalazine,Arachidonate 5-lipoxygenase inhibitor,Arachidonate 5-lipoxygenase
Procyclidine,Muscarinic acetylcholine receptor M1 antagonist,Muscarinic acetylcholine receptor M1
Sotalol,Beta-1 adrenergic receptor antagonist,Beta-1 adrenergic receptor
Sertraline,Serotonin transporter inhibitor,Serotonin transporter
Duloxetine,Serotonin transporter inhibitor,Serotonin transporter
Insulin Pork,Insulin receptor agonist,Insulin receptor
Insulin Susp Isophane Purified Beef,Insulin receptor agonist,Insulin receptor
Sumatriptan,Serotonin 1d (5-HT1d) receptor agonist,Serotonin 1d (5-HT1d) receptor
Urofollitropin,Follicle stimulating hormone receptor agonist,Follicle stimulating hormone receptor
Prednisolone,Glucocorticoid receptor agonist,Glucocorticoid receptor
Bupivacaine,Sodium channel protein type IV alpha subunit blocker,Sodium channel protein type IV alpha subunit
Methylphenidate,Norepinephrine transporter inhibitor,Norepinephrine transporter
Chloroquine,Ferriprotoporphyrin IX inhibitor,Ferriprotoporphyrin IX
Fluvastatin,HMG-CoA reductase inhibitor,HMG-CoA reductase
Naltrexone,Opioid receptors; mu/kappa/delta antagonist,Opioid receptors; mu/kappa/delta
Midodrine,Adrenergic receptor alpha-1 agonist,Adrenergic receptor alpha-1
Oxaprozin,Cyclooxygenase inhibitor,Cyclooxygenase
Hydroxyurea,Ribonucleoside-diphosphate reductase RR1 inhibitor,Ribonucleoside-diphosphate reductase RR1
Tegaserod,Serotonin 4 (5-HT4) receptor partial agonist,Serotonin 4 (5-HT4) receptor
Abatacept,T-lymphocyte activation antigen CD80 inhibitor,T-lymphocyte activation antigen CD80
Atropine,Muscarinic acetylcholine receptor M2 antagonist,Muscarinic acetylcholine receptor M2
Estazolam,GABA-A receptor; anion channel positive allosteric modulator,GABA-A receptor; anion channel
Quazepam,GABA-A receptor; anion channel positive allosteric modulator,GABA-A receptor; anion channel
Dicloxacillin,Penicillin-binding protein inhibitor,Penicillin-binding protein
Demeclocycline,Bacterial 70S ribosome inhibitor,Bacterial 70S ribosome
Interferon Alfa-2b,Interferon alpha/beta receptor agonist,Interferon alpha/beta receptor
Grepafloxacin,Topoisomerase IV inhibitor,Topoisomerase IV
Desflurane,Potassium channel subfamily K member 3 opener,Potassium channel subfamily K member 3
Ferumoxytol,Unknown,
Podofilox,Unknown,
Flibanserin,Unknown,
Chiauranib,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Omipalisib,Serine/threonine-protein kinase mTOR inhibitor,Serine/threonine-protein kinase mTOR
Mk-8353,MAP kinase ERK2 inhibitor,MAP kinase ERK2
Pf-03814735,Serine/threonine-protein kinase Aurora-B inhibitor,Serine/threonine-protein kinase Aurora-B
Ly404039,Metabotropic glutamate receptor 3 agonist,Metabotropic glutamate receptor 3
G1t28-1,Cyclin-dependent kinase 4 inhibitor,Cyclin-dependent kinase 4
Anlotinib,Vascular endothelial growth factor receptor 2 inhibitor,Vascular endothelial growth factor receptor 2
Alpelisib,PI3-kinase p110-alpha subunit inhibitor,PI3-kinase p110-alpha subunit
Ji-101,Vascular endothelial growth factor receptor 2 inhibitor,Vascular endothelial growth factor receptor 2
Verucerfont,Corticotropin releasing factor receptor 1 antagonist,Corticotropin releasing factor receptor 1
Ccx140,C-C chemokine receptor type 2 antagonist,C-C chemokine receptor type 2
Sb-773812,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Carmoterol,Beta-2 adrenergic receptor agonist,Beta-2 adrenergic receptor
Becampanel,Glutamate receptor ionotropic AMPA antagonist,Glutamate receptor ionotropic AMPA
Alvocidib,Cyclin-dependent kinase 6 inhibitor,Cyclin-dependent kinase 6
Osemozotan,Serotonin 1a (5-HT1a) receptor agonist,Serotonin 1a (5-HT1a) receptor
Ralfinamide,Monoamine oxidase B inhibitor,Monoamine oxidase B
Inotuzumab Ozogamicin,CD22 binding agent,CD22
Bitopertin,Glycine transporter 1 inhibitor,Glycine transporter 1
Dianhydrogalactitol,DNA cross-linking agent,DNA
Navitoclax,Apoptosis regulator Bcl-X inhibitor,Apoptosis regulator Bcl-X
Burosumab,Fibroblast growth factor 23 inhibitor,Fibroblast growth factor 23
Ensituximab,Mucin-5AC other,Mucin-5AC
Samalizumab,OX-2 membrane glycoprotein inhibitor,OX-2 membrane glycoprotein
Fontolizumab,Interferon gamma inhibitor,Interferon gamma
Elsilimomab,Interleukin-6 inhibitor,Interleukin-6
Oxelumab,Tumor necrosis factor ligand superfamily member 4 inhibitor,Tumor necrosis factor ligand superfamily member 4
Dusigitumab,Insulin-like growth factor I inhibitor,Insulin-like growth factor I
Dusigitumab,Insulin-like growth factor II inhibitor,Insulin-like growth factor II
Ave-1642,Insulin-like growth factor I receptor antagonist,Insulin-like growth factor I receptor
Rg-7160,Epidermal growth factor receptor erbB1 antagonist,Epidermal growth factor receptor erbB1
Perphenazine,Dopamine D2 receptor antagonist,Dopamine D2 receptor
Trimipramine,Dopamine D2 receptor antagonist,Dopamine D2 receptor
Azilsartan Medoxomil,Type-1 angiotensin II receptor antagonist,Type-1 angiotensin II receptor
Meclofenamic Acid,Arachidonate 5-lipoxygenase inhibitor,Arachidonate 5-lipoxygenase
Protriptyline,Serotonin transporter inhibitor,Serotonin transporter
Olsalazine,Peroxisome proliferator-activated receptor gamma agonist,Peroxisome proliferator-activated receptor gamma
Regorafenib,Stem cell growth factor receptor inhibitor,Stem cell growth factor receptor
Cyclosporine,Cyclophilin A modulator,Cyclophilin A
Cosyntropin,Melanocortin receptor 2 agonist,Melanocortin receptor 2
Insulin Zinc Susp Prompt Beef,Insulin receptor agonist,Insulin receptor
Naratriptan,Serotonin 1d (5-HT1d) receptor agonist,Serotonin 1d (5-HT1d) receptor
Methadone,Mu opioid receptor agonist,Mu opioid receptor
Human Fsh,Follicle stimulating hormone receptor agonist,Follicle stimulating hormone receptor
Lamivudine,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,Human immunodeficiency virus type 1 reverse transcriptase
Diethylstilbestrol,Estrogen receptor alpha agonist,Estrogen receptor alpha
Maprotiline,Norepinephrine transporter inhibitor,Norepinephrine transporter
Dichlorphenamide,Carbonic anhydrase XII inhibitor,Carbonic anhydrase XII
Nalbuphine,Opioid receptors; mu/kappa/delta agonist,Opioid receptors; mu/kappa/delta
Ponatinib,Bcr/Abl fusion protein inhibitor,Bcr/Abl fusion protein
Flurbiprofen,Cyclooxygenase inhibitor,Cyclooxygenase
Nitroglycerin,Soluble guanylate cyclase activator,Soluble guanylate cyclase
Chlorpropamide,"Sulfonylurea receptor 1, Kir6.2 blocker","Sulfonylurea receptor 1, Kir6.2"
Denileukin Diftitox,Elongation factor 2 inhibitor,Elongation factor 2
Testosterone Propionate,Androgen Receptor agonist,Androgen Receptor
Sertaconazole,Cytochrome P450 51 inhibitor,Cytochrome P450 51
Famciclovir,Human herpesvirus 1 DNA polymerase inhibitor,Human herpesvirus 1 DNA polymerase
Valacyclovir,Human herpesvirus 1 DNA polymerase inhibitor,Human herpesvirus 1 DNA polymerase
Lamivudine,DNA inhibitor,DNA
Enflurane,Glycine receptor (alpha-1/beta) positive modulator,Glycine receptor (alpha-1/beta)
Dimercaprol,Heavy metals chelating agent,Heavy metals
Clioquinol,Copper chelating agent,Copper
Thiamylal,GABA-A receptor; anion channel positive allosteric modulator,GABA-A receptor; anion channel
Trovafloxacin,Topoisomerase IV inhibitor,Topoisomerase IV
Sulfamethoxazole,Bacterial dihydropteroate synthase inhibitor,Bacterial dihydropteroate synthase
Cefuroxime,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Cefpiramide,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Erythromycin Estolate,Bacterial 70S ribosome inhibitor,Bacterial 70S ribosome
Cisplatin,DNA inhibitor,DNA
Desflurane,Potassium channel subfamily K member 2 opener,Potassium channel subfamily K member 2
Linezolid,Bacterial 70S ribosome inhibitor,Bacterial 70S ribosome
Pegademase Bovine,2'-deoxyadenosine hydrolytic enzyme,2'-deoxyadenosine
Pegademase Bovine,Adenosine hydrolytic enzyme,Adenosine
Bisacodyl,Unknown,
Auranofin,Unknown,
Menotropins,Follicle stimulating hormone receptor agonist,Follicle stimulating hormone receptor
Ceritinib,ALK tyrosine kinase receptor inhibitor,ALK tyrosine kinase receptor
Px-102,Bile acid receptor FXR agonist,Bile acid receptor FXR
Kw-2449,Tyrosine-protein kinase receptor FLT3 inhibitor,Tyrosine-protein kinase receptor FLT3
Tgr-1202,PI3-kinase p110-delta subunit inhibitor,PI3-kinase p110-delta subunit
Vgx-1027,Unknown,
Erteberel,Estrogen receptor beta agonist,Estrogen receptor beta
Atx08-001,Peroxisome proliferator-activated receptor gamma modulator,Peroxisome proliferator-activated receptor gamma
Aee-788,Vascular endothelial growth factor receptor 2 inhibitor,Vascular endothelial growth factor receptor 2
At-9283,Tyrosine-protein kinase JAK3 inhibitor,Tyrosine-protein kinase JAK3
Buparlisib,PI3-kinase class I inhibitor,PI3-kinase class I
Rociletinib,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
R-112,Tyrosine-protein kinase SYK inhibitor,Tyrosine-protein kinase SYK
Defactinib,Focal adhesion kinase 1 inhibitor,Focal adhesion kinase 1
Xl-820,Stem cell growth factor receptor inhibitor,Stem cell growth factor receptor
Xl-999,Tyrosine-protein kinase receptor FLT3 inhibitor,Tyrosine-protein kinase receptor FLT3
Rg7314,Vasopressin V1a receptor antagonist,Vasopressin V1a receptor
Pratosartan,Solute carrier family 22 member 12 inhibitor,Solute carrier family 22 member 12
Incb-047986,Tyrosine-protein kinase JAK1 inhibitor,Tyrosine-protein kinase JAK1
Vidupiprant,Prostanoid DP receptor antagonist,Prostanoid DP receptor
Mk-8777,Glutamate receptor ionotropic AMPA positive allosteric modulator,Glutamate receptor ionotropic AMPA
Muraglitazar,Peroxisome proliferator-activated receptor alpha agonist,Peroxisome proliferator-activated receptor alpha
Vatalanib,Stem cell growth factor receptor inhibitor,Stem cell growth factor receptor
Orantinib,Vascular endothelial growth factor receptor 2 inhibitor,Vascular endothelial growth factor receptor 2
Esmirtazapine,Adrenergic receptor alpha-2 antagonist,Adrenergic receptor alpha-2
Tezosentan,Endothelin receptor ET-A antagonist,Endothelin receptor ET-A
Terameprocol,DNA inhibitor,DNA
Polmacoxib,Carbonic anhydrase I inhibitor,Carbonic anhydrase I
Margetuximab,Receptor protein-tyrosine kinase erbB-2 inhibitor,Receptor protein-tyrosine kinase erbB-2
Zonampanel,Glutamate receptor ionotropic AMPA antagonist,Glutamate receptor ionotropic AMPA
Intetumumab,Integrin alpha-V/beta-3 antagonist,Integrin alpha-V/beta-3
Metelimumab,Transforming growth factor beta-1 inhibitor,Transforming growth factor beta-1
Lirilumab,Killer cell immunoglobulin-like receptor 2DL2 inhibitor,Killer cell immunoglobulin-like receptor 2DL2
Dalotuzumab,Insulin-like growth factor I receptor antagonist,Insulin-like growth factor I receptor
Tridihexethyl,Muscarinic acetylcholine receptor M3 antagonist,Muscarinic acetylcholine receptor M3
Zafirlukast,Cysteinyl leukotriene receptor 1 antagonist,Cysteinyl leukotriene receptor 1
Infliximab,TNF-alpha inhibitor,TNF-alpha
Triptorelin,Gonadotropin-releasing hormone receptor agonist,Gonadotropin-releasing hormone receptor
Betaxolol,Beta-1 adrenergic receptor antagonist,Beta-1 adrenergic receptor
Chlorthalidone,Thiazide-sensitive sodium-chloride cotransporter inhibitor,Thiazide-sensitive sodium-chloride cotransporter
Aminoglutethimide,Cytochrome P450 19A1 inhibitor,Cytochrome P450 19A1
Dinoprost,Prostanoid FP receptor agonist,Prostanoid FP receptor
Carboprost,Prostanoid FP receptor agonist,Prostanoid FP receptor
Pralidoxime,Acetylcholinesterase activator,Acetylcholinesterase
Progesterone,Progesterone receptor agonist,Progesterone receptor
Drospirenone,Progesterone receptor agonist,Progesterone receptor
Ethoxzolamide,Carbonic anhydrase inhibitor,Carbonic anhydrase
Mycophenolate Mofetil,Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor,Inosine-5'-monophosphate dehydrogenase (IMPDH)
Levallorphan,Kappa opioid receptor partial agonist,Kappa opioid receptor
Trimetrexate,Dihydrofolate reductase inhibitor,Dihydrofolate reductase
Mivacurium,Muscle-type nicotinic acetylcholine receptor antagonist,Muscle-type nicotinic acetylcholine receptor
Penicillamine,Copper chelating agent,Copper
Chloroxine,DNA inhibitor,DNA
Altretamine,DNA inhibitor,DNA
Temozolomide,DNA inhibitor,DNA
Halothane,Potassium channel subfamily K member 18 opener,Potassium channel subfamily K member 18
Fosphenytoin,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Droperidol,D2-like dopamine receptor antagonist,D2-like dopamine receptor
Lapyrium,Unknown,
Tavaborole,Leucine-tRNA ligase inhibitor,Leucine-tRNA ligase
Ombitasvir,Nonstructural protein 5A inhibitor,Nonstructural protein 5A
Aripiprazole Lauroxil,Serotonin 1a (5-HT1a) receptor partial agonist,Serotonin 1a (5-HT1a) receptor
Patiromer Calcium,Potassium chelating agent,Potassium
Pexmetinib,MAP kinase p38 alpha inhibitor,MAP kinase p38 alpha
Ave-9940,MAP kinase p38 alpha inhibitor,MAP kinase p38 alpha
Azd-7762,Serine/threonine-protein kinase Chk1 inhibitor,Serine/threonine-protein kinase Chk1
Ds-7423,Serine/threonine-protein kinase mTOR inhibitor,Serine/threonine-protein kinase mTOR
Nv-128,Mitochondrial complex I (NADH dehydrogenase) inhibitor,Mitochondrial complex I (NADH dehydrogenase)
Palomid-529,Serine/threonine-protein kinase mTOR inhibitor,Serine/threonine-protein kinase mTOR
Pf-04217903,Hepatocyte growth factor receptor inhibitor,Hepatocyte growth factor receptor
Tg-02,Cyclin-dependent kinase 9 inhibitor,Cyclin-dependent kinase 9
Pyrotinib,Receptor protein-tyrosine kinase erbB-2 inhibitor,Receptor protein-tyrosine kinase erbB-2
Abt-560,Neuronal acetylcholine receptor; alpha4/beta2 modulator,Neuronal acetylcholine receptor; alpha4/beta2
D-3263,Transient receptor potential cation channel subfamily M member 8 agonist,Transient receptor potential cation channel subfamily M member 8
Verosudil,Rho-associated protein kinase inhibitor,Rho-associated protein kinase
Bms-582949,MAP kinase p38 alpha inhibitor,MAP kinase p38 alpha
Talmapimod,MAP kinase p38 alpha inhibitor,MAP kinase p38 alpha
Gsk163090,Serotonin 1a (5-HT1a) receptor antagonist,Serotonin 1a (5-HT1a) receptor
Solabegron,Beta-3 adrenergic receptor agonist,Beta-3 adrenergic receptor
Rimegepant,Calcitonin gene-related peptide type 1 receptor antagonist,Calcitonin gene-related peptide type 1 receptor
Pf-04634817,C-C chemokine receptor type 5 antagonist,C-C chemokine receptor type 5
Srx246,Vasopressin V1a receptor antagonist,Vasopressin V1a receptor
Relugolix,Gonadotropin-releasing hormone receptor antagonist,Gonadotropin-releasing hormone receptor
Af-219,P2X purinoceptor 3 antagonist,P2X purinoceptor 3
Azd1446,Neuronal acetylcholine receptor; alpha4/beta2 agonist,Neuronal acetylcholine receptor; alpha4/beta2
Mibampator,Glutamate receptor ionotropic AMPA positive allosteric modulator,Glutamate receptor ionotropic AMPA
Alvocidib,Cyclin-dependent kinase 9 inhibitor,Cyclin-dependent kinase 9
Volociximab,Integrin alpha-5/beta-1 antagonist,Integrin alpha-5/beta-1
Avatrombopag,Thrombopoietin receptor agonist,Thrombopoietin receptor
Fosbretabulin,Tubulin inhibitor,Tubulin
Varespladib Methyl,Phospholipase A2 group IIA inhibitor,Phospholipase A2 group IIA
Omecamtiv Mecarbil,Cardiac myosin activator,Cardiac myosin
Esreboxetine,Norepinephrine transporter inhibitor,Norepinephrine transporter
Milatuzumab,HLA-DR antigens-associated invariant chain antagonist,HLA-DR antigens-associated invariant chain
Toralizumab,CD40 ligand inhibitor,CD40 ligand
Deflazacort,Glucocorticoid receptor agonist,Glucocorticoid receptor
Acetazolamide,Carbonic anhydrase I inhibitor,Carbonic anhydrase I
Aclidinium,Muscarinic acetylcholine receptor M3 antagonist,Muscarinic acetylcholine receptor M3
Thiethylperazine,Dopamine D2 receptor antagonist,Dopamine D2 receptor
Iloperidone,Dopamine D2 receptor antagonist,Dopamine D2 receptor
Rosiglitazone,Peroxisome proliferator-activated receptor gamma agonist,Peroxisome proliferator-activated receptor gamma
Allopurinol,Xanthine dehydrogenase inhibitor,Xanthine dehydrogenase
Floxuridine,Thymidylate synthase inhibitor,Thymidylate synthase
Chlorpromazine,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Methylnaltrexone,Mu opioid receptor antagonist,Mu opioid receptor
Fluprednisolone,Glucocorticoid receptor agonist,Glucocorticoid receptor
Duloxetine,Norepinephrine transporter inhibitor,Norepinephrine transporter
Sulfinpyrazone,Solute carrier family 22 member 12 inhibitor,Solute carrier family 22 member 12
Regorafenib,Platelet-derived growth factor receptor inhibitor,Platelet-derived growth factor receptor
Acetaminophen,Cyclooxygenase inhibitor,Cyclooxygenase
Phenylbutazone,Cyclooxygenase inhibitor,Cyclooxygenase
Axitinib,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Propranolol,Beta-2 adrenergic receptor antagonist,Beta-2 adrenergic receptor
Laronidase,Heparan sulfate hydrolytic enzyme,Heparan sulfate
Collagenase Clostridium Histolyticum,Collagen hydrolytic enzyme,Collagen
Nabumetone,Cyclooxygenase-2 inhibitor,Cyclooxygenase-2
Atazanavir,Human immunodeficiency virus type 1 protease inhibitor,Human immunodeficiency virus type 1 protease
Etretinate,Retinoid receptor agonist,Retinoid receptor
Isoflurane,GABA-A receptor; anion channel positive allosteric modulator,GABA-A receptor; anion channel
Pipobroman,DNA inhibitor,DNA
Cytarabine,DNA inhibitor,DNA
Lincomycin,70S ribosome inhibitor,70S ribosome
Nordihydroguaiaretic Acid,Unknown,
Nintedanib,Fibroblast growth factor receptor inhibitor,Fibroblast growth factor receptor
Ceftolozane,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Ixazomib Citrate,26S proteosome inhibitor,26S proteosome
Cep-11981,Tyrosine-protein kinase TIE-2 inhibitor,Tyrosine-protein kinase TIE-2
Mk-5108,Serine/threonine-protein kinase Aurora-A inhibitor,Serine/threonine-protein kinase Aurora-A
Tricetamide,Tyrosine-protein kinase JAK3 inhibitor,Tyrosine-protein kinase JAK3
Rg-7602,Serine/threonine-protein kinase Chk1 inhibitor,Serine/threonine-protein kinase Chk1
Gtx-758,Estrogen receptor alpha agonist,Estrogen receptor alpha
Ly-3023414,PI3-kinase class I inhibitor,PI3-kinase class I
Tecadenoson,Adenosine A1 receptor agonist,Adenosine A1 receptor
Trabodenoson,Adenosine A1 receptor agonist,Adenosine A1 receptor
Sufugolix,Gonadotropin-releasing hormone receptor antagonist,Gonadotropin-releasing hormone receptor
Robalzotan,Serotonin 1a (5-HT1a) receptor antagonist,Serotonin 1a (5-HT1a) receptor
Aleglitazar,Peroxisome proliferator-activated receptor gamma agonist,Peroxisome proliferator-activated receptor gamma
Linifanib,Macrophage colony stimulating factor receptor inhibitor,Macrophage colony stimulating factor receptor
Volasertib,Serine/threonine-protein kinase PLK1 inhibitor,Serine/threonine-protein kinase PLK1
Momelotinib,Tyrosine-protein kinase JAK1 inhibitor,Tyrosine-protein kinase JAK1
Dacomitinib,Receptor protein-tyrosine kinase erbB-4 inhibitor,Receptor protein-tyrosine kinase erbB-4
Dovitinib,Fibroblast growth factor receptor 3 inhibitor,Fibroblast growth factor receptor 3
Latanoprostene Bunod,Prostanoid FP receptor agonist,Prostanoid FP receptor
Cebranopadol,Opioid receptors; mu/kappa/delta agonist,Opioid receptors; mu/kappa/delta
Tezosentan,Endothelin receptor ET-B antagonist,Endothelin receptor ET-B
Motesanib,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Lerdelimumab,Transforming growth factor beta-2 inhibitor,Transforming growth factor beta-2
Drisapersen,Dystrophin pre-mRNA OTHER,Dystrophin pre-mRNA
Telotristat,Tryptophan 5-hydroxylase inhibitor,Tryptophan 5-hydroxylase
Neramexane,Neuronal acetylcholine receptor; alpha9/alpha10 antagonist,Neuronal acetylcholine receptor; alpha9/alpha10
Simtuzumab,Lysyl oxidase homolog 2 inhibitor,Lysyl oxidase homolog 2
Abx-Il8,Interleukin-8 inhibitor,Interleukin-8
Lixisenatide,Glucagon-like peptide 1 receptor agonist,Glucagon-like peptide 1 receptor
Ni-0401,T cell surface glycoprotein CD3 inhibitor,T cell surface glycoprotein CD3
Orlistat,Gastric lipase inhibitor,Gastric lipase
Desirudin,Thrombin inhibitor,Thrombin
Etanercept,TNF-alpha inhibitor,TNF-alpha
Oxyphenonium,Muscarinic acetylcholine receptor M1 antagonist,Muscarinic acetylcholine receptor M1
Anakinra,Interleukin-1 receptor antagonist,Interleukin-1 receptor
Zolmitriptan,Serotonin 1d (5-HT1d) receptor agonist,Serotonin 1d (5-HT1d) receptor
Fosfomycin,UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor,UDP-N-acetylglucosamine 1-carboxyvinyltransferase
Aliskiren,Renin inhibitor,Renin
Travoprost,Prostanoid FP receptor agonist,Prostanoid FP receptor
Adapalene,Retinoic acid receptor agonist,Retinoic acid receptor
Sulfadoxine,Dihydropteroate synthetase inhibitor,Dihydropteroate synthetase
Diethylpropion,Dopamine transporter inhibitor,Dopamine transporter
Betamethasone Benzoate,Glucocorticoid receptor agonist,Glucocorticoid receptor
Methotrexate,Dihydrofolate reductase inhibitor,Dihydrofolate reductase
Carmustine,Glutathione reductase inhibitor,Glutathione reductase
Trametinib,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,Dual specificity mitogen-activated protein kinase kinase 1
Dichlorphenamide,Carbonic anhydrase IV inhibitor,Carbonic anhydrase IV
Acetazolamide,Carbonic anhydrase IV inhibitor,Carbonic anhydrase IV
Regorafenib,Discoidin domain-containing receptor 2 inhibitor,Discoidin domain-containing receptor 2
Sorafenib,Serine/threonine-protein kinase B-raf inhibitor,Serine/threonine-protein kinase B-raf
Simvastatin,HMG-CoA reductase inhibitor,HMG-CoA reductase
Dexlansoprazole,Potassium-transporting ATPase inhibitor,Potassium-transporting ATPase
Piroxicam,Cyclooxygenase inhibitor,Cyclooxygenase
Flavoxate,Phosphodiesterase 7 inhibitor,Phosphodiesterase 7
Glipizide,"Sulfonylurea receptor 1, Kir6.2 blocker","Sulfonylurea receptor 1, Kir6.2"
Abatacept,T-lymphocyte activation antigen CD86 inhibitor,T-lymphocyte activation antigen CD86
Rescinnamine,Synaptic vesicular amine transporter inhibitor,Synaptic vesicular amine transporter
Tipranavir,Human immunodeficiency virus type 1 protease inhibitor,Human immunodeficiency virus type 1 protease
Propantheline,Muscarinic acetylcholine receptor M2 antagonist,Muscarinic acetylcholine receptor M2
Clioquinol,Zinc chelating agent,Zinc
Sulfamethizole,Bacterial dihydropteroate synthase inhibitor,Bacterial dihydropteroate synthase
Doripenem,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Human Interleukin-2,Interleukin-2 receptor agonist,Interleukin-2 receptor
Bacitracin,C55-isoprenyl pyrophosphate inhibitor,C55-isoprenyl pyrophosphate
Gemtuzumab Ozogamicin,DNA inhibitor,DNA
Bendamustine,DNA inhibitor,DNA
Gemcitabine,DNA polymerase (alpha/delta/epsilon) inhibitor,DNA polymerase (alpha/delta/epsilon)
Indecainide,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Strontium Chloride,Unknown,
Pasireotide,Somatostatin receptor 3 agonist,Somatostatin receptor 3
Enmd-981693,Vascular endothelial growth factor receptor 2 inhibitor,Vascular endothelial growth factor receptor 2
Ag-24322,Cyclin-dependent kinase 4 inhibitor,Cyclin-dependent kinase 4
Arq-087,Fibroblast growth factor receptor inhibitor,Fibroblast growth factor receptor
Arry-300,Hepatocyte growth factor receptor inhibitor,Hepatocyte growth factor receptor
Omipalisib,PI3-kinase class I inhibitor,PI3-kinase class I
Ro-4987655,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,Dual specificity mitogen-activated protein kinase kinase 2
Rwj-67657,MAP kinase p38 alpha inhibitor,MAP kinase p38 alpha
Mln3126,C-C chemokine receptor type 9 antagonist,C-C chemokine receptor type 9
Ly2969822,Metabotropic glutamate receptor 3 agonist,Metabotropic glutamate receptor 3
Oms405,Peroxisome proliferator-activated receptor gamma agonist,Peroxisome proliferator-activated receptor gamma
Inecalcitol,Vitamin D receptor agonist,Vitamin D receptor
Refametinib,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,Dual specificity mitogen-activated protein kinase kinase 1
Bms-690514,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Foretinib,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Mk-2206,Serine/threonine-protein kinase AKT inhibitor,Serine/threonine-protein kinase AKT
Plx-3397,Tyrosine-protein kinase receptor FLT3 inhibitor,Tyrosine-protein kinase receptor FLT3
Famitinib,Stem cell growth factor receptor inhibitor,Stem cell growth factor receptor
Tg100-801,Ephrin type-B receptor 4 inhibitor,Ephrin type-B receptor 4
Infigratinib,Fibroblast growth factor receptor inhibitor,Fibroblast growth factor receptor
Tedatioxetine,Alpha-1a adrenergic receptor antagonist,Alpha-1a adrenergic receptor
Mk-0249,Histamine H3 receptor inverse agonist,Histamine H3 receptor
Azd4818,C-C chemokine receptor type 1 antagonist,C-C chemokine receptor type 1
Azd9056,P2X purinoceptor 7 antagonist,P2X purinoceptor 7
Pozanicline,Nicotinic acetylcholine receptor alpha4/beta2/alpha5 partial agonist,Nicotinic acetylcholine receptor alpha4/beta2/alpha5
Cns-5161,Glutamate [NMDA] receptor blocker,Glutamate [NMDA] receptor
Balaglitazone,Peroxisome proliferator-activated receptor gamma partial agonist,Peroxisome proliferator-activated receptor gamma
Midostaurin,Tyrosine-protein kinase receptor FLT3 inhibitor,Tyrosine-protein kinase receptor FLT3
Pimavanserin,Serotonin 2a (5-HT2a) receptor inverse agonist,Serotonin 2a (5-HT2a) receptor
Ralfinamide,Glutamate [NMDA] receptor antagonist,Glutamate [NMDA] receptor
Solanezumab,Beta amyloid A4 protein other,Beta amyloid A4 protein
Bapineuzumab,Beta amyloid A4 protein other,Beta amyloid A4 protein
Visilizumab,T-cell surface glycoprotein CD3 epsilon chain inhibitor,T-cell surface glycoprotein CD3 epsilon chain
Reslizumab,Interleukin-5 inhibitor,Interleukin-5
Albinterferon Alfa-2b,Interferon alpha/beta receptor agonist,Interferon alpha/beta receptor
Pegnivacogin,Coagulation factor IX inhibitor,Coagulation factor IX
Fresolimumab,Transforming growth factor beta-3 inhibitor,Transforming growth factor beta-3
Rovelizumab,Integrin alpha-M/beta-2 antagonist,Integrin alpha-M/beta-2
Rg-1512,P-selectin inhibitor,P-selectin
Etaracizumab,Integrin alpha-V/beta-3 antagonist,Integrin alpha-V/beta-3
Omega-3-Carboxylic Acids,Unknown,
Tcd-717,Choline kinase alpha inhibitor,Choline kinase alpha
Methazolamide,Carbonic anhydrase VII inhibitor,Carbonic anhydrase VII
Orlistat,Pancreatic lipase inhibitor,Pancreatic lipase
Ketotifen,Histamine H1 receptor antagonist,Histamine H1 receptor
Dimenhydrinate,Histamine H1 receptor antagonist,Histamine H1 receptor
Certolizumab Pegol,TNF-alpha inhibitor,TNF-alpha
Ergoloid,Serotonin 1b (5-HT1b) receptor agonist,Serotonin 1b (5-HT1b) receptor
Fluvoxamine,Serotonin transporter inhibitor,Serotonin transporter
Cycloguanil,Dihydrofolate reductase inhibitor,Dihydrofolate reductase
Paliperidone,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Hydromorphone,Mu opioid receptor agonist,Mu opioid receptor
Flumethasone Pivalate,Glucocorticoid receptor agonist,Glucocorticoid receptor
Clocortolone Pivalate,Glucocorticoid receptor agonist,Glucocorticoid receptor
Efavirenz,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,Human immunodeficiency virus type 1 reverse transcriptase
Chenodiol,Bile acid receptor FXR agonist,Bile acid receptor FXR
Diethylpropion,Norepinephrine transporter inhibitor,Norepinephrine transporter
Ruxolitinib,Tyrosine-protein kinase JAK1 inhibitor,Tyrosine-protein kinase JAK1
Mefloquine,Ferriprotoporphyrin IX inhibitor,Ferriprotoporphyrin IX
Carvedilol,Adrenergic receptor beta antagonist,Adrenergic receptor beta
Topiramate,Glutamate receptor ionotropic kainate antagonist,Glutamate receptor ionotropic kainate
Terazosin,Adrenergic receptor alpha-1 antagonist,Adrenergic receptor alpha-1
Dextrothyroxine,Thyroid hormone receptor agonist,Thyroid hormone receptor
Levothyroxine,Thyroid hormone receptor agonist,Thyroid hormone receptor
Pirbuterol,Beta-2 adrenergic receptor agonist,Beta-2 adrenergic receptor
Ritodrine,Beta-2 adrenergic receptor agonist,Beta-2 adrenergic receptor
Penbutolol,Beta-2 adrenergic receptor antagonist,Beta-2 adrenergic receptor
Vigabatrin,Gamma-amino-N-butyrate transaminase inhibitor,Gamma-amino-N-butyrate transaminase
Ticagrelor,Purinergic receptor P2Y12 negative allosteric modulator,Purinergic receptor P2Y12
Ofatumumab,B-lymphocyte antigen CD20 inhibitor,B-lymphocyte antigen CD20
Vandetanib,Epidermal growth factor receptor inhibitor,Epidermal growth factor receptor
Metharbital,GABA-A receptor; anion channel positive allosteric modulator,GABA-A receptor; anion channel
Sulfathiazole,Bacterial dihydropteroate synthase inhibitor,Bacterial dihydropteroate synthase
Telbivudine,DNA polymerase/reverse transcriptase inhibitor,DNA polymerase/reverse transcriptase
Ropivacaine,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Isoflurane,Potassium channel subfamily K member 2 opener,Potassium channel subfamily K member 2
Chlormezanone,Unknown,
Vedolizumab,Integrin alpha-4/beta-7 inhibitor,Integrin alpha-4/beta-7
Pexmetinib,Tyrosine-protein kinase TIE-2 inhibitor,Tyrosine-protein kinase TIE-2
As-602868,Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor,Inhibitor of nuclear factor kappa B kinase beta subunit
Azd-5438,Cyclin-dependent kinase inhibitor,Cyclin-dependent kinase
Azd-6918,Neurotrophic tyrosine kinase receptor inhibitor,Neurotrophic tyrosine kinase receptor
Cep-32496,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Epitinib,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Jnj-26483327,Tyrosine-protein kinase LCK inhibitor,Tyrosine-protein kinase LCK
Vantictumab,Frizzled-2 antagonist,Frizzled-2
Amuvatinib,Tyrosine-protein kinase receptor FLT3 inhibitor,Tyrosine-protein kinase receptor FLT3
Darotropium,Muscarinic acetylcholine receptor antagonist,Muscarinic acetylcholine receptor
Aplindore,Dopamine D2 receptor partial agonist,Dopamine D2 receptor
Ccx354,C-C chemokine receptor type 1 antagonist,C-C chemokine receptor type 1
Cf102,Adenosine A3 receptor agonist,Adenosine A3 receptor
Velneperit,Neuropeptide Y receptor type 5 antagonist,Neuropeptide Y receptor type 5
Azd0328,Neuronal acetylcholine receptor protein alpha-7 subunit agonist,Neuronal acetylcholine receptor protein alpha-7 subunit
Apadenoson,Adenosine A2a receptor agonist,Adenosine A2a receptor
Tozadenant,Adenosine A2a receptor antagonist,Adenosine A2a receptor
Palifosfamide,DNA cross-linking agent,DNA
Pardoprunox,Dopamine receptors; D2 & D3 partial agonist,Dopamine receptors; D2 & D3
Varespladib Methyl,Group X secretory phospholipase A2 inhibitor,Group X secretory phospholipase A2
Mdx-447,Epidermal growth factor receptor erbB1 other,Epidermal growth factor receptor erbB1
Kb-003,Granulocyte-macrophage colony-stimulating factor inhibitor,Granulocyte-macrophage colony-stimulating factor
Ask-8007,Osteopontin inhibitor,Osteopontin
Ly-2382770,Transforming growth factor beta-1 inhibitor,Transforming growth factor beta-1
Nrx-1074,Glutamate [NMDA] receptor partial agonist,Glutamate [NMDA] receptor
Montelukast,Cysteinyl leukotriene receptor 1 antagonist,Cysteinyl leukotriene receptor 1
Epoetin Alfa,Erythropoietin receptor agonist,Erythropoietin receptor
Prochlorperazine,Dopamine D2 receptor antagonist,Dopamine D2 receptor
Dicyclomine,Muscarinic acetylcholine receptor M1 antagonist,Muscarinic acetylcholine receptor M1
Bosutinib,Tyrosine-protein kinase ABL inhibitor,Tyrosine-protein kinase ABL
Indapamide,Thiazide-sensitive sodium-chloride cotransporter inhibitor,Thiazide-sensitive sodium-chloride cotransporter
Valproic Acid,Succinate semialdehyde dehydrogenase inhibitor,Succinate semialdehyde dehydrogenase
Cimetidine,Histamine H2 receptor antagonist,Histamine H2 receptor
Insulin Zinc Susp Extended Purified Beef,Insulin receptor agonist,Insulin receptor
Insulin Aspart Protamine Recombinant,Insulin receptor agonist,Insulin receptor
Trifluoperazine,Serotonin 2c (5-HT2c) receptor antagonist,Serotonin 2c (5-HT2c) receptor
Edrophonium,Acetylcholinesterase inhibitor,Acetylcholinesterase
Abacavir,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,Human immunodeficiency virus type 1 reverse transcriptase
Codeine,Opioid receptors; mu/kappa/delta agonist,Opioid receptors; mu/kappa/delta
Becaplermin,Platelet-derived growth factor receptor agonist,Platelet-derived growth factor receptor
Carteolol,Adrenergic receptor beta antagonist,Adrenergic receptor beta
Apraclonidine,Adrenergic receptor alpha-2 agonist,Adrenergic receptor alpha-2
Incobotulinumtoxina,Synaptosomal-associated protein 25 inhibitor,Synaptosomal-associated protein 25
Econazole,Cytochrome P450 51 inhibitor,Cytochrome P450 51
Bethanechol,Muscarinic acetylcholine receptor M2 agonist,Muscarinic acetylcholine receptor M2
Doxacurium,Muscle-type nicotinic acetylcholine receptor antagonist,Muscle-type nicotinic acetylcholine receptor
Eszopiclone,GABA-A receptor; anion channel positive allosteric modulator,GABA-A receptor; anion channel
Sparfloxacin,Topoisomerase IV inhibitor,Topoisomerase IV
Enoxacin,Topoisomerase IV inhibitor,Topoisomerase IV
Piperacillin,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Praziquantel,Voltage-activated calcium channel beta 1 subunit blocker,Voltage-activated calcium channel beta 1 subunit
Azathioprine,DNA inhibitor,DNA
Cytarabine,RNA inhibitor,RNA
Cinoxacin,Bacterial DNA gyrase inhibitor,Bacterial DNA gyrase
Halothane,Potassium channel subfamily K member 2 opener,Potassium channel subfamily K member 2
Amifostine,Reactive metabolite scavenging agent,
Ly2452473,Androgen Receptor modulator,Androgen Receptor
As-703988,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,Dual specificity mitogen-activated protein kinase kinase 2
Ly-2780301,Ribosomal protein S6 kinase (P70S6K) inhibitor,Ribosomal protein S6 kinase (P70S6K)
Pd-0166285,Tyrosine-protein kinase SRC inhibitor,Tyrosine-protein kinase SRC
Pf-03715455,MAP kinase p38 alpha inhibitor,MAP kinase p38 alpha
Tg-02,Tyrosine-protein kinase receptor FLT3 inhibitor,Tyrosine-protein kinase receptor FLT3
Figopitant,Neurokinin 1 receptor antagonist,Neurokinin 1 receptor
Enmd-2076,Tyrosine-protein kinase receptor FLT3 inhibitor,Tyrosine-protein kinase receptor FLT3
Tg100-801,Vascular endothelial growth factor receptor 1 inhibitor,Vascular endothelial growth factor receptor 1
Tepotinib,Hepatocyte growth factor receptor inhibitor,Hepatocyte growth factor receptor
Tedatioxetine,Dopamine transporter inhibitor,Dopamine transporter
Uk432097,Adenosine A2a receptor agonist,Adenosine A2a receptor
S-237648,Neuropeptide Y receptor type 5 antagonist,Neuropeptide Y receptor type 5
Amelubant,Leukotriene B4 receptor 1 antagonist,Leukotriene B4 receptor 1
Labradimil,Bradykinin B2 receptor agonist,Bradykinin B2 receptor
Azd7325,GABA receptor alpha-2 subunit positive allosteric modulator,GABA receptor alpha-2 subunit
Tebanicline Tosylate,Neuronal acetylcholine receptor; alpha4/beta2 agonist,Neuronal acetylcholine receptor; alpha4/beta2
Cediranib,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Dinaciclib,Cyclin-dependent kinase 5 inhibitor,Cyclin-dependent kinase 5
Naldemedine,Mu opioid receptor antagonist,Mu opioid receptor
Zalutumumab,Epidermal growth factor receptor erbB1 antagonist,Epidermal growth factor receptor erbB1
Venetoclax,Apoptosis regulator Bcl-2 inhibitor,Apoptosis regulator Bcl-2
Birinapant,cIAP1/cIAP2 inhibitor,cIAP1/cIAP2
Cannabidiol,Cannabinoid CB1 receptor Negative allosteric modulator,Cannabinoid CB1 receptor
Bifeprunox,Dopamine D2 receptor partial agonist,Dopamine D2 receptor
Urelumab,Tumor necrosis factor receptor superfamily member 9 agonist,Tumor necrosis factor receptor superfamily member 9
Bhq-880,Dickkopf-related protein 1 inhibitor,Dickkopf-related protein 1
Biib061,Unknown,
Irinotecan,DNA topoisomerase I inhibitor,DNA topoisomerase I
Almotriptan,Serotonin 1f (5-HT1f) receptor agonist,Serotonin 1f (5-HT1f) receptor
Silodosin,Alpha-1a adrenergic receptor antagonist,Alpha-1a adrenergic receptor
Pindolol,Beta-1 adrenergic receptor partial agonist,Beta-1 adrenergic receptor
Alosetron,Serotonin 3a (5-HT3a) receptor antagonist,Serotonin 3a (5-HT3a) receptor
Trazodone,Serotonin transporter inhibitor,Serotonin transporter
Thioridazine,Serotonin 2c (5-HT2c) receptor antagonist,Serotonin 2c (5-HT2c) receptor
Trimipramine,Serotonin 2c (5-HT2c) receptor antagonist,Serotonin 2c (5-HT2c) receptor
Butorphanol,Mu opioid receptor partial agonist,Mu opioid receptor
Guanethidine,Norepinephrine transporter substrate,Norepinephrine transporter
Colchicine,Tubulin inhibitor,Tubulin
Lithium Carbonate,Glycogen synthase kinase-3 inhibitor,Glycogen synthase kinase-3
Orphenadrine,Glutamate [NMDA] receptor antagonist,Glutamate [NMDA] receptor
Guanfacine,Adrenergic receptor alpha-2 agonist,Adrenergic receptor alpha-2
Methyldopa,Adrenergic receptor alpha-2 agonist,Adrenergic receptor alpha-2
Mefenamic Acid,Cyclooxygenase inhibitor,Cyclooxygenase
Pargyline,Monoamine oxidase inhibitor,Monoamine oxidase
Clofarabine,Ribonucleoside-diphosphate reductase RR1 inhibitor,Ribonucleoside-diphosphate reductase RR1
Ocriplasmin,Laminin hydrolytic enzyme,Laminin
Lopinavir,Human immunodeficiency virus type 1 protease inhibitor,Human immunodeficiency virus type 1 protease
Clorazepic Acid,GABA-A receptor; anion channel positive allosteric modulator,GABA-A receptor; anion channel
Butalbital,GABA-A receptor; anion channel positive allosteric modulator,GABA-A receptor; anion channel
Pentobarbital,GABA-A receptor; anion channel positive allosteric modulator,GABA-A receptor; anion channel
Thiopental,GABA-A receptor; anion channel positive allosteric modulator,GABA-A receptor; anion channel
Erythromycin Ethylsuccinate,Bacterial 70S ribosome inhibitor,Bacterial 70S ribosome
Isoflurane,Potassium channel subfamily K member 10 opener,Potassium channel subfamily K member 10
Mepivacaine,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Simethicone,Antifoaming agent,
Edetate Calcium Disodium,Unknown,
Ciclopirox,Aluminium chelating agent,Aluminium
Pancrelipase,Polypeptides hydrolytic enzyme,Polypeptides
Brexpiprazole,Dopamine D2 receptor partial agonist,Dopamine D2 receptor
Aripiprazole Lauroxil,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Gsk2849466,Androgen Receptor modulator,Androgen Receptor
Cerdulatinib,Tyrosine-protein kinase JAK1 inhibitor,Tyrosine-protein kinase JAK1
Ac-430,Tyrosine-protein kinase JAK2 inhibitor,Tyrosine-protein kinase JAK2
Azd-8186,PI3-kinase p110-delta subunit inhibitor,PI3-kinase p110-delta subunit
Rg-7256,Serine/threonine-protein kinase B-raf inhibitor,Serine/threonine-protein kinase B-raf
Tak-659,Tyrosine-protein kinase SYK inhibitor,Tyrosine-protein kinase SYK
Tg-02,Tyrosine-protein kinase JAK2 inhibitor,Tyrosine-protein kinase JAK2
Wx-037,PI3-kinase class I inhibitor,PI3-kinase class I
Gs 6201,Adenosine A2b receptor antagonist,Adenosine A2b receptor
Am-211,G protein-coupled receptor 44 antagonist,G protein-coupled receptor 44
Ly2245461,Estrogen receptor modulator,Estrogen receptor
Cr 1447,Androgen Receptor agonist,Androgen Receptor
De-104,Rho-associated protein kinase inhibitor,Rho-associated protein kinase
Vabicaserin,Serotonin 2c (5-HT2c) receptor agonist,Serotonin 2c (5-HT2c) receptor
Basimglurant,Metabotropic glutamate receptor 5 modulator,Metabotropic glutamate receptor 5
Faxeladol,Serotonin transporter inhibitor,Serotonin transporter
Enrasentan,Endothelin receptor ET-A antagonist,Endothelin receptor ET-A
Azd1305,Sodium channel protein type V alpha subunit blocker,Sodium channel protein type V alpha subunit
Rivoglitazone,Peroxisome proliferator-activated receptor gamma agonist,Peroxisome proliferator-activated receptor gamma
Lestaurtinib,Tyrosine-protein kinase JAK2 inhibitor,Tyrosine-protein kinase JAK2
Alisertib,Serine/threonine-protein kinase Aurora-A inhibitor,Serine/threonine-protein kinase Aurora-A
Sarizotan,Dopamine D3 receptor agonist,Dopamine D3 receptor
Gantenerumab,Beta amyloid A4 protein other,Beta amyloid A4 protein
Obiltoxaximab,Protective antigen binding agent,Protective antigen
Plecanatide,Heat-stable enterotoxin receptor agonist,Heat-stable enterotoxin receptor
Prucalopride,Serotonin 4 (5-HT4) receptor agonist,Serotonin 4 (5-HT4) receptor
Carmegliptin,Dipeptidyl peptidase IV inhibitor,Dipeptidyl peptidase IV
Picoplatin,DNA cross-linking agent,DNA
Mocetinostat,Histone deacetylase 2 inhibitor,Histone deacetylase 2
Conbercept,Placenta growth factor inhibitor,Placenta growth factor
Eptinezumab,Calcitonin gene-related peptide_UNCURATED inhibitor,Calcitonin gene-related peptide
Ertumaxomab,T-cell surface glycoprotein CD3 epsilon chain other,T-cell surface glycoprotein CD3 epsilon chain
Iratumumab,Tumor necrosis factor receptor superfamily member 8 other,Tumor necrosis factor receptor superfamily member 8
4b5,Disialoganglioside GD2 other,Disialoganglioside GD2
Velpatasvir,Nonstructural protein 5A inhibitor,Nonstructural protein 5A
Trastuzumab Emtansine,Receptor protein-tyrosine kinase erbB-2 inhibitor,Receptor protein-tyrosine kinase erbB-2
Methylpromazine,Histamine H1 receptor antagonist,Histamine H1 receptor
Metoclopramide,Dopamine D2 receptor antagonist,Dopamine D2 receptor
Chlorothiazide,Thiazide-sensitive sodium-chloride cotransporter inhibitor,Thiazide-sensitive sodium-chloride cotransporter
Chloroguanide,Dihydrofolate reductase inhibitor,Dihydrofolate reductase
Calcitriol,Vitamin D receptor agonist,Vitamin D receptor
Risperidone,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Thioridazine,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Prednisolone Phosphoric Acid,Glucocorticoid receptor agonist,Glucocorticoid receptor
Guanadrel,Norepinephrine transporter substrate,Norepinephrine transporter
Atomoxetine,Norepinephrine transporter inhibitor,Norepinephrine transporter
Ziconotide Acetate,Voltage-gated N-type calcium channel alpha-1B subunit blocker,Voltage-gated N-type calcium channel alpha-1B subunit
Megestrol Acetate,Progesterone receptor agonist,Progesterone receptor
Cisapride,Serotonin 4 (5-HT4) receptor agonist,Serotonin 4 (5-HT4) receptor
Rifabutin,Bacterial DNA-directed RNA polymerase inhibitor,Bacterial DNA-directed RNA polymerase
Belatacept,T-lymphocyte activation antigen CD80 inhibitor,T-lymphocyte activation antigen CD80
Solifenacin,Muscarinic acetylcholine receptor M2 antagonist,Muscarinic acetylcholine receptor M2
Pazopanib,Tyrosine-protein kinase ITK/TSK inhibitor,Tyrosine-protein kinase ITK/TSK
Rocuronium,Muscle-type nicotinic acetylcholine receptor antagonist,Muscle-type nicotinic acetylcholine receptor
Ivermectin,Glutamate-gated chloride channel modulator,Glutamate-gated chloride channel
Sulfamerazine,Bacterial dihydropteroate synthase inhibitor,Bacterial dihydropteroate synthase
Ceftizoxime,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Cefepime,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Permethrin,Voltage-sensitive sodium channel blocker,Voltage-sensitive sodium channel
Topotecan,"DNA topoisomerase I, mitochondrial inhibitor","DNA topoisomerase I, mitochondrial"
Amphotericin B,Ergosterol sequestering agent,Ergosterol
Colistimethate Sodium,Cell membrane inhibitor,Cell membrane
Novobiocin,DNA gyrase inhibitor,DNA gyrase
Pramipexole,D2-like dopamine receptor agonist,D2-like dopamine receptor
Tetradecyl Sulfuric Acid,Unknown,
Testosterone Undecanoate,Androgen Receptor agonist,Androgen Receptor
Enmd-981693,Fibroblast growth factor receptor inhibitor,Fibroblast growth factor receptor
Rg-7167,Dual specificity mitogen-activated protein kinase kinase; MEK1/2 inhibitor,Dual specificity mitogen-activated protein kinase kinase; MEK1/2
Dacomitinib,Epidermal growth factor receptor inhibitor,Epidermal growth factor receptor
At-13148,MAP kinase-activated protein kinase 2 inhibitor,MAP kinase-activated protein kinase 2
Azd-4769,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Cyc-116,Vascular endothelial growth factor receptor 2 inhibitor,Vascular endothelial growth factor receptor 2
Altiratinib,Tyrosine-protein kinase TIE-2 inhibitor,Tyrosine-protein kinase TIE-2
Altiratinib,Neurotrophic tyrosine kinase receptor inhibitor,Neurotrophic tyrosine kinase receptor
Ipafricept,Frizzled-8 antagonist,Frizzled-8
Delcasertib,Protein kinase C delta inhibitor,Protein kinase C delta
R-333,Tyrosine-protein kinase SYK inhibitor,Tyrosine-protein kinase SYK
Famitinib,Vascular endothelial growth factor receptor 3 inhibitor,Vascular endothelial growth factor receptor 3
Gsk163090,Serotonin 1d (5-HT1d) receptor antagonist,Serotonin 1d (5-HT1d) receptor
Azd8683,Muscarinic acetylcholine receptor M3 antagonist,Muscarinic acetylcholine receptor M3
Lemborexant,Orexin receptor 1 antagonist,Orexin receptor 1
Naltalimide,Mu opioid receptor partial agonist,Mu opioid receptor
Stx107,Metabotropic glutamate receptor 5 negative allosteric modulator,Metabotropic glutamate receptor 5
Grc-6211,Vanilloid receptor antagonist,Vanilloid receptor
Asm-024,Neuronal acetylcholine receptor; alpha3/beta4 antagonist,Neuronal acetylcholine receptor; alpha3/beta4
Asm-024,Muscarinic acetylcholine receptor M2 antagonist,Muscarinic acetylcholine receptor M2
Cep-1347,Mitogen-activated protein kinase kinase kinase 10 inhibitor,Mitogen-activated protein kinase kinase kinase 10
Rigosertib,Proteinase-activated receptor 1 inhibitor,Proteinase-activated receptor 1
Dacomitinib,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Midostaurin,Platelet-derived growth factor receptor inhibitor,Platelet-derived growth factor receptor
Ozarelix,Gonadotropin-releasing hormone receptor antagonist,Gonadotropin-releasing hormone receptor
Fiboflapon,5-lipoxygenase activating protein inhibitor,5-lipoxygenase activating protein
Lapaquistat Acetate,Squalene synthetase inhibitor,Squalene synthetase
Dasotraline,Monoamine transporter inhibitor,Monoamine transporter
Nivocasan,Caspase-9 inhibitor,Caspase-9
Nesvacumab,Angiopoietin-2 inhibitor,Angiopoietin-2
Oncolysin B,B-lymphocyte antigen CD19 binding agent,B-lymphocyte antigen CD19
Eletriptan,Serotonin 1f (5-HT1f) receptor agonist,Serotonin 1f (5-HT1f) receptor
Brompheniramine,Histamine H1 receptor antagonist,Histamine H1 receptor
Glycopyrrolate,Muscarinic acetylcholine receptor M1 antagonist,Muscarinic acetylcholine receptor M1
Atenolol,Beta-1 adrenergic receptor antagonist,Beta-1 adrenergic receptor
Warfarin,Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor,Vitamin k epoxide reductase complex subunit 1 isoform 1
Lurasidone,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Levomethadyl Acetate,Mu opioid receptor agonist,Mu opioid receptor
Isoflurophate,Acetylcholinesterase inhibitor,Acetylcholinesterase
Hydrocortisone Butyrate,Glucocorticoid receptor agonist,Glucocorticoid receptor
Benzphetamine,Norepinephrine transporter releasing agent,Norepinephrine transporter
Pemetrexed,GAR transformylase inhibitor,GAR transformylase
Doxycycline,Matrix metalloproteinase 13 inhibitor,Matrix metalloproteinase 13
Diethylstilbestrol Diphosphate,Estrogen receptor agonist,Estrogen receptor
Naproxen,Cyclooxygenase inhibitor,Cyclooxygenase
Nateglinide,"Sulfonylurea receptor 1, Kir6.2 blocker","Sulfonylurea receptor 1, Kir6.2"
Butorphanol,Kappa opioid receptor partial agonist,Kappa opioid receptor
Methyltestosterone,Androgen Receptor agonist,Androgen Receptor
Trientine,Copper chelating agent,Copper
Sulfalene,Bacterial dihydropteroate synthase inhibitor,Bacterial dihydropteroate synthase
Sulfapyridine,Bacterial dihydropteroate synthase inhibitor,Bacterial dihydropteroate synthase
Ytterbium Pentetate,Radioactive metals chelating agent,Radioactive metals
Sulfoxone,Dihydropteroate synthase 1 inhibitor,Dihydropteroate synthase 1
Moxifloxacin,Bacterial DNA gyrase inhibitor,Bacterial DNA gyrase
Topiramate,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Tetracaine,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Levomepromazine,D2-like dopamine receptor antagonist,D2-like dopamine receptor
Pancrelipase,Starch hydrolytic enzyme,Starch
Lxr-623,LXR-alpha agonist,LXR-alpha
Ilorasertib,SRC inhibitor,SRC
Ag-24322,Cyclin-dependent kinase 1 inhibitor,Cyclin-dependent kinase 1
Azd-1080,Glycogen synthase kinase-3 inhibitor,Glycogen synthase kinase-3
Cudc-907,Histone deacetylase inhibitor,Histone deacetylase
Emd-1204831,Hepatocyte growth factor receptor inhibitor,Hepatocyte growth factor receptor
Tricetamide,Tyrosine-protein kinase JAK1 inhibitor,Tyrosine-protein kinase JAK1
Sd-0006,MAP kinase p38 alpha inhibitor,MAP kinase p38 alpha
Sns-314,Serine/threonine-protein kinase Aurora inhibitor,Serine/threonine-protein kinase Aurora
Tak-593,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Sr16234,Estrogen receptor alpha antagonist,Estrogen receptor alpha
Tanzisertib,c-Jun N-terminal kinase 3 inhibitor,c-Jun N-terminal kinase 3
Silmitasertib,Casein kinase II alpha inhibitor,Casein kinase II alpha
Voruciclib,Cyclin-dependent kinase 4 inhibitor,Cyclin-dependent kinase 4
Famitinib,Platelet-derived growth factor receptor inhibitor,Platelet-derived growth factor receptor
Pruvanserin,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Txa127,Proto-oncogene Mas agonist,Proto-oncogene Mas
Eprotirome,Thyroid hormone receptor beta-1 agonist,Thyroid hormone receptor beta-1
Cep-1347,Mitogen-activated protein kinase kinase kinase 9 inhibitor,Mitogen-activated protein kinase kinase kinase 9
Esmirtazapine,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Tiprolisant,Histamine H3 receptor inverse agonist,Histamine H3 receptor
Fulranumab,Beta-nerve growth factor inhibitor,Beta-nerve growth factor
Mitumomab,Ganglioside GD3 other,Ganglioside GD3
Aleplasinin,Plasminogen activator inhibitor-1 inhibitor,Plasminogen activator inhibitor-1
Daprodustat,HIF-prolyl hydroxylase inhibitor,Hypoxia-inducible factor prolyl hydroxylase
Cintredekin Besudotox,Interleukin-13 receptor subunit alpha-2 binding agent,Interleukin-13 receptor subunit alpha-2
Tb-402,Coagulation factor VIII inhibitor,Coagulation factor VIII
Amg-714,Interleukin-15 inhibitor,Interleukin-15
Cg250 111in,Carbonic anhydrase IX binding agent,Carbonic anhydrase IX
Dichlorphenamide,Carbonic anhydrase I inhibitor,Carbonic anhydrase I
Bethanechol,Muscarinic acetylcholine receptor M3 agonist,Muscarinic acetylcholine receptor M3
Tropicamide,Muscarinic acetylcholine receptor M3 antagonist,Muscarinic acetylcholine receptor M3
Pilocarpine,Muscarinic acetylcholine receptor M3 agonist,Muscarinic acetylcholine receptor M3
Moexipril,Angiotensin-converting enzyme inhibitor,Angiotensin-converting enzyme
Molindone,Dopamine D2 receptor antagonist,Dopamine D2 receptor
Sunitinib,Macrophage colony stimulating factor receptor inhibitor,Macrophage colony stimulating factor receptor
Tridihexethyl,Muscarinic acetylcholine receptor M1 antagonist,Muscarinic acetylcholine receptor M1
Bendroflumethiazide,Thiazide-sensitive sodium-chloride cotransporter inhibitor,Thiazide-sensitive sodium-chloride cotransporter
Febuxostat,Xanthine dehydrogenase inhibitor,Xanthine dehydrogenase
Sunitinib,Stem cell growth factor receptor inhibitor,Stem cell growth factor receptor
Pyrimethamine,Dihydrofolate reductase inhibitor,Dihydrofolate reductase
Flecainide,Sodium channel protein type V alpha subunit blocker,Sodium channel protein type V alpha subunit
Flunisolide,Glucocorticoid receptor agonist,Glucocorticoid receptor
Phenmetrazine,Norepinephrine transporter inhibitor,Norepinephrine transporter
Probenecid,Solute carrier family 22 member 6 inhibitor,Solute carrier family 22 member 6
Rabeprazole,Potassium-transporting ATPase inhibitor,Potassium-transporting ATPase
Balsalazid,Cyclooxygenase inhibitor,Cyclooxygenase
Phenoxybenzamine,Adrenergic receptor alpha antagonist,Adrenergic receptor alpha
Mecamylamine,Neuronal acetylcholine receptor; alpha3/beta4 negative allosteric modulator,Neuronal acetylcholine receptor; alpha3/beta4
Natalizumab,Integrin alpha-4/beta-1 inhibitor,Integrin alpha-4/beta-1
Acetohydroxamic Acid,Bacterial urease inhibitor,Bacterial urease
Botulinum Toxin Type A Purified Neurotoxin Complex,Synaptosomal-associated protein 25 inhibitor,Synaptosomal-associated protein 25
Penciclovir,Human herpesvirus 1 DNA polymerase inhibitor,Human herpesvirus 1 DNA polymerase
Deserpidine,Synaptic vesicular amine transporter inhibitor,Synaptic vesicular amine transporter
Ivermectin,Glutamate-gated chloride channel modulator,Glutamate-gated chloride channel
Deferoxamine,Iron chelating agent,Iron
Acetyldigitoxin,Sodium/potassium-transporting ATPase inhibitor,Sodium/potassium-transporting ATPase
Temazepam,GABA-A receptor; anion channel positive allosteric modulator,GABA-A receptor; anion channel
Praziquantel,Voltage-activated calcium channel beta 2 subunit blocker,Voltage-activated calcium channel beta 2 subunit
Quinidine,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Trimethadione,Voltage-gated T-type calcium channel blocker,Voltage-gated T-type calcium channel
Aminolevulinic Acid,DNA inhibitor,DNA
Vortioxetine,Serotonin 1a (5-HT1a) receptor agonist,Serotonin 1a (5-HT1a) receptor
Pf-03882845,Mineralocorticoid receptor antagonist,Mineralocorticoid receptor
Db959,Peroxisome proliferator-activated receptor gamma agonist,Peroxisome proliferator-activated receptor gamma
Allitinib,Receptor protein-tyrosine kinase erbB-2 inhibitor,Receptor protein-tyrosine kinase erbB-2
Azd-6703,MAP kinase p38 alpha inhibitor,MAP kinase p38 alpha
Gsk-1070916,Serine/threonine-protein kinase Aurora-B inhibitor,Serine/threonine-protein kinase Aurora-B
Hm-61713,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Pf-04965842,Tyrosine-protein kinase JAK1 inhibitor,Tyrosine-protein kinase JAK1
Sarakalim,Sulfonylurea receptors; K-ATP channels opener,Sulfonylurea receptors; K-ATP channels
Galeterone,Cytochrome P450 17A1 inhibitor,Cytochrome P450 17A1
C-1311,Tyrosine-protein kinase receptor FLT3 inhibitor,Tyrosine-protein kinase receptor FLT3
Insm-18,Insulin-like growth factor I receptor inhibitor,Insulin-like growth factor I receptor
Plx-3397,Macrophage colony stimulating factor receptor inhibitor,Macrophage colony stimulating factor receptor
Pilaralisib,PI3-kinase class I inhibitor,PI3-kinase class I
Tg100-801,SRC inhibitor,SRC
Dnk333,Neurokinin 1 receptor antagonist,Neurokinin 1 receptor
Camicinal,Motilin receptor agonist,Motilin receptor
Dabuzalgron,Alpha-1a adrenergic receptor partial agonist,Alpha-1a adrenergic receptor
Ctce-9908,C-X-C chemokine receptor type 4 antagonist,C-X-C chemokine receptor type 4
Pexacerfont,Corticotropin releasing factor receptor 1 antagonist,Corticotropin releasing factor receptor 1
Ibodutant,Neurokinin 2 receptor antagonist,Neurokinin 2 receptor
Rilotumumab,Hepatocyte growth factor inhibitor,Hepatocyte growth factor
Ganetespib,Heat shock protein HSP90 inhibitor,Heat shock protein HSP90
Entinostat,Histone deacetylase inhibitor,Histone deacetylase
Emricasan,Caspase inhibitor,Caspase
Di17e6,Integrin alpha-V/beta-3 inhibitor,Integrin alpha-V/beta-3
Drozitumab,Tumor necrosis factor receptor superfamily member 10B agonist,Tumor necrosis factor receptor superfamily member 10B
Gsk-933776,Beta amyloid A4 protein other,Beta amyloid A4 protein
Pexelizumab,Complement C5 inhibitor,Complement C5
Pasireotide,Somatostatin receptor 2 agonist,Somatostatin receptor 2
Levobunolol,Beta-1 adrenergic receptor antagonist,Beta-1 adrenergic receptor
Eletriptan,Serotonin 1b (5-HT1b) receptor agonist,Serotonin 1b (5-HT1b) receptor
Pimecrolimus,FK506-binding protein 1A inhibitor,FK506-binding protein 1A
Fenofibrate,Peroxisome proliferator-activated receptor alpha agonist,Peroxisome proliferator-activated receptor alpha
Enoxaparin Sodium,Antithrombin-III activator,Antithrombin-III
Insulin Susp Isophane Beef,Insulin receptor agonist,Insulin receptor
Dihydroergotamine,Serotonin 1d (5-HT1d) receptor agonist,Serotonin 1d (5-HT1d) receptor
Chlorotrianisene,Estrogen receptor beta modulator,Estrogen receptor beta
Desoxycorticosterone Pivalate,Mineralocorticoid receptor agonist,Mineralocorticoid receptor
Levallorphan,Mu opioid receptor antagonist,Mu opioid receptor
Methylprednisolone Hemisuccinate,Glucocorticoid receptor agonist,Glucocorticoid receptor
Rimantadine,Influenza virus A matrix protein M2 inhibitor,Influenza virus A matrix protein M2
Nortriptyline,Norepinephrine transporter inhibitor,Norepinephrine transporter
Misoprostol,Prostanoid EP3 receptor agonist,Prostanoid EP3 receptor
Crizotinib,Hepatocyte growth factor receptor inhibitor,Hepatocyte growth factor receptor
Medroxyprogesterone Acetate,Progesterone receptor agonist,Progesterone receptor
Linaclotide,Heat-stable enterotoxin receptor agonist,Heat-stable enterotoxin receptor
Naloxone,Opioid receptors; mu/kappa/delta antagonist,Opioid receptors; mu/kappa/delta
Pimozide,Dopamine receptor antagonist,Dopamine receptor
Fluoxymesterone,Androgen Receptor agonist,Androgen Receptor
Metoclopramide,Serotonin 4 (5-HT4) receptor agonist,Serotonin 4 (5-HT4) receptor
Levosalbutamol,Beta-2 adrenergic receptor agonist,Beta-2 adrenergic receptor
Diethylcarbamazine,Nematode GABA-A receptor positive modulator,Nematode GABA-A receptor
Idursulfase,Heparan sulfate hydrolytic enzyme,Heparan sulfate
Hexachlorophene,Bacterial enoyl-[acyl-carrier-protein] reductase inhibitor,Bacterial enoyl-[acyl-carrier-protein] reductase
Belatacept,T-lymphocyte activation antigen CD86 inhibitor,T-lymphocyte activation antigen CD86
Alitretinoin,Retinoid receptor agonist,Retinoid receptor
Digoxin,Sodium/potassium-transporting ATPase inhibitor,Sodium/potassium-transporting ATPase
Cefmetazole,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Cefixime,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Lomustine,DNA inhibitor,DNA
Clofazimine,DNA inhibitor,DNA
Loxapine,D2-like dopamine receptor antagonist,D2-like dopamine receptor
Alglucerase,Glucocerebroside hydrolytic enzyme,Glucocerebroside
Porfimer Sodium,DNA inhibitor,DNA
Peginterferon Beta-1a,Interferon alpha/beta receptor agonist,Interferon alpha/beta receptor
Avibactam,Bacterial beta-lactamase TEM inhibitor,Bacterial beta-lactamase TEM
Betaine,Betaine-homocysteine S-methyltransferase substrate,Betaine-homocysteine S-methyltransferase
Insulin Degludec,Insulin receptor agonist,Insulin receptor
Kd3010,Peroxisome proliferator-activated receptor delta agonist,Peroxisome proliferator-activated receptor delta
Ly-2874455,Fibroblast growth factor receptor inhibitor,Fibroblast growth factor receptor
Rg-7304,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,Dual specificity mitogen-activated protein kinase kinase 1
Puquitinib,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Telapristone Acetate,Progesterone receptor modulator,Progesterone receptor
Bgt-226,Serine/threonine-protein kinase mTOR inhibitor,Serine/threonine-protein kinase mTOR
Bms-690514,Receptor protein-tyrosine kinase erbB-2 inhibitor,Receptor protein-tyrosine kinase erbB-2
Decernotinib,Tyrosine-protein kinase JAK3 inhibitor,Tyrosine-protein kinase JAK3
Xl-999,Stem cell growth factor receptor inhibitor,Stem cell growth factor receptor
Vabicaserin,Serotonin 2b (5-HT2b) receptor antagonist,Serotonin 2b (5-HT2b) receptor
Pf-03654764,Histamine H3 receptor antagonist,Histamine H3 receptor
Tezampanel,Glutamate receptor ionotropic kainate antagonist,Glutamate receptor ionotropic kainate
Telcagepant,Calcitonin gene-related peptide type 1 receptor antagonist,Calcitonin gene-related peptide type 1 receptor
Atrasentan,Endothelin receptor ET-A antagonist,Endothelin receptor ET-A
Avosentan,Endothelin receptor ET-A antagonist,Endothelin receptor ET-A
Lenercept,TNF-alpha inhibitor,TNF-alpha
Indiplon,GABA receptor alpha-1 subunit positive allosteric modulator,GABA receptor alpha-1 subunit
Dulanermin,TRAIL receptor-1 agonist,TRAIL receptor-1
Cintredekin Besudotox,"Interleukin-13 receptor subunit alpha-1, Interleukin-4 receptor subunit alpha binding agent",Interleukin 13 receptor
Eplivanserin,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Trx-1,T-cell surface antigen CD4 inhibitor,T-cell surface antigen CD4
Lirilumab,Killer cell immunoglobulin-like receptor 2DL3 inhibitor,Killer cell immunoglobulin-like receptor 2DL3
Axomadol,Mu opioid receptor agonist,Mu opioid receptor
Dicyclomine,Muscarinic acetylcholine receptor M3 antagonist,Muscarinic acetylcholine receptor M3
Cyclopentolate,Muscarinic acetylcholine receptor M3 antagonist,Muscarinic acetylcholine receptor M3
Trospium,Muscarinic acetylcholine receptor M3 antagonist,Muscarinic acetylcholine receptor M3
Dorzolamide,Carbonic anhydrase II inhibitor,Carbonic anhydrase II
Mitoxantrone,DNA topoisomerase II alpha inhibitor,DNA topoisomerase II alpha
Captopril,Angiotensin-converting enzyme inhibitor,Angiotensin-converting enzyme
Calcitonin Salmon Recombinant,Calcitonin receptor agonist,Calcitonin receptor
Candesartan Cilexetil,Type-1 angiotensin II receptor antagonist,Type-1 angiotensin II receptor
Gonadorelin,Gonadotropin-releasing hormone receptor agonist,Gonadotropin-releasing hormone receptor
Romiplostim,Thrombopoietin receptor agonist,Thrombopoietin receptor
Maraviroc,C-C chemokine receptor type 5 antagonist,C-C chemokine receptor type 5
Thyrotropin Alfa,Thyroid stimulating hormone receptor agonist,Thyroid stimulating hormone receptor
Corticotropin Zinc Hydroxide,Melanocortin receptor 2 agonist,Melanocortin receptor 2
Mirtazapine,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Nesiritide,Atrial natriuretic peptide receptor A agonist,Atrial natriuretic peptide receptor A
Regadenoson,Adenosine A2a receptor agonist,Adenosine A2a receptor
Bosutinib,Tyrosine-protein kinase SRC inhibitor,Tyrosine-protein kinase SRC
Tramadol,Mu opioid receptor agonist,Mu opioid receptor
Aminoglutethimide,Cytochrome P450 11A1 inhibitor,Cytochrome P450 11A1
Emtricitabine,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,Human immunodeficiency virus type 1 reverse transcriptase
Quinestrol,Estrogen receptor agonist,Estrogen receptor
Vandetanib,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Rilonacept,Interleukin-1 beta inhibitor,Interleukin-1 beta
Liothyronine,Thyroid hormone receptor agonist,Thyroid hormone receptor
Buprenorphine,Kappa opioid receptor agonist,Kappa opioid receptor
Nandrolone Phenpropionate,Androgen Receptor agonist,Androgen Receptor
Cilostazol,Phosphodiesterase 3A inhibitor,Phosphodiesterase 3A
Valganciclovir,Human herpesvirus 1 DNA polymerase inhibitor,Human herpesvirus 1 DNA polymerase
Halothane,Glycine receptor (alpha-1/beta) positive modulator,Glycine receptor (alpha-1/beta)
Pentoxifylline,"3',5'-cyclic phosphodiesterase inhibitor","3',5'-cyclic phosphodiesterase"
Hydroxychloroquine,Toll-like receptor 9 antagonist,Toll-like receptor 9
Loracarbef,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Kanamycin,Bacterial 70S ribosome inhibitor,Bacterial 70S ribosome
Chlortetracycline,Bacterial 70S ribosome inhibitor,Bacterial 70S ribosome
Beractant,Surfactant agent,
Lactic Acid,pH lowering agent,
Levomilnacipran,Serotonin transporter inhibitor,Serotonin transporter
Albiglutide,Glucagon-like peptide 1 receptor agonist,Glucagon-like peptide 1 receptor
Dinutuximab,Disialoganglioside GD2 binding agent,Disialoganglioside GD2
Selexipag,Prostanoid IP receptor agonist,Prostanoid IP receptor
Su-014813,Platelet-derived growth factor receptor inhibitor,Platelet-derived growth factor receptor
Cerdulatinib,Tyrosine-protein kinase SYK inhibitor,Tyrosine-protein kinase SYK
Amg-900,Serine/threonine-protein kinase Aurora inhibitor,Serine/threonine-protein kinase Aurora
Bay-1163877,Fibroblast growth factor receptor inhibitor,Fibroblast growth factor receptor
Gdc-0994,MAP kinase ERK1 inhibitor,MAP kinase ERK1
Pa-799,PI3-kinase class I inhibitor,PI3-kinase class I
Ci-988,Cholecystokinin B receptor antagonist,Cholecystokinin B receptor
Gs-9667,Adenosine A1 receptor partial agonist,Adenosine A1 receptor
Rg-1530,Platelet-derived growth factor receptor beta inhibitor,Platelet-derived growth factor receptor beta
Tc-2216,Neuronal acetylcholine receptor; alpha4/beta2 antagonist,Neuronal acetylcholine receptor; alpha4/beta2
Rad1901,Estrogen receptor alpha degrader,Estrogen receptor alpha
Dagrocorat,Glucocorticoid receptor modulator,Glucocorticoid receptor
Bgt-226,PI3-kinase class I inhibitor,PI3-kinase class I
Bms-777607,Hepatocyte growth factor receptor inhibitor,Hepatocyte growth factor receptor
Mgcd-265,Macrophage-stimulating protein receptor inhibitor,Macrophage-stimulating protein receptor
Sb-773812,Dopamine D2 receptor antagonist,Dopamine D2 receptor
Rg3487,Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist,Neuronal acetylcholine receptor protein alpha-7 subunit
Budiodarone,Unknown,
Asoprisnil,Progesterone receptor modulator,Progesterone receptor
Canertinib,Receptor protein-tyrosine kinase erbB-2 inhibitor,Receptor protein-tyrosine kinase erbB-2
Losmapimod,MAP kinase p38 alpha inhibitor,MAP kinase p38 alpha
Ribociclib,Cyclin-dependent kinase 4 inhibitor,Cyclin-dependent kinase 4
Midostaurin,Vascular endothelial growth factor receptor 2 inhibitor,Vascular endothelial growth factor receptor 2
Ixekizumab,Interleukin 17A inhibitor,Interleukin 17A
Davunetide,Tubulin stabiliser,Tubulin
Mocetinostat,Histone deacetylase 1 inhibitor,Histone deacetylase 1
Vatiquinone,Quinone reductase 1 modulator,Quinone reductase 1)
Muparfostat,Vascular endothelial growth factor A inhibitor,Vascular endothelial growth factor A
Brolucizumab,Vascular endothelial growth factor A inhibitor,Vascular endothelial growth factor A
Matuzumab,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Ecromeximab,Ganglioside GD3 other,Ganglioside GD3
Methacholine,Muscarinic acetylcholine receptor M3 agonist,Muscarinic acetylcholine receptor M3
Tenecteplase,Plasminogen activator,Plasminogen
Tacrolimus,FK506-binding protein 1A inhibitor,FK506-binding protein 1A
Pentostatin,Adenosine deaminase inhibitor,Adenosine deaminase
Sorafenib,Platelet-derived growth factor receptor beta inhibitor,Platelet-derived growth factor receptor beta
Ranitidine,Histamine H2 receptor antagonist,Histamine H2 receptor
Ranolazine,Sodium channel protein type IV alpha subunit blocker,Sodium channel protein type IV alpha subunit
Pantoprazole,Potassium-transporting ATPase inhibitor,Potassium-transporting ATPase
Methoxamine,Adrenergic receptor alpha-1 agonist,Adrenergic receptor alpha-1
Caffeine,Adenosine receptor antagonist,Adenosine receptor
Timolol,Beta-2 adrenergic receptor antagonist,Beta-2 adrenergic receptor
Fluconazole,Cytochrome P450 51 inhibitor,Cytochrome P450 51
Flumazenil,GABA-A receptor; anion channel allosteric antagonist,GABA-A receptor; anion channel
Acamprosate,GABA-A receptor; anion channel positive modulator,GABA-A receptor; anion channel
Pregabalin,Voltage-gated calcium channel modulator,Voltage-gated calcium channel
Amylase,Starch hydrolytic enzyme,Starch
Efinaconazole,Lanosterol 14-alpha demethylase inhibitor,Lanosterol 14-alpha demethylase
Nivolumab,Programmed cell death protein 1 inhibitor,Programmed cell death protein 1
Cariprazine,Dopamine D3 receptor modulator,Dopamine D3 receptor
Rolapitant,Neurokinin 1 receptor antagonist,Neurokinin 1 receptor
As-703988,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,Dual specificity mitogen-activated protein kinase kinase 1
Y-39983,Rho-associated protein kinase inhibitor,Rho-associated protein kinase
Bpi-9016,Hepatocyte growth factor receptor inhibitor,Hepatocyte growth factor receptor
Las190792,Muscarinic acetylcholine receptor M3 antagonist,Muscarinic acetylcholine receptor M3
Cep-2563,Tyrosine-protein kinase receptor RET inhibitor,Tyrosine-protein kinase receptor RET
Mb07811,Thyroid hormone receptor beta-1 agonist,Thyroid hormone receptor beta-1
Becocalcidiol,Vitamin D receptor agonist,Vitamin D receptor
(7s)-Hydroxyl-Staurosporine,Protein kinase C (PKC) inhibitor,Protein kinase C (PKC)
Xl-281,Serine/threonine-protein kinase RAF inhibitor,Serine/threonine-protein kinase RAF
Cobiprostone,Chloride channel protein 2 activator,Chloride channel protein 2
Danirixin,Interleukin-8 receptor B antagonist,Interleukin-8 receptor B
Imiglitazar,Peroxisome proliferator-activated receptor gamma agonist,Peroxisome proliferator-activated receptor gamma
Cediranib,Platelet-derived growth factor receptor inhibitor,Platelet-derived growth factor receptor
Midostaurin,Stem cell growth factor receptor inhibitor,Stem cell growth factor receptor
Esmirtazapine,Histamine H1 receptor antagonist,Histamine H1 receptor
Afelimomab,TNF-alpha inhibitor,TNF-alpha
Istradefylline,Adenosine A2a receptor antagonist,Adenosine A2a receptor
Evofosfamide,DNA inhibitor,DNA
Aluminum Hydroxide,Unknown,
Gw493838,Adenosine A1 receptor agonist,Adenosine A1 receptor
G1t28-1,Cyclin-dependent kinase 6 inhibitor,Cyclin-dependent kinase 6
Cp-459632,Tyrosine-protein kinase receptor Tie-1 inhibitor,Tyrosine-protein kinase receptor Tie-1
Methdilazine,Histamine H1 receptor antagonist,Histamine H1 receptor
Acetophenazine,Dopamine D2 receptor antagonist,Dopamine D2 receptor
Omalizumab,Ig epsilon chain C region inhibitor,Ig epsilon chain C region
Penbutolol,Beta-1 adrenergic receptor antagonist,Beta-1 adrenergic receptor
Propafenone,Beta-1 adrenergic receptor antagonist,Beta-1 adrenergic receptor
Secretin,Secretin receptor agonist,Secretin receptor
Somatropin,Growth hormone receptor agonist,Growth hormone receptor
Mupirocin,Isoleucyl-tRNA synthetase inhibitor,Isoleucyl-tRNA synthetase
Methysergide,Serotonin 2c (5-HT2c) receptor antagonist,Serotonin 2c (5-HT2c) receptor
Decitabine,DNA (cytosine-5)-methyltransferase 1 inhibitor,DNA (cytosine-5)-methyltransferase 1
Fludrocortisone Acetate,Mineralocorticoid receptor agonist,Mineralocorticoid receptor
Halobetasol Propionate,Glucocorticoid receptor agonist,Glucocorticoid receptor
Acetazolamide,Carbonic anhydrase XII inhibitor,Carbonic anhydrase XII
Doxazosin,Adrenergic receptor alpha-1 antagonist,Adrenergic receptor alpha-1
Naftifine,Squalene monooxygenase inhibitor,Squalene monooxygenase
Denosumab,Tumor necrosis factor ligand superfamily member 11 inhibitor,Tumor necrosis factor ligand superfamily member 11
Oxybutynin,Muscarinic acetylcholine receptor M2 antagonist,Muscarinic acetylcholine receptor M2
Rituximab,B-lymphocyte antigen CD20 inhibitor,B-lymphocyte antigen CD20
Dutasteride,Steroid 5-alpha-reductase inhibitor,Steroid 5-alpha-reductase
Dalfopristin,Bacterial 70S ribosome inhibitor,Bacterial 70S ribosome
Furazolidone,DNA inhibitor,DNA
Procainamide,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Levopropoxyphene,Unknown,
Ammonium Lactate,Unknown,
Lactitol,Colonic bacteria substrate,
Prussian Blue Insoluble,Radioactive metals chelating agent,Radioactive metals
Apremilast,Phosphodiesterase 4 inhibitor,Phosphodiesterase 4
Isavuconazonium,Lanosterol 14-alpha demethylase inhibitor,Lanosterol 14-alpha demethylase
Sebelipase Alfa,Triglyceride hydrolytic enzyme,Triglyceride
Su-14813,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Lxr-623,LXR-beta agonist,LXR-beta
Clx-0921,Peroxisome proliferator-activated receptor gamma agonist,Peroxisome proliferator-activated receptor gamma
Cep-37440,ALK tyrosine kinase receptor inhibitor,ALK tyrosine kinase receptor
Ly-3009120,Serine/threonine-protein kinase A-Raf inhibitor,Serine/threonine-protein kinase A-Raf
R-1487,MAP kinase p38 alpha inhibitor,MAP kinase p38 alpha
Rgb-286638,Cyclin-dependent kinase 1 inhibitor,Cyclin-dependent kinase 1
X-396,ALK tyrosine kinase receptor inhibitor,ALK tyrosine kinase receptor
Briciclib,G1/S-specific cyclin D1 inhibitor,G1/S-specific cyclin D1
Rg-1530,Serine/threonine-protein kinase PLK4 inhibitor,Serine/threonine-protein kinase PLK4
Mbx-8025,Peroxisome proliferator-activated receptor delta agonist,Peroxisome proliferator-activated receptor delta
Dp001,Vitamin D receptor agonist,Vitamin D receptor
Amuvatinib,Platelet-derived growth factor receptor alpha inhibitor,Platelet-derived growth factor receptor alpha
Ly2828360,Cannabinoid CB2 receptor agonist,Cannabinoid CB2 receptor
Trelanserin,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Pratosartan,Type-1 angiotensin II receptor antagonist,Type-1 angiotensin II receptor
Bradanicline,Neuronal acetylcholine receptor protein alpha-7 subunit agonist,Neuronal acetylcholine receptor protein alpha-7 subunit
Raxatrigine,Sodium channel protein type IX alpha subunit blocker,Sodium channel protein type IX alpha subunit
Osimertinib,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Cobimetinib,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,Dual specificity mitogen-activated protein kinase kinase 2
Orantinib,Platelet-derived growth factor receptor inhibitor,Platelet-derived growth factor receptor
Lebrikizumab,Interleukin-13 inhibitor,Interleukin-13
Ocrelizumab,B-lymphocyte antigen CD20 other,B-lymphocyte antigen CD20
Bococizumab,Subtilisin/kexin type 9 inhibitor,Subtilisin/kexin type 9
Amrubicin,DNA topoisomerase II alpha inhibitor,DNA topoisomerase II alpha
Enlimomab Pegol,Intercellular adhesion molecule-1 antagonist,Intercellular adhesion molecule-1
Trc-105,Endoglin inhibitor,Endoglin
Ligelizumab,Ig epsilon chain C region inhibitor,Ig epsilon chain C region
Cevimeline,Muscarinic acetylcholine receptor M3 agonist,Muscarinic acetylcholine receptor M3
Bivalirudin,Thrombin inhibitor,Thrombin
Levodopa,Dopamine D3 receptor agonist,Dopamine D3 receptor
Histrelin,Gonadotropin-releasing hormone receptor agonist,Gonadotropin-releasing hormone receptor
Cevimeline,Muscarinic acetylcholine receptor M1 agonist,Muscarinic acetylcholine receptor M1
Mepenzolate,Muscarinic acetylcholine receptor M1 antagonist,Muscarinic acetylcholine receptor M1
Cycrimine,Muscarinic acetylcholine receptor M1 antagonist,Muscarinic acetylcholine receptor M1
Imatinib,Platelet-derived growth factor receptor beta inhibitor,Platelet-derived growth factor receptor beta
Mequinol,Tyrosinase inhibitor,Tyrosinase
Insulin Susp Isophane Recombinant Human,Insulin receptor agonist,Insulin receptor
Haloperidol Decanoate,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Betamethasone,Glucocorticoid receptor agonist,Glucocorticoid receptor
Pazopanib,Tyrosine-protein kinase LCK inhibitor,Tyrosine-protein kinase LCK
Cerivastatin,HMG-CoA reductase inhibitor,HMG-CoA reductase
Ibuprofen,Cyclooxygenase inhibitor,Cyclooxygenase
Eflornithine,Ornithine decarboxylase inhibitor,Ornithine decarboxylase
Oprelvekin,Interleukin 11 receptor alpha agonist,Interleukin 11 receptor alpha
Hetacillin,Penicillin-binding protein inhibitor,Penicillin-binding protein
Flavoxate,Phosphodiesterase 8 inhibitor,Phosphodiesterase 8
Alatrofloxacin,Topoisomerase IV inhibitor,Topoisomerase IV
Cefotiam,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Ampicillin,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Besifloxacin,Bacterial DNA gyrase inhibitor,Bacterial DNA gyrase
Agalsidase Beta,Globotriosylceramide hydrolytic enzyme,Globotriosylceramide
Prilocaine,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Ziprasidone,Dopamine D2 receptor antagonist,Dopamine D2 receptor
Pegaspargase,Asparagine hydrolytic enzyme,Asparagine
Su-014813,Tyrosine-protein kinase receptor FLT3 inhibitor,Tyrosine-protein kinase receptor FLT3
Ilorasertib,Serine/threonine-protein kinase Aurora inhibitor,Serine/threonine-protein kinase Aurora
Allitinib,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Cc-115,Serine/threonine-protein kinase mTOR inhibitor,Serine/threonine-protein kinase mTOR
Cep-7055,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Osi-930,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Nktr-171,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Ag-13958,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Cc-401,c-Jun N-terminal kinase 1 inhibitor,c-Jun N-terminal kinase 1
Tandutinib,Stem cell growth factor receptor inhibitor,Stem cell growth factor receptor
Milciclib,Nerve growth factor receptor Trk-A inhibitor,Nerve growth factor receptor Trk-A
Famitinib,Vascular endothelial growth factor receptor 1 inhibitor,Vascular endothelial growth factor receptor 1
Tg100-801,Platelet-derived growth factor receptor beta inhibitor,Platelet-derived growth factor receptor beta
(7s)-Hydroxyl-Staurosporine,Cyclin-dependent kinase 2 inhibitor,Cyclin-dependent kinase 2
Elubrixin,Interleukin-8 receptor B antagonist,Interleukin-8 receptor B
Rg3487,Serotonin 3 (5-HT3) receptor antagonist,Serotonin 3 (5-HT3) receptor
Adipiplon,GABA-A receptor; benzodiazepine site partial agonist,GABA-A receptor; benzodiazepine site
Dacomitinib,Receptor protein-tyrosine kinase erbB-2 inhibitor,Receptor protein-tyrosine kinase erbB-2
Fedratinib,Tyrosine-protein kinase receptor FLT3 inhibitor,Tyrosine-protein kinase receptor FLT3
Medi-500,T-cell receptor antagonist,T-cell receptor
Atezolizumab,Programmed cell death 1 ligand 1 inhibitor,Programmed cell death 1 ligand 1
Agatolimod,Toll-like receptor 9 agonist,Toll-like receptor 9
Orteronel,Cytochrome P450 17A1 inhibitor,Cytochrome P450 17A1
Arbaclofen Placarbil,GABA-B receptor agonist,GABA-B receptor
Tanespimycin,Heat shock protein HSP90 inhibitor,Heat shock protein HSP90
Aldoxorubicin,DNA topoisomerase II alpha inhibitor,DNA topoisomerase II alpha
Biib054,Alpha-synuclein inhibitor,Alpha-synuclein
Milveterol,Beta-2 adrenergic receptor agonist,Beta-2 adrenergic receptor
Anisotropine,Muscarinic acetylcholine receptor M3 antagonist,Muscarinic acetylcholine receptor M3
Meclizine,Histamine H1 receptor antagonist,Histamine H1 receptor
Methylergonovine,Serotonin 2b (5-HT2b) receptor partial agonist,Serotonin 2b (5-HT2b) receptor
"Gonadotropin, Chorionic",Luteinizing hormone/Choriogonadotropin receptor agonist,Luteinizing hormone/Choriogonadotropin receptor
Naratriptan,Serotonin 1b (5-HT1b) receptor agonist,Serotonin 1b (5-HT1b) receptor
Cholecalciferol,Vitamin D receptor agonist,Vitamin D receptor
Insulin Susp Protamine Zinc Purified Beef,Insulin receptor agonist,Insulin receptor
Bimatoprost,Prostanoid FP receptor agonist,Prostanoid FP receptor
Methylphenidate,Dopamine transporter inhibitor,Dopamine transporter
Sermorelin Acetate,Growth hormone-releasing hormone receptor agonist,Growth hormone-releasing hormone receptor
Hydrocortisone Hemisuccinate,Glucocorticoid receptor agonist,Glucocorticoid receptor
Triamcinolone Diacetate,Glucocorticoid receptor agonist,Glucocorticoid receptor
Fluocinolone Acetonide,Glucocorticoid receptor agonist,Glucocorticoid receptor
Oxiglutatione,Glutathione reductase,Glutathione reductase
Sapropterin,Phenylalanine-4-hydroxylase activator,Phenylalanine-4-hydroxylase
Ocriplasmin,Fibronectin proteolytic enzyme,Fibronectin
Pitavastatin,HMG-CoA reductase inhibitor,HMG-CoA reductase
Theophylline Glycinate,Phosphodiesterase 4 inhibitor,Phosphodiesterase 4
Dexmedetomidine,Adrenergic receptor alpha-2 agonist,Adrenergic receptor alpha-2
Mesalamine,Cyclooxygenase inhibitor,Cyclooxygenase
Fludarabine Phosphate,Ribonucleoside-diphosphate reductase RR1 inhibitor,Ribonucleoside-diphosphate reductase RR1
Sotalol,Beta-2 adrenergic receptor antagonist,Beta-2 adrenergic receptor
Esmolol,Beta-2 adrenergic receptor antagonist,Beta-2 adrenergic receptor
Azathioprine,Amidophosphoribosyltransferase inhibitor,Amidophosphoribosyltransferase
Daclizumab,Interleukin-2 receptor inhibitor,Interleukin-2 receptor
Natamycin,Ergosterol sequestering agent,Ergosterol
Azacitidine,DNA inhibitor,DNA
Clofarabine,DNA inhibitor,DNA
Capecitabine,DNA inhibitor,DNA
Ofloxacin,Bacterial DNA gyrase inhibitor,Bacterial DNA gyrase
Pentamidine,Kinetoplast DNA inhibitor,Kinetoplast DNA
Moricizine,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Quetiapine,Dopamine D2 receptor antagonist,Dopamine D2 receptor
Chymopapain,Polypeptides proteolytic enzyme,Polypeptides
Pemirolast,Unknown,
Cangrelor,Purinergic receptor P2Y12 antagonist,Purinergic receptor P2Y12
Su-14813,Stem cell growth factor receptor inhibitor,Stem cell growth factor receptor
Gsk2881078,Androgen Receptor modulator,Androgen Receptor
4sc-203,Tyrosine-protein kinase receptor FLT3 inhibitor,Tyrosine-protein kinase receptor FLT3
Azd-0424,Tyrosine-protein kinase SRC inhibitor,Tyrosine-protein kinase SRC
Bms-387032,Cyclin-dependent kinase 9 inhibitor,Cyclin-dependent kinase 9
Pki-179,PI3-kinase p110-alpha subunit inhibitor,PI3-kinase p110-alpha subunit
Ro-3201195,MAP kinase p38 alpha inhibitor,MAP kinase p38 alpha
Ttp-607,Serine/threonine-protein kinase Aurora inhibitor,Serine/threonine-protein kinase Aurora
Rg7342,Metabotropic glutamate receptor 5 modulator,Metabotropic glutamate receptor 5
Ly2969822,Metabotropic glutamate receptor 2 agonist,Metabotropic glutamate receptor 2
Puquitinib,Platelet-derived growth factor receptor beta inhibitor,Platelet-derived growth factor receptor beta
Mt-3995,Mineralocorticoid receptor antagonist,Mineralocorticoid receptor
Onapristone,Progesterone receptor antagonist,Progesterone receptor
Crenolanib,Tyrosine-protein kinase receptor FLT3 inhibitor,Tyrosine-protein kinase receptor FLT3
Osi-027,Serine/threonine-protein kinase mTOR inhibitor,Serine/threonine-protein kinase mTOR
Milciclib,Cyclin-dependent kinase 2 inhibitor,Cyclin-dependent kinase 2
Tesevatinib,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Elzasonan,Serotonin 1b (5-HT1b) receptor antagonist,Serotonin 1b (5-HT1b) receptor
Atagabalin,Voltage-gated calcium channel modulator,Voltage-gated calcium channel
Girentuximab,Carbonic anhydrase IX other,Carbonic anhydrase IX
Di17e6,Integrin alpha-V/beta-1 inhibitor,Integrin alpha-V/beta-1
Stx-100,Integrin alpha-V/beta-6 inhibitor,Integrin alpha-V/beta-6
Cantuzumab Ravtansine,Mucin-1 binding agent,Mucin-1
Intetumumab,Integrin alpha-V/beta-6 antagonist,Integrin alpha-V/beta-6
Ozoralizumab,TNF-alpha inhibitor,TNF-alpha
Atovaquone,Cytochrome b inhibitor,Cytochrome b
Tolterodine,Muscarinic acetylcholine receptor M3 antagonist,Muscarinic acetylcholine receptor M3
Mepenzolate,Muscarinic acetylcholine receptor M3 antagonist,Muscarinic acetylcholine receptor M3
Oxyphencyclimine,Muscarinic acetylcholine receptor M3 antagonist,Muscarinic acetylcholine receptor M3
Streptokinase,Plasminogen activator,Plasminogen
Reteplase,Plasminogen activator,Plasminogen
Olopatadine,Histamine H1 receptor antagonist,Histamine H1 receptor
Methimazole,Thyroid peroxidase inhibitor,Thyroid peroxidase
Ganirelix Acetate,Gonadotropin-releasing hormone receptor antagonist,Gonadotropin-releasing hormone receptor
Almotriptan,Serotonin 1b (5-HT1b) receptor agonist,Serotonin 1b (5-HT1b) receptor
Dicumarol,Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor,Vitamin k epoxide reductase complex subunit 1 isoform 1
Nizatidine,Histamine H2 receptor antagonist,Histamine H2 receptor
Insulin Aspart,Insulin receptor agonist,Insulin receptor
Dextroamphetamine,Dopamine transporter releasing agent,Dopamine transporter
Halcinonide,Glucocorticoid receptor agonist,Glucocorticoid receptor
Fluorometholone Acetate,Glucocorticoid receptor agonist,Glucocorticoid receptor
Meprednisone,Glucocorticoid receptor agonist,Glucocorticoid receptor
Ciclesonide,Glucocorticoid receptor agonist,Glucocorticoid receptor
Desipramine,Norepinephrine transporter inhibitor,Norepinephrine transporter
Amphetamine,Norepinephrine transporter releasing agent,Norepinephrine transporter
Dibucaine,Sodium channel protein type X alpha subunit blocker,Sodium channel protein type X alpha subunit
Alendronic Acid,Farnesyl diphosphate synthase inhibitor,Farnesyl diphosphate synthase
Pravastatin,HMG-CoA reductase inhibitor,HMG-CoA reductase
Diclofenac,Cyclooxygenase inhibitor,Cyclooxygenase
Isosorbide Mononitrate,Soluble guanylate cyclase activator,Soluble guanylate cyclase
Sunitinib,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Regorafenib,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Boceprevir,"Hepatitis C virus serine protease, NS3/NS4A inhibitor","Hepatitis C virus serine protease, NS3/NS4A"
Flutamide,Androgen Receptor antagonist,Androgen Receptor
Propylthiouracil,Type I iodothyronine deiodinase (Type-I 5&apos;deiodinase) (DIOI) (Type 1 DI) (5DI) inhibitor,Type I iodothyronine deiodinase (Type-I 5'-deiodinase) (DIOI) (Type 1 DI) (5DI)
Milrinone,Phosphodiesterase 3A inhibitor,Phosphodiesterase 3A
Primidone,GABA-A receptor; anion channel positive allosteric modulator,GABA-A receptor; anion channel
Ceforanide,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Quinupristin,Bacterial 70S ribosome inhibitor,Bacterial 70S ribosome
Fingolimod,Sphingosine 1-phosphate receptor agonist,Sphingosine 1-phosphate receptor
Phenazopyridine,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Tocainide,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Isoflurane,Potassium channel subfamily K member 3 opener,Potassium channel subfamily K member 3
Nedocromil,Unknown,
Cupric Sulfate,Unknown,
Fospropofol,Unknown,
Luliconazole,Cytochrome P450 51 inhibitor,Cytochrome P450 51
Droxidopa,Adrenergic receptor agonist,Adrenergic receptor
Elosulfase Alfa,Chondroitin-6-sulfate hydrolytic enzyme,Chondroitin-6-sulfate
Edoxaban,Coagulation factor X inhibitor,Coagulation factor X
Trabectedin,DNA inhibitor,DNA
Cobimetinib,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,Dual specificity mitogen-activated protein kinase kinase 2
Ac-480,Receptor protein-tyrosine kinase erbB-4 inhibitor,Receptor protein-tyrosine kinase erbB-4
Ly-2606368,Serine/threonine-protein kinase Chk1 inhibitor,Serine/threonine-protein kinase Chk1
Mk-8353,MAP kinase ERK1 inhibitor,MAP kinase ERK1
Pf-00337210,Vascular endothelial growth factor receptor 2 inhibitor,Vascular endothelial growth factor receptor 2
Rg-7603,Serine/threonine-protein kinase mTOR inhibitor,Serine/threonine-protein kinase mTOR
Irdabisant,Histamine H3 receptor antagonist,Histamine H3 receptor
Puquitinib,PI3-kinase class I inhibitor,PI3-kinase class I
Azd3161,Sodium channel protein type IX alpha subunit blocker,Sodium channel protein type IX alpha subunit
Elpetrigine,Voltage-gated L-type calcium channel blocker,Voltage-gated L-type calcium channel
Pac-14028,Vanilloid receptor antagonist,Vanilloid receptor
Mk-0533,Peroxisome proliferator-activated receptor gamma modulator,Peroxisome proliferator-activated receptor gamma
Aee-788,Receptor protein-tyrosine kinase erbB-2 inhibitor,Receptor protein-tyrosine kinase erbB-2
Telatinib,Platelet-derived growth factor receptor beta inhibitor,Platelet-derived growth factor receptor beta
E-6201,Mitogen-activated protein kinase kinase kinase 1 inhibitor,Mitogen-activated protein kinase kinase kinase 1
Pd-0325901,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,Dual specificity mitogen-activated protein kinase kinase 1
Chir-265,Serine/threonine-protein kinase B-raf inhibitor,Serine/threonine-protein kinase B-raf
Apitolisib,PI3-kinase class I inhibitor,PI3-kinase class I
Bms-833923,Smoothened homolog antagonist,Smoothened homolog
Ur-63325,Histamine H4 receptor antagonist,Histamine H4 receptor
Capadenoson,Adenosine A1 receptor partial agonist,Adenosine A1 receptor
Enrasentan,Endothelin receptor ET-B antagonist,Endothelin receptor ET-B
Saracatinib,Tyrosine-protein kinase ABL inhibitor,Tyrosine-protein kinase ABL
Lestaurtinib,Tyrosine-protein kinase receptor FLT3 inhibitor,Tyrosine-protein kinase receptor FLT3
Alvocidib,Cyclin-dependent kinase 7 inhibitor,Cyclin-dependent kinase 7
Binimetinib,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,Dual specificity mitogen-activated protein kinase kinase 1
Esuberaprost,Prostanoid IP receptor agonist,Prostanoid IP receptor
Encenicline,Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist,Neuronal acetylcholine receptor protein alpha-7 subunit
Figitumumab,Insulin-like growth factor I receptor antagonist,Insulin-like growth factor I receptor
Indibulin,Tubulin inhibitor,Tubulin
Oliceridine,Mu opioid receptor agonist,Mu opioid receptor
Conbercept,Vascular endothelial growth factor C inhibitor,Vascular endothelial growth factor C
Mm-302,DNA topoisomerase II alpha inhibitor,DNA topoisomerase II alpha
Sotatercept,Inhibin beta A chain inhibitor,Inhibin beta A chain
Sar-3419,B-lymphocyte antigen CD19 binding agent,B-lymphocyte antigen CD19
Fg-3019,Connective tissue growth factor inhibitor,Connective tissue growth factor
Decoglurant,Metabotropic glutamate receptor 3 modulator,Metabotropic glutamate receptor 3
Pegaptanib Sodium,Vascular endothelial growth factor A antagonist,Vascular endothelial growth factor A
Quinapril,Angiotensin-converting enzyme inhibitor,Angiotensin-converting enzyme
Fexofenadine,Histamine H1 receptor antagonist,Histamine H1 receptor
Dexbrompheniramine,Histamine H1 receptor antagonist,Histamine H1 receptor
Chlorprothixene,Dopamine D3 receptor antagonist,Dopamine D3 receptor
Insulin Susp Isophane Semisynthetic Purified Human,Insulin receptor agonist,Insulin receptor
Didanosine,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,Human immunodeficiency virus type 1 reverse transcriptase
Pseudoephedrine,Norepinephrine transporter releasing agent,Norepinephrine transporter
Orphenadrine,Norepinephrine transporter inhibitor,Norepinephrine transporter
Lisdexamfetamine,Norepinephrine transporter releasing agent,Norepinephrine transporter
Hydroxychloroquine,Ferriprotoporphyrin IX inhibitor,Ferriprotoporphyrin IX
Norethindrone Acetate,Progesterone receptor agonist,Progesterone receptor
Ethynodiol Diacetate,Progesterone receptor agonist,Progesterone receptor
Nebivolol,Beta-2 adrenergic receptor antagonist,Beta-2 adrenergic receptor
Erythromycin,Bacterial 70S ribosome inhibitor,Bacterial 70S ribosome
Plicamycin,DNA inhibitor,DNA
Carmustine,DNA inhibitor,DNA
Sevelamer,Unknown,
Dimethyl Sulfoxide,Unknown,
Calcium Acetate,Phosphate sequestering agent,Phosphate
Crofelemer,Anoctamin-1 blocker,Anoctamin-1
Amg-319,PI3-kinase p110-delta subunit inhibitor,PI3-kinase p110-delta subunit
Azd-8330,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,Dual specificity mitogen-activated protein kinase kinase 2
Cr-3465,Cysteinyl leukotriene receptor 1 antagonist,Cysteinyl leukotriene receptor 1
Rg-7420,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,Dual specificity mitogen-activated protein kinase kinase 1
Elpetrigine,Sodium channel protein type II alpha subunit blocker,Sodium channel protein type II alpha subunit
Ly-518674,Peroxisome proliferator-activated receptor alpha agonist,Peroxisome proliferator-activated receptor alpha
Akn-028,Tyrosine-protein kinase receptor FLT3 inhibitor,Tyrosine-protein kinase receptor FLT3
Copanlisib,PI3-kinase class I inhibitor,PI3-kinase class I
Amuvatinib,Stem cell growth factor receptor inhibitor,Stem cell growth factor receptor
Voxtalisib,Serine/threonine-protein kinase mTOR inhibitor,Serine/threonine-protein kinase mTOR
Incb-40093,PI3-kinase p110-delta subunit inhibitor,PI3-kinase p110-delta subunit
Retosiban,Oxytocin receptor antagonist,Oxytocin receptor
Jnj-17216498,Histamine H3 receptor antagonist,Histamine H3 receptor
Ponesimod,Sphingosine 1-phosphate receptor Edg-1 agonist,Sphingosine 1-phosphate receptor Edg-1
Ladarixin,Interleukin-8 receptor B modulator,Interleukin-8 receptor B
Ce-224535,P2X purinoceptor 7 antagonist,P2X purinoceptor 7
Tc-6499,Neuronal acetylcholine receptor; alpha4/beta2 agonist,Neuronal acetylcholine receptor; alpha4/beta2
Indantadol,Glutamate [NMDA] receptor antagonist,Glutamate [NMDA] receptor
Nerispirdine,Voltage-gated potassium channel blocker,Voltage-gated potassium channel
Cediranib,Stem cell growth factor receptor inhibitor,Stem cell growth factor receptor
Neratinib,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Midostaurin,Protein kinase C (PKC) inhibitor,Protein kinase C (PKC)
Aplaviroc,C-C chemokine receptor type 5 antagonist,C-C chemokine receptor type 5
Arbaclofen,GABA-B receptor agonist,GABA-B receptor
Obatoclax,Apoptosis regulator Bcl-2 inhibitor,Apoptosis regulator Bcl-2
Talazoparib,Poly [ADP-ribose] polymerase-1 inhibitor,Poly [ADP-ribose] polymerase-1
Diphemanil,Muscarinic acetylcholine receptor M3 antagonist,Muscarinic acetylcholine receptor M3
Acetylcholine,Muscarinic acetylcholine receptor M3 agonist,Muscarinic acetylcholine receptor M3
Clidinium,Muscarinic acetylcholine receptor M3 antagonist,Muscarinic acetylcholine receptor M3
Methazolamide,Carbonic anhydrase II inhibitor,Carbonic anhydrase II
Lanreotide,Somatostatin receptor 2 agonist,Somatostatin receptor 2
Peginesatide Acetate,Erythropoietin receptor agonist,Erythropoietin receptor
Promethazine,Histamine H1 receptor antagonist,Histamine H1 receptor
Propiomazine,Histamine H1 receptor antagonist,Histamine H1 receptor
Tripelennamine,Histamine H1 receptor antagonist,Histamine H1 receptor
Valsartan,Type-1 angiotensin II receptor antagonist,Type-1 angiotensin II receptor
Cyclothiazide,Thiazide-sensitive sodium-chloride cotransporter inhibitor,Thiazide-sensitive sodium-chloride cotransporter
Benzthiazide,Thiazide-sensitive sodium-chloride cotransporter inhibitor,Thiazide-sensitive sodium-chloride cotransporter
Escitalopram,Serotonin transporter inhibitor,Serotonin transporter
Pazopanib,Stem cell growth factor receptor inhibitor,Stem cell growth factor receptor
Sitagliptin,Dipeptidyl peptidase IV inhibitor,Dipeptidyl peptidase IV
Linagliptin,Dipeptidyl peptidase IV inhibitor,Dipeptidyl peptidase IV
Seractide Acetate,Melanocortin receptor 2 agonist,Melanocortin receptor 2
Treprostinil,Prostanoid IP receptor agonist,Prostanoid IP receptor
Zalcitabine,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,Human immunodeficiency virus type 1 reverse transcriptase
Miglitol,Maltase-glucoamylase inhibitor,Maltase-glucoamylase
Eribulin,Tubulin inhibitor,Tubulin
Carvedilol,Adrenergic receptor alpha-1 antagonist,Adrenergic receptor alpha-1
Thioguanine,Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor,Inosine-5'-monophosphate dehydrogenase (IMPDH)
Phenelzine,Monoamine oxidase inhibitor,Monoamine oxidase
Ethylestrenol,Androgen Receptor agonist,Androgen Receptor
Nandrolone Decanoate,Androgen Receptor agonist,Androgen Receptor
Testosterone Cypionate,Androgen Receptor agonist,Androgen Receptor
Pipecuronium,Muscle-type nicotinic acetylcholine receptor antagonist,Muscle-type nicotinic acetylcholine receptor
Metocurine,Muscle-type nicotinic acetylcholine receptor antagonist,Muscle-type nicotinic acetylcholine receptor
Halazepam,GABA-A receptor; anion channel positive allosteric modulator,GABA-A receptor; anion channel
Interferon Gama-1b,Interferon gamma receptor agonist,Interferon gamma receptor
Tinidazole,DNA inhibitor,DNA
Articaine,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Ethosuximide,Voltage-gated T-type calcium channel blocker,Voltage-gated T-type calcium channel
Poractant Alfa,Surfactant agent,
Selenium Sulfide,Unknown,
Sucroferric Oxyhydroxide,Phosphate sequestering agent,Phosphate
Olodaterol,Beta-2 adrenergic receptor agonist,Beta-2 adrenergic receptor
Finafloxacin,DNA gyrase inhibitor,DNA gyrase
Dronedarone,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 blocker,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4
Db959,Peroxisome proliferator-activated receptor delta agonist,Peroxisome proliferator-activated receptor delta
4sc-203,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Altiratinib,Vascular endothelial growth factor receptor 2 inhibitor,Vascular endothelial growth factor receptor 2
Kw-2449,Tyrosine-protein kinase ABL inhibitor,Tyrosine-protein kinase ABL
Pl-225b,Insulin-like growth factor I receptor inhibitor,Insulin-like growth factor I receptor
Rg-7741,Serine/threonine-protein kinase Chk1 inhibitor,Serine/threonine-protein kinase Chk1
Sb-85635,MAP kinase p38 alpha inhibitor,MAP kinase p38 alpha
Tg-02,Cyclin-dependent kinase 2 inhibitor,Cyclin-dependent kinase 2
Tg-02,Cyclin-dependent kinase 7 inhibitor,Cyclin-dependent kinase 7
Leq506,Smoothened homolog antagonist,Smoothened homolog
Msc-2364447,Tyrosine-protein kinase BTK inhibitor,Tyrosine-protein kinase BTK
Cb-03-01,Androgen Receptor antagonist,Androgen Receptor
Abemaciclib,Cyclin-dependent kinase 6 inhibitor,Cyclin-dependent kinase 6
Milciclib,Cyclin-dependent kinase 1 inhibitor,Cyclin-dependent kinase 1
Cenicriviroc,C-C chemokine receptor type 5 antagonist,C-C chemokine receptor type 5
Patidegib,Smoothened homolog antagonist,Smoothened homolog
Modimelanotide,Melanocortin receptor 3 agonist,Melanocortin receptor 3
Binimetinib,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,Dual specificity mitogen-activated protein kinase kinase 2
Bremelanotide,Melanocortin receptor 4 agonist,Melanocortin receptor 4
Vapreotide,Somatostatin receptor 2 agonist,Somatostatin receptor 2
Brivaracetam,Synaptic vesicle glycoprotein 2A modulator,Synaptic vesicle glycoprotein 2A
Becatecarin,DNA topoisomerase I inhibitor,DNA topoisomerase I
Roxadustat,HIF-prolyl hydroxylase inhibitor,Hypoxia-inducible factor prolyl hydroxylase
Obatoclax,Bcl-2-like protein 10,Bcl-2-like protein 10
Rivipansel,Leukocyte adhesion molecule-1 antagonist,Leukocyte adhesion molecule-1
Di17e6,Vitronectin receptor alpha inhibitor,Vitronectin receptor alpha
Oportuzumab Monatox,Epithelial cell adhesion molecule binding agent,Epithelial cell adhesion molecule
M195,Myeloid cell surface antigen CD33 other,Myeloid cell surface antigen CD33
Ad-159,Envelope glycoprotein gp160 inhibitor,Envelope glycoprotein gp160
Cal,Parathyroid hormone-related protein inhibitor,Parathyroid hormone-related protein
Cetirizine,Histamine H1 receptor antagonist,Histamine H1 receptor
Isoniazid,Enoyl-[acyl-carrier-protein] reductase inhibitor,Enoyl-[acyl-carrier-protein] reductase
Finasteride,Steroid 5-alpha-reductase 2 inhibitor,Steroid 5-alpha-reductase 2
Sorafenib,Serine/threonine-protein kinase RAF inhibitor,Serine/threonine-protein kinase RAF
Methysergide,Serotonin 1a (5-HT1a) receptor partial agonist,Serotonin 1a (5-HT1a) receptor
Dextromethorphan,Glutamate [NMDA] receptor subunit epsilon 1 antagonist,Glutamate [NMDA] receptor subunit epsilon 1
Filgrastim,Granulocyte colony stimulating factor receptor agonist,Granulocyte colony stimulating factor receptor
Armodafinil,Dopamine transporter inhibitor,Dopamine transporter
Hydrocortamate,Glucocorticoid receptor agonist,Glucocorticoid receptor
Estradiol Acetate,Estrogen receptor alpha agonist,Estrogen receptor alpha
Menthol,Transient receptor potential cation channel subfamily A member 1 opener,Transient receptor potential cation channel subfamily A member 1
Amlexanox,Phosphodiesterase 4 inhibitor,Phosphodiesterase 4
"Estrogens, Conjugated Synthetic A",Estrogen receptor agonist,Estrogen receptor
Ketorolac,Cyclooxygenase inhibitor,Cyclooxygenase
Oxybate,GABA-B receptor agonist,GABA-B receptor
Deslanoside,Sodium/potassium-transporting ATPase inhibitor,Sodium/potassium-transporting ATPase
Digitoxin,Sodium/potassium-transporting ATPase inhibitor,Sodium/potassium-transporting ATPase
Mercaptopurine,Amidophosphoribosyltransferase inhibitor,Amidophosphoribosyltransferase
Paromomycin,Bacterial 70S ribosome inhibitor,Bacterial 70S ribosome
Interferon Beta-1a,Interferon alpha/beta receptor agonist,Interferon alpha/beta receptor
Ustekinumab,Interleukin-12 inhibitor,Interleukin-12
Lomefloxacin,Bacterial DNA gyrase inhibitor,Bacterial DNA gyrase
Niclosamide,DNA inhibitor,DNA
Enflurane,Potassium channel subfamily K member 3 opener,Potassium channel subfamily K member 3
Phensuximide,Voltage-gated T-type calcium channel blocker,Voltage-gated T-type calcium channel
Calfactant,Surfactant agent,
Potassium Sulfate,Unknown,
Metaxalone,Unknown,
Obinutuzumab,B-lymphocyte antigen CD20 inhibitor,B-lymphocyte antigen CD20
Pembrolizumab,Programmed cell death protein 1 inhibitor,Programmed cell death protein 1
Su-14813,Platelet-derived growth factor receptor inhibitor,Platelet-derived growth factor receptor
Bms-794833,Hepatocyte growth factor receptor inhibitor,Hepatocyte growth factor receptor
Mofarotene,Retinoid receptor modulator,Retinoid receptor
Cm-082,Stem cell growth factor receptor inhibitor,Stem cell growth factor receptor
Gsk-690693,Protein kinase C (PKC) inhibitor,Protein kinase C (PKC)
Balamapimod,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,Dual specificity mitogen-activated protein kinase kinase 2
Pha-793887,Cyclin-dependent kinase inhibitor,Cyclin-dependent kinase
Pwt-33587,PI3-kinase class I inhibitor,PI3-kinase class I
Cep-2563,Neurotrophic tyrosine kinase receptor inhibitor,Neurotrophic tyrosine kinase receptor
Imd-2560,Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor,Inhibitor of nuclear factor kappa B kinase beta subunit
Arry-797,MAP kinase p38 alpha inhibitor,MAP kinase p38 alpha
Savolitinib,Hepatocyte growth factor receptor inhibitor,Hepatocyte growth factor receptor
Selumetinib,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,Dual specificity mitogen-activated protein kinase kinase 1
Tedatioxetine,Serotonin transporter inhibitor,Serotonin transporter
Tedatioxetine,Serotonin 3 (5-HT3) receptor antagonist,Serotonin 3 (5-HT3) receptor
Vestipitant,Neurokinin 1 receptor antagonist,Neurokinin 1 receptor
Taladegib,Smoothened homolog antagonist,Smoothened homolog
Oc000459,G protein-coupled receptor 44 antagonist,G protein-coupled receptor 44
Davalintide,"Amylin receptor AMY1, CALCR/RAMP1 agonist","Amylin receptor AMY1, CALCR/RAMP1"
K-877,Peroxisome proliferator-activated receptor alpha agonist,Peroxisome proliferator-activated receptor alpha
Bardoxolone Methyl,Keap1/Nrf2 inhibitor,Keap1/Nrf2
Linifanib,Tyrosine-protein kinase receptor FLT3 inhibitor,Tyrosine-protein kinase receptor FLT3
Tivozanib,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Ulimorelin,Ghrelin receptor agonist,Ghrelin receptor
Reminertant,Neurotensin receptor 1 antagonist,Neurotensin receptor 1
Ralfinamide,Voltage-gated N-type calcium channel alpha-1B subunit blocker,Voltage-gated N-type calcium channel alpha-1B subunit
Oregovomab,Mucin-16 other,Mucin-16
Patiromer,Potassium chelating agent,Potassium
Varespladib,Phospholipase A2 group IIA inhibitor,Phospholipase A2 group IIA
Obatoclax,Induced myeloid leukemia cell differentiation protein Mcl-1 inhibitor,Induced myeloid leukemia cell differentiation protein Mcl-1
Aminosalicylic Acid,Dihydrofolate reductase inhibitor,Dihydrofolate reductase
Flanvotumab,"5,6-dihydroxyindole-2-carboxylic acid oxidase other","5,6-dihydroxyindole-2-carboxylic acid oxidase"
Baminercept,Tumor necrosis factor ligand superfamily member 14 inhibitor,Tumor necrosis factor ligand superfamily member 14
Talizumab,Ig epsilon chain C region inhibitor,Ig epsilon chain C region
Rg-7686,Ganglioside GD3 other,Ganglioside GD3
Pwt-33579,Serine/threonine-protein kinase mTOR inhibitor,Serine/threonine-protein kinase mTOR
Ruplizumab,CD40 ligand inhibitor,CD40 ligand
Nafarelin,Gonadotropin-releasing hormone receptor agonist,Gonadotropin-releasing hormone receptor
Bisoprolol,Beta-1 adrenergic receptor antagonist,Beta-1 adrenergic receptor
Ardeparin Sodium,Antithrombin-III activator,Antithrombin-III
Pemetrexed,Thymidylate synthase inhibitor,Thymidylate synthase
Anastrozole,Cytochrome P450 19A1 inhibitor,Cytochrome P450 19A1
Insulin Zinc Susp Semisynthetic Purified Human,Insulin receptor agonist,Insulin receptor
Promazine,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Risperidone,Serotonin 2c (5-HT2c) receptor antagonist,Serotonin 2c (5-HT2c) receptor
Glucagon Hydrochloride,Glucagon receptor agonist,Glucagon receptor
Eplerenone,Mineralocorticoid receptor antagonist,Mineralocorticoid receptor
Iloprost,Prostanoid IP receptor agonist,Prostanoid IP receptor
Phendimetrazine,Dopamine transporter inhibitor,Dopamine transporter
Clobetasol Propionate,Glucocorticoid receptor agonist,Glucocorticoid receptor
Fluticasone Propionate,Glucocorticoid receptor agonist,Glucocorticoid receptor
Alefacept,T-cell surface antigen CD2 inhibitor,T-cell surface antigen CD2
Oseltamivir,Neuraminidase inhibitor,Neuraminidase
Protriptyline,Norepinephrine transporter inhibitor,Norepinephrine transporter
Cabozantinib,Hepatocyte growth factor receptor inhibitor,Hepatocyte growth factor receptor
Doxycycline,Matrix metalloproteinase 7 inhibitor,Matrix metalloproteinase 7
Lovastatin,HMG-CoA reductase inhibitor,HMG-CoA reductase
Abciximab,Integrin alpha-IIb/beta-3 inhibitor,Integrin alpha-IIb/beta-3
Paclitaxel,Tubulin inhibitor,Tubulin
Cabazitaxel,Tubulin inhibitor,Tubulin
Nepafenac,Cyclooxygenase inhibitor,Cyclooxygenase
Oxyphenbutazone,Cyclooxygenase inhibitor,Cyclooxygenase
Gallium Nitrate,Ribonucleoside-diphosphate reductase RR1 inhibitor,Ribonucleoside-diphosphate reductase RR1
Dromostanolone Propionate,Androgen Receptor agonist,Androgen Receptor
Rivaroxaban,Coagulation factor X inhibitor,Coagulation factor X
Carfilzomib,26S proteosome inhibitor,26S proteosome
Bortezomib,26S proteosome inhibitor,26S proteosome
Spinosad,Nicotinic acetylcholine receptor agonist,Nicotinic acetylcholine receptor
Rasburicase,Uric acid oxidative enzyme,Uric acid
Cefotetan,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Minocycline,Bacterial 70S ribosome inhibitor,Bacterial 70S ribosome
Nystatin,Ergosterol sequestering agent,Ergosterol
Thioguanine,DNA inhibitor,DNA
Clofarabine,DNA polymerase (alpha/delta/epsilon) inhibitor,DNA polymerase (alpha/delta/epsilon)
Lipase,Fatty acids hydrolytic enzyme,Fatty acids
Secukinumab,Interleukin 17A inhibitor,Interleukin 17A
Jte-151,Nuclear receptor ROR-gamma antagonist,Nuclear receptor ROR-gamma
Azd-6738,Serine-protein kinase ATR inhibitor,Serine-protein kinase ATR
Cyc-116,Serine/threonine-protein kinase Aurora inhibitor,Serine/threonine-protein kinase Aurora
Glpg-0555,Tyrosine-protein kinase JAK1 inhibitor,Tyrosine-protein kinase JAK1
Sf-1126,Serine/threonine-protein kinase mTOR inhibitor,Serine/threonine-protein kinase mTOR
Elpetrigine,Sodium channel protein type III alpha subunit blocker,Sodium channel protein type III alpha subunit
Pf-04958242,Glutamate receptor ionotropic AMPA positive allosteric modulator,Glutamate receptor ionotropic AMPA
Irx-4204,Retinoid X receptor agonist,Retinoid X receptor
Prinaberel,Estrogen receptor beta agonist,Estrogen receptor beta
Picropodophyllotoxin,Insulin-like growth factor I receptor inhibitor,Insulin-like growth factor I receptor
Azd-1775,Serine/threonine-protein kinase WEE1 inhibitor,Serine/threonine-protein kinase WEE1
Sapitinib,Receptor protein-tyrosine kinase erbB-2 inhibitor,Receptor protein-tyrosine kinase erbB-2
Foretinib,Tyrosine-protein kinase TIE-2 inhibitor,Tyrosine-protein kinase TIE-2
Rabusertib,Serine/threonine-protein kinase Chk1 inhibitor,Serine/threonine-protein kinase Chk1
Pf-04691502,PI3-kinase class I inhibitor,PI3-kinase class I
Gedatolisib,PI3-kinase class I inhibitor,PI3-kinase class I
Ronacaleret,Calcium sensing receptor antagonist,Calcium sensing receptor
Regrelor,Purinergic receptor P2Y12 antagonist,Purinergic receptor P2Y12
Bedoradrine,Beta-2 adrenergic receptor agonist,Beta-2 adrenergic receptor
Frakefamide,Mu opioid receptor agonist,Mu opioid receptor
Pozanicline,Neuronal acetylcholine receptor; alpha6/beta2 partial agonist,Neuronal acetylcholine receptor; alpha6/beta2
Linifanib,Platelet-derived growth factor receptor inhibitor,Platelet-derived growth factor receptor
Etrolizumab,Integrin beta-7 antagonist,Integrin beta-7
Pemtumomab,Mucin-1 binding agent,Mucin-1
Ra-18c3,Interleukin-1 alpha inhibitor,Interleukin-1 alpha
Eteplirsen,Dystrophin pre-mRNA modulator,Dystrophin pre-mRNA
Azilsartan,Type-1 angiotensin II receptor antagonist,Type-1 angiotensin II receptor
Udenafil,Phosphodiesterase 5A inhibitor,Phosphodiesterase 5A
Tafamidis,Transthyretin stabiliser,Transthyretin
Apaziquone,DNA inhibitor,DNA
Bexagliflozin,Sodium/glucose cotransporter 2 inhibitor,Sodium/glucose cotransporter 2
Mocetinostat,Histone deacetylase 3,Histone deacetylase 3
Fasinumab,Beta-nerve growth factor inhibitor,Beta-nerve growth factor
Elenbecestat,Beta-secretase 1 inhibitor,Beta-secretase 1
Methazolamide,Carbonic anhydrase I inhibitor,Carbonic anhydrase I
Methscopolamine,Muscarinic acetylcholine receptor M3 antagonist,Muscarinic acetylcholine receptor M3
Ramipril,Angiotensin-converting enzyme inhibitor,Angiotensin-converting enzyme
Clidinium,Muscarinic acetylcholine receptor M1 antagonist,Muscarinic acetylcholine receptor M1
Calcipotriene,Vitamin D receptor agonist,Vitamin D receptor
Ranolazine,Sodium channel protein type V alpha subunit blocker,Sodium channel protein type V alpha subunit
Insulin Zinc Susp Recombinant Human,Insulin receptor agonist,Insulin receptor
Dexamethasone Phosphoric Acid,Glucocorticoid receptor agonist,Glucocorticoid receptor
Desoximetasone,Glucocorticoid receptor agonist,Glucocorticoid receptor
Regorafenib,MAP kinase p38 beta inhibitor,MAP kinase p38 beta
Palifermin,Fibroblast growth factor receptor 2 agonist,Fibroblast growth factor receptor 2
Chlorzoxazone,Intermediate conductance calcium-activated potassium channel protein 4 opener,Intermediate conductance calcium-activated potassium channel protein 4
Amodiaquine,Ferriprotoporphyrin IX inhibitor,Ferriprotoporphyrin IX
Lithium Citrate,Glycogen synthase kinase-3 inhibitor,Glycogen synthase kinase-3
Ramelteon,Melatonin receptor agonist,Melatonin receptor
Bromfenac,Cyclooxygenase inhibitor,Cyclooxygenase
Ipilimumab,Cytotoxic T-lymphocyte protein 4 inhibitor,Cytotoxic T-lymphocyte protein 4
Hydroxychloroquine,Toll-like receptor 7 antagonist,Toll-like receptor 7
Nelfinavir,Human immunodeficiency virus type 1 protease inhibitor,Human immunodeficiency virus type 1 protease
Fesoterodine,Muscarinic acetylcholine receptor M2 antagonist,Muscarinic acetylcholine receptor M2
Sulbactam,Bacterial beta-lactamase TEM inhibitor,Bacterial beta-lactamase TEM
Chlorhexidine,Cell membrane inhibitor,Cell membrane
Grepafloxacin,DNA gyrase inhibitor,DNA gyrase
Bepridil,Voltage-gated calcium channel blocker,Voltage-gated calcium channel
Radium Dichloride,Radiotherapy agent,
Icosapent Ethyl,Unknown,
Ethinamate,Unknown,
Tedizolid Phosphate,Bacterial 70S ribosome inhibitor,Bacterial 70S ribosome
Eliglustat,Ceramide glucosyltransferase inhibitor,Ceramide glucosyltransferase
Alectinib,ALK tyrosine kinase receptor inhibitor,ALK tyrosine kinase receptor
Chf4227,Estrogen receptor modulator,Estrogen receptor
Amg-208,Hepatocyte growth factor receptor inhibitor,Hepatocyte growth factor receptor
Azd-0424,Tyrosine-protein kinase ABL inhibitor,Tyrosine-protein kinase ABL
Cp-724714,Receptor protein-tyrosine kinase erbB-2 inhibitor,Receptor protein-tyrosine kinase erbB-2
Mln-0415,Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor,Inhibitor of nuclear factor kappa B kinase beta subunit
Mln-1117,PI3-kinase p110-alpha subunit inhibitor,PI3-kinase p110-alpha subunit
Msc-2363318a,Serine/threonine-protein kinase AKT inhibitor,Serine/threonine-protein kinase AKT
Plx-7486,Nerve growth factor receptor Trk-A inhibitor,Nerve growth factor receptor Trk-A
Sr-13668,Serine/threonine-protein kinase AKT inhibitor,Serine/threonine-protein kinase AKT
Xl-228,Tyrosine-protein kinase ABL inhibitor,Tyrosine-protein kinase ABL
Gw590735,Peroxisome proliferator-activated receptor alpha agonist,Peroxisome proliferator-activated receptor alpha
Anlotinib,Platelet-derived growth factor receptor beta inhibitor,Platelet-derived growth factor receptor beta
At-9283,Tyrosine-protein kinase JAK2 inhibitor,Tyrosine-protein kinase JAK2
Bms-754807,Insulin-like growth factor I receptor inhibitor,Insulin-like growth factor I receptor
Tanzisertib,c-Jun N-terminal kinase 1 inhibitor,c-Jun N-terminal kinase 1
Ci-1040,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,Dual specificity mitogen-activated protein kinase kinase 1
Enmd-2076,Vascular endothelial growth factor receptor 2 inhibitor,Vascular endothelial growth factor receptor 2
Ly377604,Beta-3 adrenergic receptor agonist,Beta-3 adrenergic receptor
Mk-1029,G protein-coupled receptor 44 antagonist,G protein-coupled receptor 44
Azd2423,C-C chemokine receptor type 2 antagonist,C-C chemokine receptor type 2
Sb-705498,Vanilloid receptor antagonist,Vanilloid receptor
Arn-509,Androgen Receptor antagonist,Androgen Receptor
Alvocidib,Cyclin-dependent kinase 2 inhibitor,Cyclin-dependent kinase 2
Vicriviroc,C-C chemokine receptor type 5 antagonist,C-C chemokine receptor type 5
Verecimon,C-C chemokine receptor type 9 antagonist,C-C chemokine receptor type 9
Serelaxin,Relaxin receptor 1 activator,Relaxin receptor 1
Plovamer Acetate,"HLA class II histocompatibility antigen, DRB1-15 beta chain modulator","HLA class II histocompatibility antigen, DRB1-15 beta chain"
Irosustat,Steryl-sulfatase inhibitor,Steryl-sulfatase
Lexibulin,Tubulin inhibitor,Tubulin
Tacedinaline,Histone deacetylase inhibitor,Histone deacetylase
Marizomib,20S Proteasome inhibitor,20S proteosome
Forodesine,Purine nucleoside phosphorylase inhibitor,Purine nucleoside phosphorylase
Vonapanitase,Elastin proteolytic enzyme,Elastin
Dulanermin,Tumor necrosis factor receptor superfamily member 10B agonist,Tumor necrosis factor receptor superfamily member 10B
Thalidomide,CRL4(CRBN) E3 ubiquitin ligase inhibitor,CRL4(CRBN) E3 ubiquitin ligase
Enavatuzumab,Tumor necrosis factor receptor superfamily member 12A agonist,Tumor necrosis factor receptor superfamily member 12A
Fresolimumab,Transforming growth factor beta-2 inhibitor,Transforming growth factor beta-2
Veltuzumab,B-lymphocyte antigen CD20 inhibitor,B-lymphocyte antigen CD20
Mab-425,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
F16sip,Tenascin binding agent,Tenascin
Decoglurant,Metabotropic glutamate receptor 2 modulator,Metabotropic glutamate receptor 2
Rg-547,Cyclin-dependent kinase 4 inhibitor,Cyclin-dependent kinase 4
Cetrorelix,Gonadotropin-releasing hormone receptor antagonist,Gonadotropin-releasing hormone receptor
Acebutolol,Beta-1 adrenergic receptor antagonist,Beta-1 adrenergic receptor
Granisetron,Serotonin 3a (5-HT3a) receptor antagonist,Serotonin 3a (5-HT3a) receptor
Imipramine,Serotonin transporter inhibitor,Serotonin transporter
Medrysone,Glucocorticoid receptor agonist,Glucocorticoid receptor
Triamcinolone,Glucocorticoid receptor agonist,Glucocorticoid receptor
Prednisolone Acetate,Glucocorticoid receptor agonist,Glucocorticoid receptor
Etravirine,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,Human immunodeficiency virus type 1 reverse transcriptase
Capsaicin,Vanilloid receptor opener,Vanilloid receptor
Norgestimate,Progesterone receptor agonist,Progesterone receptor
Rosuvastatin,HMG-CoA reductase inhibitor,HMG-CoA reductase
Nalmefene,Opioid receptors; mu/kappa/delta antagonist,Opioid receptors; mu/kappa/delta
Mycophenolic Acid,Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor,Inosine-5'-monophosphate dehydrogenase (IMPDH)
Denileukin Diftitox,Interleukin-2 receptor binding agent,Interleukin-2 receptor
Interferon Beta-1b,Interferon alpha/beta receptor agonist,Interferon alpha/beta receptor
Uracil Mustard,DNA inhibitor,DNA
Valrubicin,DNA inhibitor,DNA
Sparfloxacin,Bacterial DNA gyrase inhibitor,Bacterial DNA gyrase
Isoflurane,Potassium channel subfamily K member 18 opener,Potassium channel subfamily K member 18
Rotigotine,D2-like dopamine receptor agonist,D2-like dopamine receptor
Trifluoperazine,D2-like dopamine receptor antagonist,D2-like dopamine receptor
Protease,Polypeptides hydrolytic enzyme,Polypeptides
Trimethobenzamide,Unknown,
Sofosbuvir,Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor,Hepatitis C virus NS5B RNA-dependent RNA polymerase
Bazedoxifene,Estrogen receptor modulator,Estrogen receptor
Vancomycin,Peptidoglycan inhibitor,Peptidoglycan
Dalbavancin,Peptidoglycan inhibitor,Peptidoglycan
Netupitant,Neurokinin 1 receptor antagonist,Neurokinin 1 receptor
Lenvatinib,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Necitumumab,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Enmd-981693,Platelet-derived growth factor receptor inhibitor,Platelet-derived growth factor receptor
Bay-1082439,PI3-kinase p110-alpha subunit inhibitor,PI3-kinase p110-alpha subunit
Cep-5214,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Cudc-907,PI3-kinase p110-delta subunit inhibitor,PI3-kinase p110-delta subunit
Plx-5622,Macrophage colony stimulating factor receptor inhibitor,Macrophage colony stimulating factor receptor
Rg7893,Sodium channel protein type IX alpha subunit blocker,Sodium channel protein type IX alpha subunit
Drf-10945,Peroxisome proliferator-activated receptor alpha agonist,Peroxisome proliferator-activated receptor alpha
Arhalofenate,Solute carrier family 22 member 12 inhibitor,Solute carrier family 22 member 12
Varlitinib,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Telatinib,Stem cell growth factor receptor inhibitor,Stem cell growth factor receptor
Bms-863233,Cell division cycle 7-related protein kinase inhibitor,Cell division cycle 7-related protein kinase
Defactinib,Protein tyrosine kinase 2 beta inhibitor,Protein tyrosine kinase 2 beta
Methylsamidorphan,Mu opioid receptor antagonist,Mu opioid receptor
Sonedenoson,Adenosine A2a receptor agonist,Adenosine A2a receptor
Fosdagrocorat,Glucocorticoid receptor modulator,Glucocorticoid receptor
Pefcalcitol,Vitamin D receptor agonist,Vitamin D receptor
Dinaciclib,Cyclin-dependent kinase 2 inhibitor,Cyclin-dependent kinase 2
Reparixin,Interleukin-8 receptor B modulator,Interleukin-8 receptor B
Preladenant,Adenosine A2a receptor antagonist,Adenosine A2a receptor
Serelaxin,Relaxin receptor 2 activator,Relaxin receptor 2
Romosozumab,Sclerostin inhibitor,Sclerostin
Semuloparin Sodium,Antithrombin-III inhibitor,Antithrombin-III
Tenapanor,Sodium/hydrogen exchanger 3 inhibitor,Sodium/hydrogen exchanger 3
Epacadostat,"Indoleamine 2,3-dioxygenase inhibitor","Indoleamine 2,3-dioxygenase"
Vosaroxin,DNA inhibitor,DNA
Becatecarin,DNA topoisomerase II inhibitor,DNA topoisomerase II
Fresolimumab,Transforming growth factor beta-1 inhibitor,Transforming growth factor beta-1
Stamulumab,Growth/differentiation factor 8 inhibitor,Growth/differentiation factor 8
Pro-140,C-C chemokine receptor type 5 antagonist,C-C chemokine receptor type 5
Rg-547,Cyclin-dependent kinase 2 inhibitor,Cyclin-dependent kinase 2
Robatumumab,Insulin-like growth factor I receptor antagonist,Insulin-like growth factor I receptor
Aminocaproic Acid,Plasminogen inhibitor,Plasminogen
Ribavirin,Inosine-5'-monophosphate dehydrogenase 1 inhibitor,Inosine-5'-monophosphate dehydrogenase 1
Tolazoline,Histamine H1 receptor agonist,Histamine H1 receptor
Losartan,Type-1 angiotensin II receptor antagonist,Type-1 angiotensin II receptor
Irbesartan,Type-1 angiotensin II receptor antagonist,Type-1 angiotensin II receptor
Troglitazone,Peroxisome proliferator-activated receptor gamma agonist,Peroxisome proliferator-activated receptor gamma
Phenindione,Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor,Vitamin k epoxide reductase complex subunit 1 isoform 1
Corticotropin,Melanocortin receptor 2 agonist,Melanocortin receptor 2
Insulin Susp Isophane Purified Pork,Insulin receptor agonist,Insulin receptor
Ecallantide,Plasma kallikrein inhibitor,Plasma kallikrein
Bupropion,Dopamine transporter inhibitor,Dopamine transporter
Tapentadol,Mu opioid receptor agonist,Mu opioid receptor
Amcinonide,Glucocorticoid receptor agonist,Glucocorticoid receptor
Tamoxifen,Estrogen receptor alpha modulator,Estrogen receptor alpha
Methyldopate,Adrenergic receptor alpha-2 agonist,Adrenergic receptor alpha-2
Ketoprofen,Cyclooxygenase inhibitor,Cyclooxygenase
Rauwolfia Serpentina,Adrenergic receptor alpha antagonist,Adrenergic receptor alpha
Regorafenib,Tyrosine-protein kinase receptor RET inhibitor,Tyrosine-protein kinase receptor RET
Vandetanib,Ephrin receptor inhibitor,Ephrin receptor
Sevoflurane,Glycine receptor (alpha-1/beta) positive modulator,Glycine receptor (alpha-1/beta)
Zolpidem,GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator,GABA A receptor alpha-1/beta-1/gamma-2
Nafcillin,Penicillin-binding protein inhibitor,Penicillin-binding protein
Netilmicin,Bacterial 70S ribosome inhibitor,Bacterial 70S ribosome
Methenamine,DNA inhibitor,DNA
Entecavir,DNA polymerase/reverse transcriptase inhibitor,DNA polymerase/reverse transcriptase
Olanzapine,D2-like dopamine receptor antagonist,D2-like dopamine receptor
Halothane,Potassium channel subfamily K member 3 opener,Potassium channel subfamily K member 3
Galsulfase,Dermatan sulfate hydrolytic enzyme,Dermatan sulfate
Levomefolic Acid,Unknown,
Omacetaxine Mepesuccinate,Protein synthesis inhibitor,
Macitentan,"Endothelin receptor, ET-A/ET-B antagonist","Endothelin receptor, ET-A/ET-B"
Levomilnacipran,Norepinephrine transporter inhibitor,Norepinephrine transporter
Sacubitril,Neprilysin inhibitor,Neprilysin
Enmd-981693,Serine/threonine-protein kinase Aurora-A inhibitor,Serine/threonine-protein kinase Aurora-A
Azd-7451,NT-3 growth factor receptor inhibitor,NT-3 growth factor receptor
Bms-817378,Vascular endothelial growth factor receptor 2 inhibitor,Vascular endothelial growth factor receptor 2
Xl-844,Serine/threonine-protein kinase Chk2 inhibitor,Serine/threonine-protein kinase Chk2
Tedalinab,Cannabinoid CB2 receptor agonist,Cannabinoid CB2 receptor
Netoglitazone,Peroxisome proliferator-activated receptor gamma modulator,Peroxisome proliferator-activated receptor gamma
Tradipitant,Neurokinin 1 receptor antagonist,Neurokinin 1 receptor
Faxeladol,Mu opioid receptor agonist,Mu opioid receptor
Faxeladol,Norepinephrine transporter inhibitor,Norepinephrine transporter
Mk0686,Bradykinin B1 receptor antagonist,Bradykinin B1 receptor
Bms-223131,Calcium-activated potassium channel subunit alpha-1 activator,Calcium-activated potassium channel subunit alpha-1
Egf816,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Dexmecamylamine,Neuronal acetylcholine receptor; alpha4/beta2 antagonist,Neuronal acetylcholine receptor; alpha4/beta2
Peginesatide,Erythropoietin receptor agonist,Erythropoietin receptor
Varespladib Methyl,Phospholipase A2 group V inhibitor,Phospholipase A2 group V
Onercept,TNF-alpha inhibitor,TNF-alpha
Pro-542,Envelope glycoprotein gp160 inhibitor,Envelope glycoprotein gp160
Rucaparib,"PARP 1, 2 and 3 inhibitor","PARP 1, 2 and 3"
Amiselimod,Sphingosine 1-phosphate receptor modulator,Sphingosine 1-phosphate receptor
Patritumab,Receptor tyrosine-protein kinase erbB-3 inhibitor,Receptor tyrosine-protein kinase erbB-3
Gsk-610677,MAP kinase p38 alpha inhibitor,MAP kinase p38 alpha
Piperacetazine,Unknown,
Lanreotide,Somatostatin receptor 5 agonist,Somatostatin receptor 5
Dabigatran Etexilate,Thrombin inhibitor,Thrombin
Cyproheptadine,Histamine H1 receptor antagonist,Histamine H1 receptor
Asenapine,Dopamine D2 receptor antagonist,Dopamine D2 receptor
Methixene,Muscarinic acetylcholine receptor M1 antagonist,Muscarinic acetylcholine receptor M1
Levamisole,Nicotinic acetylcholine receptor alpha subunit agonist,Nicotinic acetylcholine receptor alpha subunit
Sotalol,HERG blocker,HERG
Insulin Susp Protamine Zinc Beef/Pork,Insulin receptor agonist,Insulin receptor
Nefazodone,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Pyridostigmine,Acetylcholinesterase inhibitor,Acetylcholinesterase
Mitotane,Cytochrome P450 11A1 inhibitor,Cytochrome P450 11A1
Difluprednate,Glucocorticoid receptor agonist,Glucocorticoid receptor
Prednisolone Tebutate,Glucocorticoid receptor agonist,Glucocorticoid receptor
Zidovudine,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,Human immunodeficiency virus type 1 reverse transcriptase
Doxepin,Norepinephrine transporter inhibitor,Norepinephrine transporter
Pramlintide,"Amylin receptor AMY1, CALCR/RAMP1 agonist","Amylin receptor AMY1, CALCR/RAMP1"
Ergotamine,Adrenergic receptor alpha agonist,Adrenergic receptor alpha
Triamterene,"Amiloride-sensitive sodium channel, ENaC blocker","Amiloride-sensitive sodium channel, ENaC"
Nifedipine,Voltage-gated L-type calcium channel blocker,Voltage-gated L-type calcium channel
Felodipine,Voltage-gated L-type calcium channel blocker,Voltage-gated L-type calcium channel
Mebendazole,Tubulin inhibitor,Tubulin
Carprofen,Cyclooxygenase-2 inhibitor,Cyclooxygenase-2
Metformin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,Mitochondrial complex I (NADH dehydrogenase)
Zaleplon,GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator,GABA A receptor alpha-1/beta-1/gamma-2
Dasatinib,SRC inhibitor,SRC
Cyclacillin,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Gentamicin,Bacterial 70S ribosome inhibitor,Bacterial 70S ribosome
Neomycin,Bacterial 70S ribosome inhibitor,Bacterial 70S ribosome
Bedaquiline,ATP synthase inhibitor,ATP synthase
Streptozotocin,DNA inhibitor,DNA
Capecitabine,RNA inhibitor,RNA
Trovafloxacin,Bacterial DNA gyrase inhibitor,Bacterial DNA gyrase
Pegloticase,Uric acid oxidative enzyme,Uric acid
Paramethadione,Voltage-gated T-type calcium channel blocker,Voltage-gated T-type calcium channel
Thyroglobulin,Iodine storage agent,
Benzyl Alcohol,Unknown,
Sodium Benzoate,Unknown,
Chlorphenesin Carbamate,Unknown,
Crotamiton,Unknown,
Benzyl Benzoate,Unknown,
Acetaminophen,Vanilloid receptor opener,Vanilloid receptor
Menotropins,Luteinizing hormone/Choriogonadotropin receptor agonist,Luteinizing hormone/Choriogonadotropin receptor
Afatinib,Receptor protein-tyrosine kinase erbB-4 inhibitor,Receptor protein-tyrosine kinase erbB-4
Brexpiprazole,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Cs-8080,LXR-alpha agonist,LXR-alpha
Hyodeoxycholic_Acid,LXR-alpha agonist,LXR-alpha
Mubritinib,Receptor protein-tyrosine kinase erbB-2 inhibitor,Receptor protein-tyrosine kinase erbB-2
Tak-733,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,Dual specificity mitogen-activated protein kinase kinase 1
Azd6280,GABA receptor alpha-2 subunit positive allosteric modulator,GABA receptor alpha-2 subunit
Evt401,P2X purinoceptor 7 antagonist,P2X purinoceptor 7
Afimoxifene,Estrogen receptor modulator,Estrogen receptor
Lucitanib,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Entospletinib,Tyrosine-protein kinase SYK inhibitor,Tyrosine-protein kinase SYK
Kw-2450,Insulin-like growth factor I receptor inhibitor,Insulin-like growth factor I receptor
Amuvatinib,Hepatocyte growth factor receptor inhibitor,Hepatocyte growth factor receptor
Tedatioxetine,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Vabicaserin,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Batefenterol,Beta-2 adrenergic receptor agonist,Beta-2 adrenergic receptor
Capeserod,Serotonin 4 (5-HT4) receptor partial agonist,Serotonin 4 (5-HT4) receptor
Vofopitant,Neurokinin 1 receptor antagonist,Neurokinin 1 receptor
Ezlopitant,Neurokinin 1 receptor antagonist,Neurokinin 1 receptor
Cerc-301,Glutamate NMDA receptor; GRIN1/GRIN2B antagonist,Glutamate NMDA receptor; GRIN1/GRIN2B
Qbw251,Cystic fibrosis transmembrane conductance regulator activator,Cystic fibrosis transmembrane conductance regulator
Cp-601927,Neuronal acetylcholine receptor; alpha4/beta2 partial agonist,Neuronal acetylcholine receptor; alpha4/beta2
Naminidil,Sulfonylurea receptors; K-ATP channels opener,Sulfonylurea receptors; K-ATP channels
Masitinib,Fibroblast growth factor receptor 3 inhibitor,Fibroblast growth factor receptor 3
Losmapimod,MAP kinase p38 beta inhibitor,MAP kinase p38 beta
Vatalanib,Platelet-derived growth factor receptor inhibitor,Platelet-derived growth factor receptor
Peginterferon Lambda-1a,Interferon lambda receptor agonist,Interferon lambda receptor
Gosogliptin,Dipeptidyl peptidase IV inhibitor,Dipeptidyl peptidase IV
Trelagliptin,Dipeptidyl peptidase IV inhibitor,Dipeptidyl peptidase IV
Talazoparib,Poly [ADP-ribose] polymerase-1 inhibitor,Poly [ADP-ribose] polymerase-1
Atacicept,Tumor necrosis factor ligand superfamily member 13 inhibitor,Tumor necrosis factor ligand superfamily member 13
Tenatumomab,Tenascin other,Tenascin
Morab-004,Endosialin inhibitor,Endosialin
Bezlotoxumab,Toxin B inhibitor,Toxin B
Hexocyclium,Muscarinic acetylcholine receptor M3 antagonist,Muscarinic acetylcholine receptor M3
Antazoline,Histamine H1 receptor antagonist,Histamine H1 receptor
Methscopolamine,Muscarinic acetylcholine receptor M1 antagonist,Muscarinic acetylcholine receptor M1
Desvenlafaxine,Serotonin transporter inhibitor,Serotonin transporter
Chlorphentermine,Serotonin transporter substrate,Serotonin transporter
Gemfibrozil,Peroxisome proliferator-activated receptor alpha agonist,Peroxisome proliferator-activated receptor alpha
Heparin Sodium,Antithrombin-III activator,Antithrombin-III
Ergotamine,Serotonin 1d (5-HT1d) receptor agonist,Serotonin 1d (5-HT1d) receptor
Quetiapine,Serotonin 2c (5-HT2c) receptor antagonist,Serotonin 2c (5-HT2c) receptor
Cilastatin,Renal dipeptidase inhibitor,Renal dipeptidase
Lumefantrine,Ferriprotoporphyrin IX inhibitor,Ferriprotoporphyrin IX
Vincristine,Tubulin inhibitor,Tubulin
Trimipramine,Adrenergic receptor alpha-1 antagonist,Adrenergic receptor alpha-1
Tolmetin,Cyclooxygenase inhibitor,Cyclooxygenase
Sulindac,Cyclooxygenase inhibitor,Cyclooxygenase
Pinacidil,"Sulfonylurea receptor 2, Kir6.2 opener","Sulfonylurea receptor 2, Kir6.2"
Diltiazem,Voltage-gated L-type calcium channel blocker,Voltage-gated L-type calcium channel
Metaproterenol,Beta-2 adrenergic receptor agonist,Beta-2 adrenergic receptor
Mitotane,Cytochrome P450 11B1 inhibitor,Cytochrome P450 11B1
Acyclovir,Human herpesvirus 1 DNA polymerase inhibitor,Human herpesvirus 1 DNA polymerase
Tofacitinib,Janus Kinase (JAK) inhibitor,Janus Kinase (JAK)
Methoxyflurane,GABA-A receptor; anion channel positive modulator,GABA-A receptor; anion channel
Norfloxacin,Topoisomerase IV inhibitor,Topoisomerase IV
Probucol,ATP-binding cassette sub-family A member 1 inhibitor,ATP-binding cassette sub-family A member 1
Colistin,Cell outer membrane inhibitor,Cell outer membrane
Quinidine Polygalacturonate,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Oxcarbazepine,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Sevoflurane,Potassium channel subfamily K member 3 opener,Potassium channel subfamily K member 3
Mipomersen,Apo-B 100 mRNA antisense inhibitor,Apo-B 100 mRNA
Pramoxine,Unknown,
Pasireotide,Somatostatin receptor 2 agonist,Somatostatin receptor 2
Spebrutinib,Tyrosine-protein kinase BTK inhibitor,Tyrosine-protein kinase BTK
Kw-2449,Serine/threonine-protein kinase Aurora-B inhibitor,Serine/threonine-protein kinase Aurora-B
Mk-6592,Serine/threonine-protein kinase Aurora inhibitor,Serine/threonine-protein kinase Aurora
Mp-412,Receptor protein-tyrosine kinase erbB-2 inhibitor,Receptor protein-tyrosine kinase erbB-2
Pd-0166285,Platelet-derived growth factor receptor beta inhibitor,Platelet-derived growth factor receptor beta
Pki-166,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Pwt-33587,Serine/threonine-protein kinase mTOR inhibitor,Serine/threonine-protein kinase mTOR
Sgi-1776,Serine/threonine-protein kinase PIM inhibitor,Serine/threonine-protein kinase PIM
Xl-228,SRC inhibitor,SRC
Apd371,Cannabinoid CB2 receptor agonist,Cannabinoid CB2 receptor
Arhalofenate,Peroxisome proliferator-activated receptor gamma modulator,Peroxisome proliferator-activated receptor gamma
Sapitinib,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Golvatinib,Vascular endothelial growth factor receptor 2 inhibitor,Vascular endothelial growth factor receptor 2
Plx-3397,Stem cell growth factor receptor inhibitor,Stem cell growth factor receptor
R-333,Tyrosine-protein kinase JAK3 inhibitor,Tyrosine-protein kinase JAK3
Apitolisib,Serine/threonine-protein kinase mTOR inhibitor,Serine/threonine-protein kinase mTOR
Vx-745,MAP kinase p38 alpha inhibitor,MAP kinase p38 alpha
Pf-06291874,Glucagon receptor antagonist,Glucagon receptor
Ladarixin,Interleukin-8 receptor A modulator,Interleukin-8 receptor A
Talnetant,Neurokinin 3 receptor antagonist,Neurokinin 3 receptor
Bremelanotide,Melanocortin receptor 3 agonist,Melanocortin receptor 3
Galiximab,T-lymphocyte activation antigen CD80 inhibitor,T-lymphocyte activation antigen CD80
Imetelstat,Telomerase reverse transcriptase inhibitor,Telomerase reverse transcriptase
Rintatolimod,Toll-like receptor 3 agonist,Toll-like receptor 3
Firategrast,Integrin alpha-4/beta-1 antagonist,Integrin alpha-4/beta-1
Rilapladib,LDL-associated phospholipase A2 inhibitor,LDL-associated phospholipase A2
Cilengitide,Integrin alpha-V/beta-3 antagonist,Integrin alpha-V/beta-3
Efaproxiral,Hemoglobin HbA negative modulator,Hemoglobin HbA
Erenumab,Calcitonin gene-related peptide type 1 receptor antagonist,Calcitonin gene-related peptide type 1 receptor
Amatuximab,Mesothelin inhibitor,Mesothelin
Evt-101,Glutamate NMDA receptor; GRIN1/GRIN2B antagonist,Glutamate NMDA receptor; GRIN1/GRIN2B
Vorinostat,Histone deacetylase 3 inhibitor,Histone deacetylase 3
Dopamine,Beta-1 adrenergic receptor agonist,Beta-1 adrenergic receptor
Arsenic Trioxide,Thioredoxin reductase 1 inhibitor,Thioredoxin reductase 1
Tolazoline,Histamine H2 receptor agonist,Histamine H2 receptor
Vilazodone,Serotonin 1a (5-HT1a) receptor partial agonist,Serotonin 1a (5-HT1a) receptor
Danaparoid Sodium,Antithrombin-III activator,Antithrombin-III
Mecasermin,Insulin-like growth factor I receptor agonist,Insulin-like growth factor I receptor
Trimipramine,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Olanzapine,Serotonin 2c (5-HT2c) receptor antagonist,Serotonin 2c (5-HT2c) receptor
Glucagon Hydrochloride Recombinant,Glucagon receptor agonist,Glucagon receptor
Phentermine,Norepinephrine transporter releasing agent,Norepinephrine transporter
Doxycycline,Matrix metalloproteinase 8 inhibitor,Matrix metalloproteinase 8
Teduglutide,Glucagon-like peptide 2 receptor agonist,Glucagon-like peptide 2 receptor
Romidepsin,Histone deacetylase inhibitor,Histone deacetylase
Repaglinide,"Sulfonylurea receptor 1, Kir6.2 blocker","Sulfonylurea receptor 1, Kir6.2"
Oxprenolol,Beta-2 adrenergic receptor antagonist,Beta-2 adrenergic receptor
Mebendazole,Tubulin inhibitor,Tubulin
Etodolac,Cyclooxygenase-2 inhibitor,Cyclooxygenase-2
Vandetanib,Tyrosine-protein kinase receptor RET inhibitor,Tyrosine-protein kinase receptor RET
Ezogabine,KCNQ (Kv7) potassium channel blocker,KCNQ (Kv7) potassium channel
Glutethimide,GABA-A receptor; anion channel positive modulator,GABA-A receptor; anion channel
Secobarbital,GABA-A receptor; anion channel positive allosteric modulator,GABA-A receptor; anion channel
Sulfameter,Bacterial dihydropteroate synthase inhibitor,Bacterial dihydropteroate synthase
Clindamycin,Bacterial 70S ribosome inhibitor,Bacterial 70S ribosome
Tocilizumab,Interleukin-6 receptor alpha subunit inhibitor,Interleukin-6 receptor alpha subunit
Busulfan,DNA inhibitor,DNA
Mitomycin,DNA inhibitor,DNA
Hydroxystilbamidine,DNA inhibitor,DNA
Carmustine,RNA inhibitor,RNA
Benoxinate,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Lindane,GABA-A receptor negative allosteric modulator,GABA-A receptor
Nitazoxanide,Pyruvate:ferredoxin oxidoreductase inhibitor,Pyruvate:ferredoxin oxidoreductase
Doxapram,Potassium channel subfamily K member 9 blocker,Potassium channel subfamily K member 9
Sinecatechins,Unknown,
Pancrelipase,Fatty acids hydrolytic enzyme,Fatty acids
Su-014813,Stem cell growth factor receptor inhibitor,Stem cell growth factor receptor
Panulisib,Serine/threonine-protein kinase mTOR inhibitor,Serine/threonine-protein kinase mTOR
Tak-285,Receptor protein-tyrosine kinase erbB-2 inhibitor,Receptor protein-tyrosine kinase erbB-2
Vs-4718,Focal adhesion kinase 1 inhibitor,Focal adhesion kinase 1
Ly404039,Metabotropic glutamate receptor 2 agonist,Metabotropic glutamate receptor 2
Incb-040093,PI3-kinase p110-delta subunit inhibitor,PI3-kinase p110-delta subunit
Azd6280,GABA receptor alpha-3 subunit positive allosteric modulator,GABA receptor alpha-3 subunit
Farglitazar,Peroxisome proliferator-activated receptor gamma agonist,Peroxisome proliferator-activated receptor gamma
At-7519,Cyclin-dependent kinase inhibitor,Cyclin-dependent kinase
Azd-2014,Serine/threonine-protein kinase mTOR inhibitor,Serine/threonine-protein kinase mTOR
Azd-4547,Fibroblast growth factor receptor inhibitor,Fibroblast growth factor receptor
Ulixertinib,MAP kinase ERK2 inhibitor,MAP kinase ERK2
Seliciclib,Cyclin-dependent kinase 7 inhibitor,Cyclin-dependent kinase 7
Poziotinib,Epidermal growth factor receptor inhibitor,Epidermal growth factor receptor
Pf-04691502,Serine/threonine-protein kinase mTOR inhibitor,Serine/threonine-protein kinase mTOR
Tg100-801,Fibroblast growth factor receptor 2 inhibitor,Fibroblast growth factor receptor 2
Axelopran,Mu opioid receptor antagonist,Mu opioid receptor
Samidorphan,Mu opioid receptor antagonist,Mu opioid receptor
Sparsentan,Type-1 angiotensin II receptor antagonist,Type-1 angiotensin II receptor
Raseglurant,Metabotropic glutamate receptor 5 modulator,Metabotropic glutamate receptor 5
Nonabine,Cannabinoid CB1 receptor agonist,Cannabinoid CB1 receptor
Tezampanel,Glutamate receptor ionotropic AMPA antagonist,Glutamate receptor ionotropic AMPA
Farampator,Glutamate receptor ionotropic AMPA positive allosteric modulator,Glutamate receptor ionotropic AMPA
Taranabant,Cannabinoid CB1 receptor inverse agonist,Cannabinoid CB1 receptor
Taspoglutide,Glucagon-like peptide 1 receptor agonist,Glucagon-like peptide 1 receptor
Odulimomab,Leukocyte adhesion glycoprotein LFA-1 alpha inhibitor,Leukocyte adhesion glycoprotein LFA-1 alpha
Tipifarnib,Protein farnesyltransferase inhibitor,Protein farnesyltransferase
Anacetrapib,Cholesteryl ester transfer protein inhibitor,Cholesteryl ester transfer protein
Letaxaban,Coagulation factor X inhibitor,Coagulation factor X
Vintafolide,Folate receptor alpha binding agent,Folate receptor alpha
Pegpleranib Sodium,Platelet-derived growth factor subunit B inhibitor,Platelet-derived growth factor subunit B
Aducanumab,Beta amyloid A4 protein other,Beta amyloid A4 protein
Gsk-249320,Myelin-associated glycoprotein inhibitor,Myelin-associated glycoprotein
Axomadol,Delta opioid receptor agonist,Delta opioid receptor
Isosorbide,Unknown,
Artemotil,Unknown,
Telmisartan,Type-1 angiotensin II receptor antagonist,Type-1 angiotensin II receptor
Erlotinib,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Nebivolol,Beta-1 adrenergic receptor antagonist,Beta-1 adrenergic receptor
Aminocaproic Acid,Tissue-type plasminogen activator inhibitor,Tissue-type plasminogen activator
Ethambutol,Arabinosyltransferase A inhibitor,Arabinosyltransferase A
Fenofibric Acid,Peroxisome proliferator-activated receptor alpha agonist,Peroxisome proliferator-activated receptor alpha
Ibutilide,HERG blocker,HERG
Dibucaine,Sodium channel protein type V alpha subunit blocker,Sodium channel protein type V alpha subunit
Clozapine,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Drospirenone,Mineralocorticoid receptor antagonist,Mineralocorticoid receptor
Alfentanil,Mu opioid receptor agonist,Mu opioid receptor
Dienestrol,Estrogen receptor alpha agonist,Estrogen receptor alpha
Canagliflozin,Sodium/glucose cotransporter 2 inhibitor,Sodium/glucose cotransporter 2
Bosutinib,Tyrosine-protein kinase Lyn inhibitor,Tyrosine-protein kinase Lyn
Vemurafenib,Serine/threonine-protein kinase B-raf inhibitor,Serine/threonine-protein kinase B-raf
Norethynodrel,Progesterone receptor agonist,Progesterone receptor
Etonogestrel,Progesterone receptor agonist,Progesterone receptor
Flavoxate,Phosphodiesterase 4 inhibitor,Phosphodiesterase 4
Acamprosate,Glutamate [NMDA] receptor antagonist,Glutamate [NMDA] receptor
Metaraminol,Adrenergic receptor alpha-1 agonist,Adrenergic receptor alpha-1
Isradipine,Voltage-gated L-type calcium channel blocker,Voltage-gated L-type calcium channel
Itraconazole,Cytochrome P450 51 inhibitor,Cytochrome P450 51
Lamivudine,DNA inhibitor,DNA
Tazarotene,Retinoic acid receptor agonist,Retinoic acid receptor
Chlordiazepoxide,GABA-A receptor; anion channel positive allosteric modulator,GABA-A receptor; anion channel
Clobazam,GABA-A receptor; anion channel positive allosteric modulator,GABA-A receptor; anion channel
Talbutal,GABA-A receptor; anion channel positive allosteric modulator,GABA-A receptor; anion channel
Sevoflurane,GABA-A receptor; anion channel positive allosteric modulator,GABA-A receptor; anion channel
Ceftaroline Fosamil,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Gatifloxacin,DNA gyrase inhibitor,DNA gyrase
Gabapentin Enacarbil,Voltage-gated calcium channel modulator,Voltage-gated calcium channel
Rufinamide,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Capreomycine,70S ribosome inhibitor,70S ribosome
Edetate Disodium,Calcium chelating agent,Calcium
Bms-794833,Vascular endothelial growth factor receptor 2 inhibitor,Vascular endothelial growth factor receptor 2
Cs-8080,LXR-beta agonist,LXR-beta
Abl-001,Tyrosine-protein kinase ABL inhibitor,Tyrosine-protein kinase ABL
Altiratinib,Hepatocyte growth factor receptor inhibitor,Hepatocyte growth factor receptor
Sulfatinib,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Jnj-26483327,Tyrosine-protein kinase YES inhibitor,Tyrosine-protein kinase YES
Jnj-40346527,Macrophage colony stimulating factor receptor inhibitor,Macrophage colony stimulating factor receptor
Lgh-447,Serine/threonine-protein kinase PIM inhibitor,Serine/threonine-protein kinase PIM
Irbinitinib,Receptor protein-tyrosine kinase erbB-2 inhibitor,Receptor protein-tyrosine kinase erbB-2
Tak-285,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Xl-418,Ribosomal protein S6 kinase (P70S6K) inhibitor,Ribosomal protein S6 kinase (P70S6K)
Mgcd-265,Tyrosine-protein kinase TIE-2 inhibitor,Tyrosine-protein kinase TIE-2
(7s)-Hydroxyl-Staurosporine,Serine/threonine-protein kinase Chk1 inhibitor,Serine/threonine-protein kinase Chk1
Piclozotan,Serotonin 1a (5-HT1a) receptor agonist,Serotonin 1a (5-HT1a) receptor
Rafabegron,Beta-3 adrenergic receptor agonist,Beta-3 adrenergic receptor
Gilteritinib,Tyrosine-protein kinase receptor FLT3 inhibitor,Tyrosine-protein kinase receptor FLT3
Imiglitazar,Peroxisome proliferator-activated receptor alpha agonist,Peroxisome proliferator-activated receptor alpha
Bardoxolone Methyl,Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor,Inhibitor of nuclear factor kappa B kinase beta subunit
Flindokalner,Calcium-activated potassium channel subunit alpha-1 opener,Calcium-activated potassium channel subunit alpha-1
Tremelimumab,Cytotoxic T-lymphocyte protein 4 inhibitor,Cytotoxic T-lymphocyte protein 4
Idraparinux,Coagulation factor X inhibitor,Coagulation factor X
Eslicarbazepine,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Squalamine,Sodium/hydrogen exchanger 3 inhibitor,Sodium/hydrogen exchanger 3
Rivipansel,Selectin E antagonist,Selectin E
Mm-302,Receptor protein-tyrosine kinase erbB-2 binding agent,Receptor protein-tyrosine kinase erbB-2
Cedelizumab,T-cell surface antigen CD4 inhibitor,T-cell surface antigen CD4
Avelumab,Programmed cell death 1 ligand 1 other,Programmed cell death 1 ligand 1
Mdx-210,Receptor protein-tyrosine kinase erbB-2 other,Receptor protein-tyrosine kinase erbB-2
Vasopressin Tannate,Vasopressin V2 receptor agonist,Vasopressin V2 receptor
Teriparatide,Parathyroid hormone receptor agonist,Parathyroid hormone receptor
Benazepril,Angiotensin-converting enzyme inhibitor,Angiotensin-converting enzyme
Lapatinib,Receptor protein-tyrosine kinase erbB-2 inhibitor,Receptor protein-tyrosine kinase erbB-2
Quinethazone,Thiazide-sensitive sodium-chloride cotransporter inhibitor,Thiazide-sensitive sodium-chloride cotransporter
Ondansetron,Serotonin 3a (5-HT3a) receptor antagonist,Serotonin 3a (5-HT3a) receptor
Ergoloid,Serotonin 1a (5-HT1a) receptor agonist,Serotonin 1a (5-HT1a) receptor
Insulin Lispro Protamine Recombinant,Insulin receptor agonist,Insulin receptor
Pimozide,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Estramustine Phosphate,Estrogen receptor beta,Estrogen receptor beta
Sulfacytine,Dihydropteroate synthetase inhibitor,Dihydropteroate synthetase
Desonide,Glucocorticoid receptor agonist,Glucocorticoid receptor
Betamethasone Valerate,Glucocorticoid receptor agonist,Glucocorticoid receptor
Stavudine,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,Human immunodeficiency virus type 1 reverse transcriptase
Norgestrel,Progesterone receptor agonist,Progesterone receptor
Lansoprazole,Potassium-transporting ATPase inhibitor,Potassium-transporting ATPase
Esomeprazole,Potassium-transporting ATPase inhibitor,Potassium-transporting ATPase
Naphazoline,Adrenergic receptor alpha agonist,Adrenergic receptor alpha
Amiloride,"Amiloride-sensitive sodium channel, ENaC blocker","Amiloride-sensitive sodium channel, ENaC"
Amlodipine,Voltage-gated L-type calcium channel blocker,Voltage-gated L-type calcium channel
Nisoldipine,Voltage-gated L-type calcium channel blocker,Voltage-gated L-type calcium channel
Dezocine,Kappa opioid receptor antagonist,Kappa opioid receptor
Formoterol,Beta-2 adrenergic receptor agonist,Beta-2 adrenergic receptor
Metipranolol,Beta-2 adrenergic receptor antagonist,Beta-2 adrenergic receptor
Lomitapide,Microsomal triglyceride transfer protein inhibitor,Microsomal triglyceride transfer protein
Valdecoxib,Cyclooxygenase-2 inhibitor,Cyclooxygenase-2
Dronabinol,Cannabinoid CB1 receptor agonist,Cannabinoid CB1 receptor
Cisatracurium,Muscle-type nicotinic acetylcholine receptor antagonist,Muscle-type nicotinic acetylcholine receptor
Suxamethonium,Muscle-type nicotinic acetylcholine receptor agonist,Muscle-type nicotinic acetylcholine receptor
Isoflurane,Glycine receptor (alpha-1/beta) positive modulator,Glycine receptor (alpha-1/beta)
Mezlocillin,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Human Dnase-1,DNA hydrolytic enzyme,DNA
Methoxsalen,DNA inhibitor,DNA
Propoxycaine,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Haloperidol Decanoate,D2-like dopamine receptor inverse agonist,D2-like dopamine receptor
Velaglucerase Alfa,Glucocerebroside hydrolytic enzyme,Glucocerebroside
Mebutamate,Unknown,
Ac-480,Receptor protein-tyrosine kinase erbB-2 inhibitor,Receptor protein-tyrosine kinase erbB-2
Arq-092,Serine/threonine-protein kinase AKT inhibitor,Serine/threonine-protein kinase AKT
Mln-8054,Serine/threonine-protein kinase Aurora-A inhibitor,Serine/threonine-protein kinase Aurora-A
Nms-1116354,Cell division cycle 7-related protein kinase inhibitor,Cell division cycle 7-related protein kinase
Rgb-286638,Cyclin-dependent kinase 4 inhibitor,Cyclin-dependent kinase 4
Rg-1530,Serine/threonine-protein kinase Aurora-A inhibitor,Serine/threonine-protein kinase Aurora-A
Cc-223,Serine/threonine-protein kinase mTOR inhibitor,Serine/threonine-protein kinase mTOR
Ct-327,Nerve growth factor receptor Trk-A inhibitor,Nerve growth factor receptor Trk-A
Bafetinib,Tyrosine-protein kinase Lyn inhibitor,Tyrosine-protein kinase Lyn
Ji-101,Ephrin type-B receptor 4 inhibitor,Ephrin type-B receptor 4
Pd-0325901,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,Dual specificity mitogen-activated protein kinase kinase 2
Gedatolisib,Serine/threonine-protein kinase mTOR inhibitor,Serine/threonine-protein kinase mTOR
Voxtalisib,PI3-kinase class I inhibitor,PI3-kinase class I
Azd3199,Beta-2 adrenergic receptor agonist,Beta-2 adrenergic receptor
Afacifenacin,Sodium channel protein type X alpha subunit blocker,Sodium channel protein type X alpha subunit
Nelivaptan,Vasopressin V1b receptor antagonist,Vasopressin V1b receptor
Itriglumide,Cholecystokinin B receptor antagonist,Cholecystokinin B receptor
Pf-00446687,Melanocortin receptor 4 agonist,Melanocortin receptor 4
Lesogaberan,GABA-B receptor 2 agonist,GABA-B receptor 2
Ribociclib,Cyclin-dependent kinase 6 inhibitor,Cyclin-dependent kinase 6
Tonapofylline,Adenosine A1 receptor antagonist,Adenosine A1 receptor
Smc021,Calcitonin receptor agonist,Calcitonin receptor
Nerelimomab,TNF-alpha inhibitor,TNF-alpha
Sarilumab,Interleukin-6 receptor alpha subunit antagonist,Interleukin-6 receptor alpha subunit
Verubulin,Tubulin disrupting agent,Tubulin
Valbenazine,Synaptic vesicular amine transporter inhibitor,Synaptic vesicular amine transporter
Obatoclax,Apoptosis regulator Bcl-X inhibitor,Apoptosis regulator Bcl-X
Firategrast,Integrin alpha-4/beta-7 antagonist,Integrin alpha-4/beta-7
Liprotamase,Starch hydrolytic enzyme,Starch
Nusinersen Sodium,SMN2 pre-mRNA modulator,SMN2 pre-mRNA
Cp-459632,Fibroblast growth factor receptor inhibitor,Fibroblast growth factor receptor
Oxybutynin,Muscarinic acetylcholine receptor M3 antagonist,Muscarinic acetylcholine receptor M3
Conivaptan,Vasopressin V2 receptor antagonist,Vasopressin V2 receptor
Diphenidol,Muscarinic acetylcholine receptor M1 antagonist,Muscarinic acetylcholine receptor M1
Imatinib,Tyrosine-protein kinase ABL inhibitor,Tyrosine-protein kinase ABL
Oxprenolol,Beta-1 adrenergic receptor antagonist,Beta-1 adrenergic receptor
Hydroflumethiazide,Thiazide-sensitive sodium-chloride cotransporter inhibitor,Thiazide-sensitive sodium-chloride cotransporter
Trichlormethiazide,Thiazide-sensitive sodium-chloride cotransporter inhibitor,Thiazide-sensitive sodium-chloride cotransporter
Milnacipran,Serotonin transporter inhibitor,Serotonin transporter
Amiodarone,HERG blocker,HERG
Methylprednisolone,Glucocorticoid receptor agonist,Glucocorticoid receptor
Selegiline,Monoamine oxidase B inhibitor,Monoamine oxidase B
Estradiol Valerate,Estrogen receptor alpha agonist,Estrogen receptor alpha
Estrone Sulfuric Acid,Estrogen receptor alpha agonist,Estrogen receptor alpha
Mestranol,Estrogen receptor alpha agonist,Estrogen receptor alpha
Levobupivacaine,Sodium channel protein type IV alpha subunit blocker,Sodium channel protein type IV alpha subunit
Imipramine,Norepinephrine transporter inhibitor,Norepinephrine transporter
Varenicline,Neuronal acetylcholine receptor; alpha4/beta2 agonist,Neuronal acetylcholine receptor; alpha4/beta2
Nitric Oxide,Soluble guanylate cyclase activator,Soluble guanylate cyclase
Arformoterol,Beta-2 adrenergic receptor agonist,Beta-2 adrenergic receptor
Butenafine,Squalene monooxygenase inhibitor,Squalene monooxygenase
Butoconazole,Cytochrome P450 51 inhibitor,Cytochrome P450 51
Sulfaphenazole,Bacterial dihydropteroate synthase inhibitor,Bacterial dihydropteroate synthase
Meropenem,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Bromocriptine,D2-like dopamine receptor agonist,D2-like dopamine receptor
Alkavervir,Unknown,
Verteporfin,DNA inhibitor,DNA
Ciclopirox,Iron chelating agent,Iron
Dulaglutide,Glucagon-like peptide 1 receptor agonist,Glucagon-like peptide 1 receptor
Cholic Acid,Unknown,
Arry-502,G protein-coupled receptor 44 antagonist,G protein-coupled receptor 44
Apc-100,Androgen Receptor antagonist,Androgen Receptor
Ls-104,Tyrosine-protein kinase JAK2 inhibitor,Tyrosine-protein kinase JAK2
Rgb-286638,Cyclin-dependent kinase 7 inhibitor,Cyclin-dependent kinase 7
Vs-5584,PI3-kinase class I inhibitor,PI3-kinase class I
Mavatrep,Vanilloid receptor antagonist,Vanilloid receptor
Roniciclib,Cyclin-dependent kinase inhibitor,Cyclin-dependent kinase
Duvelisib,PI3-kinase p110-gamma subunit inhibitor,PI3-kinase p110-gamma subunit
Duvelisib,PI3-kinase p110-delta subunit inhibitor,PI3-kinase p110-delta subunit
Abediterol,Beta-2 adrenergic receptor agonist,Beta-2 adrenergic receptor
Ibipinabant,Cannabinoid CB1 receptor antagonist,Cannabinoid CB1 receptor
Donitriptan,Serotonin 1d (5-HT1d) receptor agonist,Serotonin 1d (5-HT1d) receptor
Tezacaftor,Cystic fibrosis transmembrane conductance regulator positive modulator,Cystic fibrosis transmembrane conductance regulator
Asm-024,Neuronal acetylcholine receptor protein alpha-7 subunit modulator,Neuronal acetylcholine receptor protein alpha-7 subunit
Encorafenib,Serine/threonine-protein kinase B-raf inhibitor,Serine/threonine-protein kinase B-raf
Semaxanib,Stem cell growth factor receptor inhibitor,Stem cell growth factor receptor
Satavaptan,Vasopressin V2 receptor antagonist,Vasopressin V2 receptor
Setipiprant,G protein-coupled receptor 44 antagonist,G protein-coupled receptor 44
Farletuzumab,Folate receptor alpha inhibitor,Folate receptor alpha
Fosbretabulin,Tubulin disrupting agent,Tubulin
Rivipansel,P-selectin antagonist,P-selectin
Prexasertib,Serine/threonine-protein kinase Chk2 inhibitor,Serine/threonine-protein kinase Chk2
Citatuzumab Bogatox,Epithelial cell adhesion molecule binding agent,Epithelial cell adhesion molecule
Fezakinumab,Interleukin-22 inhibitor,Interleukin-22
Clenoliximab,T-cell surface antigen CD4 inhibitor,T-cell surface antigen CD4
Labetuzumab,Carcinoembryonic antigen-related cell adhesion molecule 5 other,Carcinoembryonic antigen-related cell adhesion molecule 5
Iph-2101,Killer cell immunoglobulin-like receptor 2DL3 inhibitor,Killer cell immunoglobulin-like receptor 2DL3
Gemtuzumab Ozogamicin,Myeloid cell surface antigen CD33 binding agent,Myeloid cell surface antigen CD33
Metoclopramide,Serotonin 3a (5-HT3a) receptor antagonist,Serotonin 3a (5-HT3a) receptor
Capecitabine,Thymidylate synthase inhibitor,Thymidylate synthase
Exemestane,Cytochrome P450 19A1 inhibitor,Cytochrome P450 19A1
Epoprostenol,Prostanoid IP receptor agonist,Prostanoid IP receptor
Donepezil,Acetylcholinesterase inhibitor,Acetylcholinesterase
Clomiphene,Estrogen receptor alpha modulator,Estrogen receptor alpha
Methazolamide,Carbonic anhydrase IV inhibitor,Carbonic anhydrase IV
Vinorelbine Base,Tubulin inhibitor,Tubulin
Alseroxylon,Adrenergic receptor alpha antagonist,Adrenergic receptor alpha
Canakinumab,Interleukin-1 beta inhibitor,Interleukin-1 beta
Aprepitant,Neurokinin 1 receptor antagonist,Neurokinin 1 receptor
Inamrinone,Phosphodiesterase 3A inhibitor,Phosphodiesterase 3A
Terconazole,Cytochrome P450 51 inhibitor,Cytochrome P450 51
Oxiconazole,Cytochrome P450 51 inhibitor,Cytochrome P450 51
Besifloxacin,Topoisomerase IV inhibitor,Topoisomerase IV
Sulfisoxazole,Bacterial dihydropteroate synthase inhibitor,Bacterial dihydropteroate synthase
Penicillin V,Bacterial penicillin-binding protein inhibitor,Bacterial penicillin-binding protein
Nitrofurazone,DNA inhibitor,DNA
Nitrofurantoin,DNA inhibitor,DNA
Dactinomycin,DNA inhibitor,DNA
Tiludronic Acid,ATP inhibitor,ATP
Dronedarone,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Etidocaine,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Efalizumab,Integrin alpha-L/beta-2 (LFA-1) inhibitor,Integrin alpha-L/beta-2 (LFA-1)
Tiopronin,Reducing agent,
Pyrithione,Unknown,
2-Mercaptoethane,Unknown,
Eslicarbazepine Acetate,Sodium channel alpha subunit blocker,Sodium channel alpha subunit
Peramivir,Neuraminidase inhibitor,Neuraminidase
He3235,Androgen Receptor modulator,Androgen Receptor
Cort 108297,Glucocorticoid receptor antagonist,Glucocorticoid receptor
Ilorasertib,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Asp-3026,ALK tyrosine kinase receptor inhibitor,ALK tyrosine kinase receptor
Las101057,Adenosine A2b receptor antagonist,Adenosine A2b receptor
Vantictumab,Frizzled-5 antagonist,Frizzled-5
Abt-107,Neuronal acetylcholine receptor protein alpha-7 subunit agonist,Neuronal acetylcholine receptor protein alpha-7 subunit
Pyrotinib,Epidermal growth factor receptor erbB1 inhibitor,Epidermal growth factor receptor erbB1
Lonaprisan,Progesterone receptor antagonist,Progesterone receptor
Selumetinib,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,Dual specificity mitogen-activated protein kinase kinase 2
Refametinib,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,Dual specificity mitogen-activated protein kinase kinase 2
Bms-911543,Tyrosine-protein kinase JAK2 inhibitor,Tyrosine-protein kinase JAK2
Enmd-2076,Fibroblast growth factor receptor 3 inhibitor,Fibroblast growth factor receptor 3
Riviciclib,Cyclin-dependent kinase 9 inhibitor,Cyclin-dependent kinase 9
Tamatinib,Tyrosine-protein kinase SYK inhibitor,Tyrosine-protein kinase SYK
Vx-702,MAP kinase p38 alpha inhibitor,MAP kinase p38 alpha
Mk-0893,Glucagon receptor antagonist,Glucagon receptor
Vidupiprant,G protein-coupled receptor 44 antagonist,G protein-coupled receptor 44
Asm-024,Muscarinic acetylcholine receptor M3 antagonist,Muscarinic acetylcholine receptor M3
Etazolate,GABA receptor beta-3 subunit positive allosteric modulator,GABA receptor beta-3 subunit
Droloxifene,Estrogen receptor modulator,Estrogen receptor
Saracatinib,Tyrosine-protein kinase SRC inhibitor,Tyrosine-protein kinase SRC
Brivanib Alaninate,Fibroblast growth factor receptor inhibitor,Fibroblast growth factor receptor
Dovitinib,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
Sarizotan,Dopamine D2 receptor partial agonist,Dopamine D2 receptor
Iti-007,Serotonin 2a (5-HT2a) receptor antagonist,Serotonin 2a (5-HT2a) receptor
Bevacizumab 111in,Vascular endothelial growth factor A binding agent,Vascular endothelial growth factor A
Tosedostat,Aminopeptidases inhibitor,Aminopeptidase
Tofogliflozin,Sodium/glucose cotransporter 2 inhibitor,Sodium/glucose cotransporter 2
Conbercept,Vascular endothelial growth factor B inhibitor,Vascular endothelial growth factor B
Glembatumumab Vedotin,Transmembrane glycoprotein NMB binding agent,Transmembrane glycoprotein NMB
Pateclizumab,TNF-beta inhibitor,TNF-beta
Pf-04236921,Interleukin-6 inhibitor,Interleukin-6
Cetyl Alcohol,Unknown,
Cp-459632,Vascular endothelial growth factor receptor inhibitor,Vascular endothelial growth factor receptor
